| S |
| S Motta |
- |
Proposal of Immunotolerance Induction in Haemophiliacs A with Inhibitors Undergoing to Pressing Elective Surgery by Using FVIII/vWF-enriched Pure Plasmaderivates |
| S Linari |
- |
Pegylated Interferon and Ribavirin Anti-hepatitis C Therapy in Patients with Hemophilia Is as Effective and Safe as in Non-hemophilic Patients |
| S Zeinali |
- |
National Program for Prevention of Hemophilia in Iran |
| S Zeinali |
- |
Genotyping of Hemophilia B in Iran by SSCP and Sequencing |
| SA Oliveira |
- |
Evaluation of Hemostasis Changes in Patients Underwent Coronary Artery Bypass Graft (CABG). The Partial Results in a Brazilian Hospital |
| Saad JA |
- |
Increased Plasma Levels of Lipoprotein(a) Correlate with Severity of Angiographically Defined Coronary Artery Disease |
| Saat R |
- |
A Heterodimeric Metalloprotease from Vipera Lebetina Venom Induces Human Endothelial Cell Apoptosis |
| Sabater-Leal M |
- |
Effect of F7 Gene Promoter Polymorphisms on Factor VII Antigenic Levels |
| Sabatier F |
- |
Endothelial Microparticle Elevation in Uremia: A New Aspect of Endothelial Dysfunction Related to Uremic Toxins |
| |
- |
Lentiviral Vector-Mediated A20 Gene Transfer to Generate Endothelial (Progenitor) Cells that are Resistant to Inflammatory Stimuli |
| Sabatini F |
- |
Warfarin Therapy in AF Patients: Females Are Still at Risk |
| Sabatino G |
- |
Host-Drug Interaction: The Influence of Small Intestinal Bacterial Overgrowth on Oral Anticoagulant Dose Requirement |
| Sabbà C |
- |
Should Asymptomatic Children with Hereditary Haemorrhagic Telangiectasia (HHT) Be Screened for Vascular Malformations? |
| Saberi F |
- |
Validation of Overt Disseminated Intravascular Coagulation (DIC) Scoring Algorithm Use in Critically Ill Patients: Correlation with Inflammatory Markers and APACHE and SOFA Scores |
| Sabine G |
- |
Aspirin Induces Receptor Shedding in Platelets by TNFaConverting Enzyme (TACE) |
| Sabino AP |
- |
Factor V Leiden: An Important Risk Factor for Venous and Arterial Thrombosis in Brazilian Patients |
| Sabzi A |
- |
Epidemiological Aspects of Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura In Southern Iran (an Experience of 13 years) |
| Sacchi E |
- |
A New Automatic Method to Measure Adamts 13 |
| Sacco R |
- |
Oral Surgery in Patients on Oral Anticoagulant Therapy: A Randomized Comparison of Different INR Targets |
| Sacco M |
- |
Oral Surgery in Patients on Oral Anticoagulant Therapy: A Randomized Comparison of Different INR Targets |
| Sacewicz I |
- |
Downregulation of Angiogenesis by DNAzymes to b1 mRNA Integrin Subunit |
| Sachiko K |
- |
Decreased Contribution of ADP and Thromboxane A2 to Aggregation Induced by Collagen in Platelets from Chediak-Higashi Syndrome Affected Cattle |
| Sachs UJH |
- |
The Junctional Adhesion Molecule-C Promotes Neutrophils Transendothelial Migration in vitro and in vivo |
| Sachs U |
- |
Platelets in Atherothrombosis: Lessons from Mouse Models |
| Sachs UJH |
- |
A Short Tandem Repeat Polymorphism Leads to Differential Expression of the Neonatal Fc Receptor |
| Sadeghian K |
- |
Dental Procedure Using Recombinant Activated Factor VII (Novo Seven) in 22 Patients with Platelet Function Disorder in Iran |
| Sadler JE |
- |
Platelet-VWF Complexes Are Preferred Substrates of ADAMTS13 Under Shear Stress |
| Sadler JE |
- |
Synergistic Effects of Zinc and Calcium Ions on ADAMTS13 Proteolysis of Von Willebrand Factor and FRETS-VWF73 |
| Sadler JE |
- |
von Willebrand Factor: Two Sides of a Coin |
| |
- |
Modeling VWF Catabolism Predicts the Multimer Pattern and Subunit Degradation in VWD Vicenza, Type 1, Type 2A, and Healthy Controls after DDAVP Infusion |
| |
- |
Analysis of Free Thiols During Von Willebrand Factor Biosynthesis: Implications for the Oxidoreductase Mechanism of Multimerization |
| Saeki K |
- |
Novel Function of Histidine-rich Glycoprotein with Cell Differentiation-promoting Activity |
| Saenko EL |
- |
Factor VIIIa Regulates Substrate Delivery to the Intrinsic Factor X-Activating Complex |
| Saenko E |
- |
Identification of Factor VIII Binding Sites for Very Low Density Lipoprotein Receptor |
| Saenko EL |
- |
Two Subpopulations of Activated Platelets Differ in Their Binding of the Components of the Intrinsic fX-Activating Complex |
| Saenko E |
- |
Identification of Coagulation Factor VIII A2 Domain Residues Forming the Binding Epitope for Low-Density Lipoprotein Receptor-Related Protein |
| |
- |
Identification of Regions in Low-Density Lipoprotein Receptor-Related Protein Responsible for Interaction with A2 and A1/A3-C1-C2 Portions of Coagulation Factor VIII |
| |
- |
The A2 Domain of Coagulation Factor VIII Shares Residues Critical for Interaction with Three Members of LDL Receptor Superfamily LRP, VLDL and Megalin Receptors |
| Saenko E |
- |
Receptor-mediated Catabolism and Clearance of Factor VIII |
| Saenz DA |
- |
Comparative Effects of Nitroxil (HNO) and NO on Platelet Function and Tyrosine Phosphorilation Pattern of Activated Human Platelets |
| Sáez CG |
- |
Activated Human Platelets Synthesize Functional Tissue Factor |
| |
- |
Circulating Platelet-Derived Microparticles in Systemic Lupus Erythematosus: Association with Increased Thrombin Generation and Procoagulant State |
| Safa O |
- |
Investigation of Performance and Sample Interferences for a New Automated Protein S Functional Activity Assay (HemosIL ProS) |
| Safa O |
- |
HemosIL ThromboPath: A Chromogenic Assay Sensitive to Major Prothrombotic Risk Factors Affecting the Protein C Pathway |
| Safadi FF |
- |
A Synthetic Peptide Derived From Thrombospondin-1 (TSP1) Type 3 Repeats Modulates Angiogenesis and the Disease Course in an Animal Model of Rheumatoid Arthritis (RA) by Down-Regulating Connective Tissue Growth Factor (CTGF) Expression |
| Sage SO |
- |
TRPC Associations in Human Platelets |
| Sage SO |
- |
A Role for Calpain in Store-Operated Calcium Entry in Human Platelets |
| |
- |
Calcineurin and Protein Kinase C Reciprocally Regulate PAR-1 Dependent Ca2+ Release In Human Platelets |
| Saggau W |
- |
Monitoring of Heparinization during Extracorporeal Circulation (ECC) with the New Anti-Factor Xa (FXa) Point-of-Care (POC) Clotting Assay Heptest-POC-Hi |
| Sahni A |
- |
Potentiation of Endothelial Nitric Oxide Synthase By Fibrinogen-bound IL-1b Requires aVb3 |
| Sahni SK |
- |
Potentiation of Endothelial Nitric Oxide Synthase By Fibrinogen-bound IL-1b Requires aVb3 |
| Sahud MA |
- |
ELISA for Detecting Immune Responses to Factor VIII |
| Sahud M |
- |
Characterization of Factor VIII Autoantibodies with Complex Reaction Kinetics is Improved by Heat Inactivation of the Test Plasma to Remove Residual Factor Activity |
| Sahun M |
- |
Study of the Prethrombotic State in Patients at High Risk of Developing Type 2 Diabetes Mellitus |
| Saint-Remy JM |
- |
Antigen Binding Site Glycosylation Determines the Anticoagulant Activity of a Type II Factor VIII Antibody without Modifying Affinity or Epitope Specificity |
| Saint-Remy J-M |
- |
Anti-idiotypic Monoclonal Antibodies (Anti-Id mabs) Neutralizing Anti-FVIII Antibodies (abs) Directed Towards Heavy and Light Chains Fully Protect FVIII Function |
| Saint-Remy JM |
- |
IgE Mediated Anaphylaxis to Factor VIII |
| Sainz IM |
- |
A Monoclonal Antibody to High Molecular Weight Kininogen Reduces Inflammation in the HLA-B27 Transgenic Rat Model of Inflammatory Bowel Disease and Arthritis |
| Sainz I |
- |
The Antithrombotic Activity of Kininogen is Mediated by Inhibitory Effects of Domain 3 on Thrombin-Induced Platelet Activation, In Vivo |
| Saitgareeva L |
- |
Study of Spontaneous Production of Cytokines in Patients with Depression of Haemopoiesis During High Mountainous Adaptation. |
| Saito H |
- |
In vitro Characterization of Two Missense Mutations Associated with Quantitative Protein S Deficiency |
| Saito J |
- |
Nattokinase and Vitamin K2 Production Using Sake Cake, in Particular Distilled Cake, as the Fermented Material |
| Saito H |
- |
Factor VIII Mimetic Antibody: (2) In Vitro Assessment of Cofactor Activity in Hemophilia A |
| Saito H |
- |
Factor VIII Mimetic Antibody: (1) Establishment and Characterization of Anti-factor IX/Anti-factor X Bispecific Antibodies |
| Saito T |
- |
Diverging Signaling Events Control the Pathway of GPVI Down-Regulation in vivo |
| Saito H |
- |
In vitro Characterization of Increased Factor V 1 Form by Factor V R2 Haplotype |
| |
- |
Targeted Disruption of Mouse Ortholog of the Human MYH9 Responsible for Macrothrombocytopenia with Different Organ Involvement: Hematological, Nephrological, and Otological Studies of Heterozygous KO Mice |
| Saito T |
- |
Pharmacological Properties of YM-254890, a Specific Gaq/11 Inhibitor, on Thrombosis and Neointima Formation in Mice |
| Sakai Y |
- |
Determination of IgM Phosphatidylserine Dependent Antiprothrombin Antibodies Improves the Diagnostic Yield of Antiphospholipid Syndrome |
| Sakamoto T |
- |
Elevated Platelet Delivered Microparticles and Lesion Morphology in Acute Coronary Syndrome |
| Sakara H |
- |
Coagulation Defects in Thai Adolescents with Menorrhagia |
| Sakata Y |
- |
Intervention of Plasminogen Activator Inhibitor-1 in Nasal Allergy |
| |
- |
Aspirin Resistance Detected with Aggregometry Can Not Be Explained by Failure to Suppress Cyclooxygenase Activity: Possible Involvement of Other Signaling Pathway(s) in Cardiovascular Events of Aspirin-treated Patients |
| |
- |
Phenotype Correction of Hemophilia a Mice with Adeno-associated Virus (AAV) Vectors Carrying the B domain Deleted Canine Factor VIII Gene |
| |
- |
Phenotype Correction of Hemophilia A Mice with Adeno-associated Virus (AAV) Vectors Carrying the B domain Deleted Canine Factor VIII Gene |
| Saker K |
- |
Venous Thromboembolism and Spinal Surgery |
| Sako D |
- |
The Activity of GPG-290, An Antagonist of vWF-mediated Platelet Capture, Can Be Rapidly Monitored Using the PFA-100 Assay |
| |
- |
Prevention of Canine Coronary Artery Thrombosis by the von Willebrand Factor Antagonist, GPG290 |
| Sakon M |
- |
Pulmonary Thromboembolism in Cancer Patients Autopsied in a Japanese General Hospital |
| Sakrana M |
- |
Soluble P-Selectin Levels in Diabetes Mellitus Patients with Coronary Artery Disease |
| Sakthivel MSM |
- |
Ristocetin Cofactor (VWF:Rco) Assay A Comparison of a Rapid Automated Method on ACL10000 Coagulometer and Conventional Aggregometry |
| Sakthivel MSM |
- |
Data From APTT Clot Curves of Automated Photo-Optical Coagulometers Correlates Better with Heterogeneity of Clinical Presentation in Severe Hemophilia A than FVIII: C Levels |
| Sakundarno AM |
- |
Coagulation Disorders in Severe leptospirosis in Indonesia |
| Sakurai G |
- |
A Novel Molecular Marker of Soluble Fibrin Monomer-Fibrinogen Complex Is Quite Valuable for Diffrential Diagnosis of Septic Pneumonia and Simple Pneumonia |
| |
- |
Development of a Latex Agglutination Test for the Measurement of Elastase-Digests of Fibrin in Plasma and Its Application to Clinical Samples |
| Sakurai Y |
- |
Factor VIII Mimetic Antibody: (2) In Vitro Assessment of Cofactor Activity in Hemophilia A |
| |
- |
Adenovirus-Mediated Transfer of Human Placental Ecto-Nucleoside Triphosphate Diphosphohydrolase to Vascular Smooth Muscle Cells Suppresses Platelet Aggregation in vitro and Arterial Thrombus Formation in vivo |
| Sakurai G |
- |
Clinical Importance of Measurement of Soluble Fibrin Monomer-Fibrinogen Complex in Patients with Disseminated Intravascular Coagulation Syndrome and Hypercoagulable State |
| Sala M |
- |
HGF Activates Its Met Receptor on Human Platelets and Inhibits Platelets Aggregation |
| Saladin-Théron C |
- |
Influence of 10 Polymorphisms Located in Genes Coding for Factors Involved in Coagulation and Fibrinolysis on the Risk of Venous Thrombosis in Factor V Leiden Homozygotes: Study of 233 Subjects |
| Salaj P |
- |
Syndrome Kasabach-Merritt and Severe Postoperative Bleeding |
| |
- |
Project HemIS (Haemophilia Information System): Multicentric Information System of Patients with Haemophilia |
| |
- |
A Multicentre Study on 50 Cases with Thrombotic Thrombocytopenic Purpura in the Czech Republic: Recurrent Mutation in ADAMTS13 Gene as a Cause of a Hereditary Thrombotic Thrombocytopenic Purpura |
| Salama A |
- |
A Concept for Preoperative Management of Patients with Impaired Primary Hemostasis |
| |
- |
A Concept for Preoperative Identification of Patients with Impaired Primary Hemostasis |
| Salazar D |
- |
Effect of Ketoconazole on the Pharmacokinetics and Pharmacodynamics of CS-747 (Prasugrel, LY640315) and Clopidogrel in Healthy Subjects |
| Salazar-Páramo M |
- |
Circulating oxLDL/b2GPI Complexes, Autoantibodies and Intima-media Thickness in Patients with Systemic Lupus Erythematosus: Possible Role in Autoimmune-mediated Atherosclerosis |
| Salerno F |
- |
Evidence of Normal Thrombin Generation in Cirrhosis Despite Abnormal Conventional Coagulation Tests |
| Sales M |
- |
Management Study with the New HemosIL D-Dimer HS For Exclusion of Venous Thromboembolism (VTE) |
| Sales M |
- |
Clinical Management Study of Venous Thromboembolism (VTE) Using the HemosIL D-Dimer |
| |
- |
Analytical Performance of the New HemosIL D-Dimer HS Assay That Overcomes the Rheumatoid Factor (RF) Interference |
| Sales M |
- |
Clinical Evaluation of Thromboembolic Samples with the New HemosIL D-Dimer HS and the HemosIL D-Dimer Assays on the ACL TOP |
| Säll T |
- |
Large Deletions Explain Protein S Deficiency in Many Cases Where Previous Mutation Detection Has Failed |
| |
- |
The Haplotype Structure of the von Willebrand Factor (VWF) Gene Promoter Indicates Balancing Selection |
| Sallai K |
- |
Modeling VWF Catabolism Predicts the Multimer Pattern and Subunit Degradation in VWD Vicenza, Type 1, Type 2A, and Healthy Controls after DDAVP Infusion |
| Salle JL |
- |
Antiphospholipid Syndrome Secondary to Renal Cell Carcinoma in a Twelve year Old Boy |
| Salles I |
- |
Development of a High-throughput ELISA Assay to Study Platelet Function |
| Salmela B |
- |
Different Monitoring Methods for in Vitro and in Vivo Lepirudin, a Direct Thrombin Inhibitor: Diluted Thrombin Time (dTT), Activated Partial Thromboplastin Time (aPTT) and Ecarin Clotting Time (ECT) |
| Salmela KT |
- |
Generation of Activated Protein C and Phagocyte Activation Associated with Immmunosuppression Using Anti-Thymocyte Globulin for Kidney Transplantation |
| Salmistraro G |
- |
Is There a Role of Thrombophilia in the Progression of Carotid Plaques and/or in the Onset of Cerebrovascular Ischemic Events in Asymptomatic Patients? Results of a Prospective Study (CAST Study) |
| |
- |
Different Thromboprophylaxis Approaches in Patients Undergoing Knee Arthroscopy (KANT Study): A Prospective Randomized Study |
| Salmon J |
- |
A Monoclonal Anti-C5 Antibody Reverses Antiphospholipid Antibody-mediated Thrombosis |
| Salomaa V |
- |
MORGAM An International Pooling of Cardiovascular Cohorts to Investigate Risk Profiles of Arterial Thrombosis |
| Salomon O |
- |
Identification and Characterization of 10 Novel Mutations Causing Factor XI Deficiency |
| |
- |
Mechanisms of Thrombin Generation Induced by High Concentrations of Recombinant Factor VIIa |
| Salsmann A |
- |
Increased outside-in Signaling and Adhesive Functions under Shear Conditions of Cells Expressing the aIIbb3T562N Integrin |
| Salsmann A |
- |
A New Functional Role of the Fibrinogen RGD Motif as the Molecular Switch that Selectively Triggers Integrin aIIbb3-Dependent Cell Spreading, but not Cell Attachment |
| Salucci V |
- |
Endothelial Protein C Receptor Is Expressed by CD83+ Dendritic Cells in the Human Gut Mucosa and Is Down-Regulated by Bacterial Antigens on Monocyte-Derived Dendritic Cells |
| Salvadori M |
- |
High Risk of Recurrence in Renal Transplant Recipients after a First Episode of Venous Thromboembolism |
| Salvati A |
- |
Cerebral Sinovenous Thrombosis during L-Asparaginase Treatment |
| Salvetti A |
- |
Adrenergic and Cholinergic Regulation of Local t-PA Release in Human Vasculature |
| Salvi R |
- |
Duration of Anticoagulant Treatment and Recurrence of Venous Thromboembolism in Patients with and without Thrombophilia |
| Salvia M |
- |
Assessment of Protein S on Hepatopaths at the Last Stage |
| |
- |
Assessment of the Thrombophilic Risk in Women Candidates to Hormone Replacement Therapy |
| |
- |
Idiopathic Acquired Haemophilia: Two Case Reports with Different Severity of Clinical Manifestation, Both in Rapid Disappearing with Non-Aggressive Immunotherapy |
| Salviato R |
- |
Gene Mutation and ITT Response in the Italian Cohort of Patients with Haemophilia A |
| Salzer U |
- |
Diagnosis of Central Venous Line-Related Thrombotic Events in the Upper Venous System in Children: Combination of Venography, Venous Ultrasound, and Echocardiography |
| Samad F |
- |
Expression, Regulation and Functional Significance of KC Chemokine During Adipose Development and Obesity |
| |
- |
Auto-Amplification of TNF-Alpha: A Potential Mechanism for the Maintenance of Elevated TNF-Alpha in Male But Not Female Obese Mice |
| Samama MM |
- |
Retrospective Study of 41 Patients Homozygous for the Prothrombin G20210A Mutation |
| Samama MM |
- |
Effect Of BAY 59-7939 A Novel, Oral, Direct Factor Xa Inhibitor on Clot-Bound Factor Xa Activity in vitro |
| |
- |
Pregnancy-associated Venous Thrombosis (VTE) in Women with Hereditary Heterozygous Factor V Leiden or Factor II 20210A Gene Mutation or Both |
| |
- |
Pregnancy-Associated Venous Thrombosis (VTE) in Women with Hereditary Heterozygous Factor V Leiden or Factor II 20210A Gene Mutation or Both |
| Samama MM |
- |
Risk of Venous Thromboembolism (VTE) Related to first Pregnancy in At-Deficient Women. One-Center Study of 43 Pregnant Women without Prophylaxis |
| Samama M |
- |
Identification and Characterization of 10 Novel Mutations Causing Factor XI Deficiency |
| Samama ChM |
- |
Symptomatic Venous Thromboembolism and Mortality after Hip Fracture Surgery: The ESCORTE Study |
| Samama MM |
- |
A Mutation in Vitamin K Epoxide Reductase Complex Subunit-1 (VKORC1) in a Patient with Vitamin K Antagonist Resistance |
| Samama MM |
- |
Atypical Mutations of the Prothrombin Gene Located at 20209, 20218 and 20219 Position: A Report of 10 Patients with Venous Thromboembolism History |
| Samama MM |
- |
Influence of Fondaparinux on INR Expression in Patients Receiving Oral Vitamin K Antagonists |
| Samama MM |
- |
Use Of F1+2 and TAT as Markers of Prothrombinase Activity in Hemophiliacs |
| Samama M-M |
- |
The Oral, Direct Factor Xa Inhibitor BAY 59-7939 Inhibits Thrombin Generation in vitro after Tissue Factor Pathway Activation |
| Samama CM |
- |
Anti-fibrinolytic Use in Major Orthopaedic Surgery Reduces Allogeneic Blood Transfusion. A Meta-analysis of Randomised Trials |
| Samani NJ |
- |
Increased Levels of Procoagulant Factors Associated with Increased Potential for Thrombin Generation in Patients with Premature Myocardial Infarction |
| Samarasinghe I |
- |
Comparison of Four D-Dimer Tests Combined with Clinical Probability Assessment to Exclude Deep Venous Thrombosis in Symptomatic Outpatients |
| Samel M |
- |
Snake Venom Apoptotic L-Amino Acid Oxidase (LAAO) Inhibits Platelet Aggregation |
| Samis JA |
- |
Inactivation of Factor V during Sepsis-Induced Disseminated Intravascular Coagulation: Reconciliation of Total Factor V Activity with Its Cleavage and Inactivation as Assessed by SDS-PAGE and Immunoblotting |
| |
- |
The Mechanism of Alpha-1-Protease Inhibitor Inactivation During Sepsis-Induced Disseminated Intravascular Coagulation |
| Samko A |
- |
Matrix Metalloproteinases and Markers of Thrombin Generation in Patients with Restenosis after Percutaneous Coronary Interventions |
| Sampietro F |
- |
Association of High Lipoprotein(a) and Fibrinogen Levels Predicts Coronary Heart Disease and Cerebro-vascular Mortality in an Elderly (>=65 years) Northern Italian Population |
| Sampol J |
- |
Endothelial Microparticle Elevation in Uremia: A New Aspect of Endothelial Dysfunction Related to Uremic Toxins |
| |
- |
Circulating Endothelial Cell Count as a Diagnostic Marker for Non-ST Elevation Acute Coronary Syndromes |
| Samson A |
- |
t-PA Enhances NMDA-Induced Changes in Free Intracellular Calcium in Individual Neurons |
| San Juan J |
- |
Catastrophic Antiphospholipid Syndrome and Kikuchi-Fujimoto Disease: The First Case Reported |
| Sanak M |
- |
Venous Thromboembolism, Arterial Thrombosis and Plasma Homocysteine Levels in Families with Inherited Thrombophilia |
| |
- |
Aspirin Resistance |
| |
- |
Anti-thrombotic Action of Clopidogrel is More Pronounced in Patients with Coronary Artery Disease Carrying PlA2 Allele of Beta3 Integrin |
| |
- |
Complementary Antithrombotic Effects of Aspirin and Clopidogrel Based on PlA1/A2 Glycoprotein IIIa Polymorphism |
| |
- |
Prediction of the Excessive Perioperative Bleeding in Patients Undergoing Coronary Artery Bypass Grafting: Role of Aspirin and Platelet Glycoprotein IIIa Polymorphism |
| Sanchez O |
- |
Derivation and Validation of a Simple Standardized Clinical Score to Predict Pulmonary Embolism in Emergency Patients: The Revised Geneva Score |
| Sanchez J |
- |
Nitric Oxide Enhances Eosinophil and Basophil Degranulation without Affecting Contact and Complement Activation |
| Sanchez O |
- |
Multi-detector Row Computed Tomography in Outpatients with Suspected Pulmonary Embolism |
| Sánchez T |
- |
Management Study with the New HemosIL D-Dimer HS For Exclusion of Venous Thromboembolism (VTE) |
| Sanchez J |
- |
Heparinization of the Pancreatic Islet Surface as a Mean to Reduce Harmful Blood Clotting after Intraportal Islet Transplantation |
| Sanchez Luceros A |
- |
Anti Factor VIII Inhibitor: A Single Institution Experience |
| |
- |
Determination of ADAMTS-13 Activity in 13 Patients with Ischemic Stroke |
| Sanchez-Luceros A |
- |
Oral Anticoagulation in Patients over 80 Years with Atrial Fibrillation |
| |
- |
Hyperhomocysteinemia, Anticardiolipin Antibodies, and Risk for Vascular Access Thrombosis in Hemodialysis Patients |
| Sandbæk G |
- |
Markers of Vascular Inflammation Are Associated with the Degree of Atherosclerosis Assessed as Angiographic Score and Treadmill Walking Distance in Patients with Peripheral Arterial Occlusive Disease |
| Sandra R |
- |
Selective Thrombosis of Tumor Vasculature by RGD-directed Delivery of Truncated Tissue Factor (tTF) |
| Sandset PM |
- |
17b-Estradiol Lowers Production of Tissue Factor Pathway Inhibitor (TFPI) in HUVEC Cells |
| |
- |
A Fast Track Strategy for Managing Suspected Pulmonary Embolism (PE) in Outpatients |
| Sandset PM |
- |
Dose-Dependent And Differential Effects of Two Doses of Continuous Combined Hormone Replacement Therapy (HRT), Tibolone And Raloxifene on Markers of Coagulation Activation |
| |
- |
Decreased Anticoagulant Response to Recombinant Tissue Factor Pathway Inhibitor (TFPI) in Pooled Normal Plasma with IgG Fractions from Patients with Lupus Anticoagulant is Associated with Increased Thrombin Generation |
| Sandvik L |
- |
Dose-Dependent And Differential Effects of Two Doses of Continuous Combined Hormone Replacement Therapy (HRT), Tibolone And Raloxifene on Markers of Coagulation Activation |
| Sane CD |
- |
Engineering of a Recombinant Vitamin K-Dependent Gamma-Carboxylation System with Enhanced Gamma-Carboxyglutamic Acid (Gla) Forming Capacity. Evidence for a Functional CXXC RedOx Center in the System |
| Sanei-Moghaddam E |
- |
High Sensitivity of Monochloroacetic Acid 1% Clot Lysis Test for Diagnosis of Severe FXIII Deficiency |
| Sangle S |
- |
Perinatal or Fetal Thrombosis in Babies Allowing Detection of the Anti-phospholipid Syndrome in Mothers |
| Sango V |
- |
Homocysteine Levels and MTHFR C677T Genotypes in Patients with Myocardial Infarction under Age 45 years |
| Sanguigni S |
- |
Thrombus Growth Is Mediated by Gp91phox |
| Sanmarco M |
- |
Anti-Protein S and Anti-Phosphatidylethanolamine (aPE) Antibodies in Patients with Clinical Features of Antiphospholipid Syndrome (APS) |
| Sansilvestri-Morel P |
- |
Silencing of Plasminogen Activator Inhibitor-1 by Small Interfering RNA Increases the Expression of Tissue Plasminogen Activator |
| Santacroce R |
- |
Successful Diagnosis in Pregnant Obligate Carriers of Hemophilia a of Fetal Sex Using Conventional Pcr Analysis of Maternal Plasma |
| Santagostino E |
- |
High Success Rate of Immune Tolerance Induction with Recombinant Factor VIII (rFVIII) in High-responders with Intron 22 Inversions (int22inv) in the F8 Gene |
| Santagostino E |
- |
Pharmacokinetics, Efficacy and Safety of Solvent/Detergent (S/D) Treated Plasma in Patients with Rare Inherited Coagulation Disorders (RICDs) |
| Santagostino E |
- |
Immunotolerance Induction (ITI) with High Purity FVIII/VWF Concentrates in Inhibitors Patients with a High Risk of a Poor Response to ITI: A Prospective Surveillance |
| Santagostino E |
- |
Prophylaxis with Factor VIII Protects Children with Hemophilia a from Inhibitor Development |
| Santamaría A |
- |
Effect of F7 Gene Promoter Polymorphisms on Factor VII Antigenic Levels |
| SantamaríaAlmasy AL |
- |
A Quantitative Trait Locus on Chromosome 12q14.1 Influences Plasminogen Levels in the San Antonio Heart Family Study (SAFHS) |
| Santamaria R |
- |
Favorable Outcome in the Pregnancy behind Treatment with Heparin in Women with Mutation of Methylenetetrahydrofolate Reductase (MTHFR) Gene and Fetal Loss Previous |
| Santiago FS |
- |
Injury-Inducible Yin Yang-1 Inhibits Vascular Smooth Muscle Cell Growth and Intimal Thickening by Repressing p21WAF1/Cip1 Transcription and Perturbing Cyclin D1-Cdk4-p21WAF1/Cip1 Assembly |
| Santiago FS |
- |
Hydrogen Peroxide Activation of Platelet-Derived Growth Factor D-chain Transcription Is Mediated by the Winged Helix-Turn-Helix Protein Ets-1 and its Interplay with Sp1 |
| Santilli F |
- |
Insulin Resistance and Platelet Activation in Obese Women |
| Santomaso AC |
- |
Von Willebrand Factor-Mediated Platelet Adhesion in Flowing Blood is Influenced by Hematocrit |
| Santoro A |
- |
Risk Factors for CVC-Associated Thrombosis in Cancer Patients: Analysis of the ETHIC Study |
| Santoro N |
- |
Cerebral Sinovenous Thrombosis during L-Asparaginase Treatment |
| Santoro R |
- |
Factor VIII Inhibitor in a Patient with Mild Haemophilia A |
| |
- |
Fibrinogen Storage Disease with Hypofibrinogenaemia |
| Santoro C |
- |
Different Reactivity of Factor VIII Inhibitor in Congenital and Acquired Haemophilia A |
| Santoro N |
- |
Hemostatic Alterations in Pediatric Leukemias |
| Santoso S |
- |
A Naturally Occurring Leu33Val Mutation In Beta3 Integrin Impairs the HPA-1a Epitope and Receptor Function: The Third Allele of HPA-1 |
| |
- |
The Junctional Adhesion Molecule-C Promotes Neutrophils Transendothelial Migration in vitro and in vivo |
| |
- |
A Short Tandem Repeat Polymorphism Leads to Differential Expression of the Neonatal Fc Receptor |
| Santoso S |
- |
Antibodies Against the Human Platel et al. loantigen (HPA)-1a impair Cell Adhesion to Fibrinogen |
| Saour J |
- |
Prevalence of FVL, Prothrombin G20210A and MTHFR C667T in Saudi Arabia: A preliminary report for the Saudi Thrombosis and Familial Thrombophelia (S-TAFT) Registry |
| Saracco P |
- |
Hemostatic Alterations in Pediatric Leukemias |
| Saracini C |
- |
Managed Hemostasis Point-Of-Care Testing in a Large Hospital: A Three-Year Experience and the Assessment of Clotting Tests |
| |
- |
C677T and A1298C MTHFR, A2756G MTR and 844ins68 CBS Gene Polymorphisms in Atrial Fibrillation |
| Sarafanov A |
- |
Identification of Coagulation Factor VIII A2 Domain Residues Forming the Binding Epitope for Low-Density Lipoprotein Receptor-Related Protein |
| Sarafanov A |
- |
The A2 Domain of Coagulation Factor VIII Shares Residues Critical for Interaction with Three Members of LDL Receptor Superfamily LRP, VLDL and Megalin Receptors |
| Sarafanov A |
- |
Identification of Regions in Low-Density Lipoprotein Receptor-Related Protein Responsible for Interaction with A2 and A1/A3-C1-C2 Portions of Coagulation Factor VIII |
| Saranya R |
- |
Coagulation Defects in Thai Adolescents with Menorrhagia |
| Sarawate C |
- |
Monitoring International Normalized Ratio (INR) in Patients with Chronic Non-Valvular Atrial Fibrillation: Relationships between INR and Adverse Outcomes? |
| Sardini A |
- |
Reduced Expression of ABCA1 and A Novel Missense Mutation That Results in Altered Protein Trafficking Underlie Scott Syndrome |
| Sardjono CT |
- |
The Palmitolyated Cysteine 595 Residue of PECAM-1 Is Required for Constitutive Association of PECAM-1 into Membrane Microdomains |
| Sari I |
- |
Thrombosis in Cancer Patients |
| Sarif J |
- |
Rebound after Discontinuation of Long-term Oral Anticoagulation (OAC): Effects of a 4 week Course of LMWH on VTE Recurrences |
| Sarig G |
- |
Endothelial Protein C Receptor (EPCR) Gene Polymorphisms and sEPCR Levels in Women with Recurrent Pregnancy Loss |
| |
- |
ProC Global Assay in the Evaluation of Women at Risk for VTE While Using Hormonal Therapy |
| Sarigiannis Y |
- |
Linear and Cyclic RGD Peptides Containing Salicylic Acid Derivatives and Their Antiplatelet Activity In Vitro |
| Sarin E |
- |
Diagnosing and Treating Haemorrhagic Disorders in a Developing Country |
| Sarkar S |
- |
Differential Translocation of Syk, Akt, and Endothelial Nitric Oxide Synthase (eNOS) in Stimulated Platelets |
| Sarkar R |
- |
The Impact of Acquired Thrombophilia on Maternal and Fetal Wellbeing in a Low-risk Population |
| |
- |
Non-Viral Gene Delivery for Treatment of Haemophilia a in Mice: Assessment of Low Factor VIII Levels Using a Fluorogenic Thrombin Generation Test (FTGT) |
| Sarker KP |
- |
Endocannabinoid Anandamide Induces High Mobility Group Box 1 (HMGB1) Protein Release in Monocytes and Macrophages |
| Sarno M |
- |
Successful Diagnosis in Pregnant Obligate Carriers of Hemophilia a of Fetal Sex Using Conventional Pcr Analysis of Maternal Plasma |
| Sarode R |
- |
Lack of Correlation between OD Value of Elisa and Clinical Thrombosis in Patients with Heparin Induced Thrombocytopenia (HIT) |
| |
- |
Strong Lupus Anticoagulant (LA) Appears to Interfere with Activated Protein C Resistance Assay (APCR) |
| Sarrami R |
- |
Carrier Detection and Prenatal Diagnosis of Two Short Tandem Repeats within Factor VIII Gene in Iranian Population |
| Sartor D |
- |
Vein Abnormalities and the Post-Thrombotic Syndrome. A Prospective Study |
| Sartor RB |
- |
High Molecular Weight Kininogen (HK) Fragments Stimulate the Secretion of Interleukin 1b (IL-1b) through CD11b/CD18 (Mac-1) in Human Blood Mononuclear Cells |
| |
- |
The Antithrombotic Activity of Kininogen is Mediated by Inhibitory Effects of Domain 3 on Thrombin-Induced Platelet Activation, In Vivo |
| Sartor D |
- |
Sudden Versus Gradual Discontinuation of Oral Anticoagulation in Patients with Acute Venous Thromboembolism. A Randomized Study |
| Sartorello F |
- |
FV Leiden Mitigates Bleeding Tendency in Recessive Type 1 von Willebrand Disease |
| |
- |
How von Willebrand Factor Survival Contributes to Determining von Willebrand Disease Phenotype |
| Sartori MT |
- |
High Prevalence of Cardiac Abnormalities in Patients with Congenital FV Deficiency |
| |
- |
Oral Contraceptives in the Management of Rare Coagulation Bleeding Disorders |
| |
- |
Venous Thrombosis in Women on Oral Contraceptives: A Study of 201 Cases |
| Sartori R |
- |
Acute Myocardial Infarction in Haemophillia A or B Patients: A Cardiological Evaluation of 44 Reported Cases |
| Sartori MT |
- |
Mutations in Homozygotes and Compound Heterozygotes with FXII Deficiency |
| Sartori MT |
- |
Cerebral Venous Thrombosis: The Padua Experience |
| Sasamata M |
- |
Evaluation of GPIIb/IIIa Antagonist YM128 Using Monkeys with Photochemically-Induced Middle Cerebral Artery Occlusions |
| Sassanee H |
- |
Vitamin K Status in Mothers and Their Newborn Babies: Role of Dietary Phylloquinone Intake |
| Sastry P |
- |
Utility of a Whole-Blood Single-Platelet Counting Assay in Monitoring the Effects of Tirofiban |
| Satler LF |
- |
Transendocardial Autologous Bone Marrow Cell Transplantation in Patients with Advanced Ischemic Heart Disease A Multi-Center Feasibility Study |
| Sato Y |
- |
Transcriptome of Vascular Endothelium in Angiogenesis: Isolation and Characterization of a Novel Endothelium-Derived Angiogenesis Inhibitor, Vasohibin |
| Satoh K |
- |
Signaling Mediated by Glycoprotein Ib-IX-V/VWF Interaction Mainly Takes Place in GEMs In Human Platelets |
| Satoh K |
- |
Development of ADP-coated Bead Columns for Ticlopidine Monitoring |
| Satoh Y |
- |
Thrombomodulin Inhibits Tumor Cell Invasion Through Three Different Domains of the Molecule |
| Satoshi G |
- |
A Multicenter, Prospective Validation of Disseminated Intravascular Coagulation Diagnostic Criteria for Critically Ill Patients: Comparing Current Criteria |
| Satoshi O |
- |
Diagnosis of Deep Vein Thrombosis by Soluble Fibrin or D-dimer |
| Satta N |
- |
The Activation of Mouse Fibroblasts by Antiphospholipid Antibodies Requires TLR2 |
| Satta N |
- |
Atherosclerosis in LDLR Knock-Out Mice Immunized with b2GP1: Effect of High Cholesterol Diet and Pravastatin Supplementation |
| Sau A |
- |
Determinants of Platelet Activation in Alzheimer's Disease |
| Sauerwein RW |
- |
Malaria Infection Induced Thrombocytopenia Is not Related to Systemic Platelet Activation |
| Sauger A |
- |
Evaluation of a New Manufacturing Process for Therapeutic Fibrinogen |
| |
- |
A Comparison of Two Manufacturing Processes for an Antithrombin Concentrate |
| Saugier-Veber P |
- |
Activated Protein C Resistance and Factor V Arg306Thr Mutation: A Case Report |
| Sauls DL |
- |
Reaction of Fibrinogen with Homocysteine Thiolactone Renders the Resulting Fibrin Clots Resistant to Lysis |
| Saunders RE |
- |
The Factor XI Deficiency Database: An Interactive Web Database of Mutations, Phenotypes and Structural Analysis Tools |
| Saut N |
- |
TAFI Gene Polymorphisms and Plasma TAFI Levels: A Trans-Ethnic Association Study |
| Sautiere K |
- |
Plasma Levels of Tissue Factor and von Willebrand Factor Predict Long Term Clinical Outcome after Percutaneous Coronary Revascularization |
| Savage B |
- |
Modulation of Von Willebrand Factor A1 Domain-Mediated Platelet Aggregation by a-Thrombin |
| Savchuk O |
- |
Influence of Streptokinase on the Fibrinolytic System Components in vivo |
| Saver JL |
- |
Magnesium Sulfate in Doses Up to 8-Fold Greater than Physiologic Concentration does Not Affect TPA-Mediated Clot Lysis: An in vitro Study |
| Savi P |
- |
Mice Lacking Gas6 are Protected from Graft-Versus-Host Disease in the Liver Due to a Reduced Activation of the Endothelium |
| Savi P |
- |
Fgf-Receptor Signalling is Involved in Differentiation and Recruitment of Bone Marrow Progenitor Cells into Endothelial Progenitor Cells |
| Savidge GF |
- |
Successful Immune Tolerance Induction in a High-Responding Factor VIII Inhibitor Hemophilia a Patient Treated with FVIII/VWF Plasma-Derived Concentrate, Fanhdi®. Cost Effectiveness Analysis |
| |
- |
Absence of Exon V Deleted Factor XI mRNA in Homozygous Factor XI Deficiency |
| Savidge G |
- |
Thrombin Generation Assay A Sensitive Tool to Follow the Pharmacokinetics of Factor VIII Replacement Therapy in Haemophilia Patients |
| Savina EI |
- |
Differences in the VWF : Rico/VWF : Ag Ratios among Patients with Venous or Arterial Thromboses |
| Savion N |
- |
Platelets Promote CD4+ Lymphocyte Adhesion to Extracellular Matrix and Fibronectin Under Flow: Role of Integrins, CD40 Ligand and P-Selectin Glycoprotein Ligand-1 |
| Savion N |
- |
Low rate of Responsiveness to Aspirin in Acute Brain Ischemia: Association with Stroke Severity and Clinical Outcome |
| |
- |
High Rate of Unresponsiveness to Clopidogrel in Patients with Acute Coronary Syndrome (ACS) As Determined by the Impact-R [Cone And Plate(let) Analyzer] |
| |
- |
Aspirin Resistance in Acute Brain Ischemia: Association with Stroke Severity and Outcome |
| |
- |
Statins Confer a Direct Anti-Platelet Effect in Patients with Acute Myocardial Infarction Treated with Aspirin and Clopidrogel: Ex-vivo and in-vitro Study Results |
| |
- |
Platelet Mediated Clot Formation in Whole Blood under Flow: A New Screening Method for Coagulation Disorders and for Drug Monitoring |
| Savoia H |
- |
Chromogenic and Clot Based Protein C Assays Contribute to the Management Of Homozygous Protein C Deficient Patients |
| |
- |
Incidence of Major Bleeding in a Large Paediatric Cohort of Patients Requiring Warfarin Therapy |
| |
- |
Multi Modal Management of Purpura Fulminans due to Homozygous Protein C Deficiency |
| Savoia A |
- |
Both Haploinsufficiency and Dominant Negative Effect Are Responsible for Hematological Abnormalities of Patients with  -Related Disease |
| Savushkin AV |
- |
Clotting Time and Fibrinogen Concentration |
| |
- |
Plasma Clot: Kinetics of Permeability and Hydraulic Resistance during Fibrinolysis |
| |
- |
Hydraulic Firmness of Clots and Fibrinogen Concentration |
| Savushkin AV |
- |
Hydraulic Resistance of Fibrin Clot: Influence of Fibrinogen Concentration |
| Savushkin AV |
- |
Fibrin Clot Deformability: Influence of Fibrinogen Concentration |
| |
- |
Changes in Fibrinolysis as a Result of Leakage Through Clot |
| |
- |
Permeability of Fibrin Clots: Influence of Fibrinogen Concentration |
| Sawai RS |
- |
Resuscitation with Lactated Ringers (LR) vs. Normal Saline (NS) Leads to a Hypercoagulable State in an Uncontrolled Hemorrhagic Shock Swine Model |
| Sawai T |
- |
Development of a Latex Agglutination Test for the Measurement of Elastase-Digests of Fibrin in Plasma and Its Application to Clinical Samples |
| Saxena R |
- |
FcgRIIa Platelet Polymorphism in Asian Indians: Its Association with Development of Heparin Induced Thrombocytopenia |
| Saxena K |
- |
Long-Term Clinical Experience with FEIBA VH in Hemophilia Patients with Inhibitors |
| Saxena R |
- |
Gene Conversions Are a Common Cause of von Willebrand Disease |
| Sayad AE |
- |
Combined Deficiency of Factor V and Factor VIII: Compound Heterozygosity For Two Novel Truncating Mutations in ERGIC53/LMAN1 |
| Sayago C |
- |
A Missense Mutation in Exon 28 (C4120T) of the Von Willebrand Factor Gene is the Cause for Von Willebrand Disease in a Large Amish Pedigree |
| Sayer MS |
- |
Protein Z Gene Polymorphisms, Protein Z Concentration and Ischaemic Stroke |
| Sazanova E |
- |
Platelet Function in Patients with Cerebrovascular Pathology in Changes of Geomagnetic Field of Earth |
| Sazonova I |
- |
Proteolysis of Streptokinase during Plasminogen Activation Regulates the Potency and Specificity of Fibrinolysis |
| |
- |
Pro-Fibrinolytic Monoclonal Antibodies That Convert a2-Antiplasmin from a Plasmin Inhibitor to a Substrate |
| SC Nair |
- |
Thirty Novel Mutations in the Factor VIII Gene of Indian Patients with Haemophilia A |
| Scaff M |
- |
Sticky Platelet Syndrome Is a Cause of Cerebral Venous Thrombosis |
| Scalone L |
- |
Quality of Life is Associated to Orthopedic Status in Hemophilic Patients with Inhibitors |
| |
- |
Quality of Life in Hemophilic Patients without Inhibitors: The Coche Study |
| Scalone L |
- |
The Cost of Care of Hemophilic Patients without Inhibitors: The Coche Study |
| |
- |
Differences between Patients, Physicians and Pharmacists Preferences for Treatment Products in Hemophilia. A Discrete Choice Experiment |
| Scamardella F |
- |
Resistance to Activated Proteine C (aPCR) in Subjects Negative for Factor V Leiden (FVL) and Positive for Antiphospholipid Antibodies (APL) |
| Scamardella F |
- |
Different Intracytoplasmatic Pattern of BCL-2 Family Proteins in Lymphocytes from Subjects Positive for Antiphospholipid Antibodies (APL) |
| Scanavini D |
- |
CRM+ Factor V Deficiency Arg2080Cys: A Model to Investigate Altered C2 Domain-Membrane Interaction |
| Scanavini D |
- |
Intragenic and Extragenic Components Modulating Coagulation Factor VIII Levels and the Risk of Venous Thrombosis |
| |
- |
Factor VIII:c Levels in Subjects with the Factor V R2Ppolymorphism |
| Scandellari R |
- |
Prevalence of Helicobater Pylori Infection and Clinical Response to Eradication Therapy in Patients Wwith Immune Thrombocytopenic Purpura (ITP) |
| Scapoli GL |
- |
Common Factor XIII Gene Polymorphisms in Venous Leg Ulcers |
| Scarabin PY |
- |
Interactions between Prothrombotic Mutations and Hormone Therapy in Relation to the Risk of Venous Thromboembolism: Impact of the Route of Estrogen Administration |
| |
- |
The Use of Calibrated Automated Thrombin Generation to Detect Alterations of the Clotting System Brought About by Hormone Administration in Pre- and Postmenopausal Women |
| Scarabin PY |
- |
Hormone Therapy and Venous Thromboembolism among Postmenopausal Women: Impact of the Route of Estrogen Administration and Progestogens |
| Scarabin PY |
- |
The Relation Between in vitro Thrombin Generation and Signs of in vivo Thrombin Generation; Influence of Pro- and Anti-coagulant Plasma Factors |
| Scarrott TJ, Grant PJ |
- |
CCAAT Enhancer Binding Proteins: Co-Regulators of Haemostasis and the Metabolic Syndrome? |
| Schaap NP |
- |
Transfusion of Blood Products in Trauma Patients with Lethal Hemorrhagic Shock |
| Schaap M |
- |
Congenital Deficiency of Factor XIII Caused by Two Missense Mutations in a Dutch Family |
| Schaar J |
- |
Imaging and Plaque Instability |
| Schaeffer P |
- |
Fgf-Receptor Signalling is Involved in Differentiation and Recruitment of Bone Marrow Progenitor Cells into Endothelial Progenitor Cells |
| Schäfer W |
- |
Application of Filtration Technologies for Prion Removal from Plasma Product Intermediates |
| Schafer A |
- |
Fractalkine Mediates Leukocyte Recruitment to Inflammatory Endothelial Cells in Flowing Whole Blood |
| Schafer W |
- |
Nanofiltration Removes Virus Infectivity But Not NAT/PCR Signal for a Wide Range of Viruses |
| |
- |
Efficient Reduction of Prions by the Manufacturing Process of Plasma-Derived Products |
| SchäferWöltje CM |
- |
Enhanced Blood Coagulation and Fibrinolysis in Mice Lacking Histidine-Rich Glycoprotein/HRG |
| Schaffner-Reckinger E |
- |
A New Functional Role of the Fibrinogen RGD Motif as the Molecular Switch that Selectively Triggers Integrin aIIbb3-Dependent Cell Spreading, but not Cell Attachment |
| Schambeck C |
- |
Venous Thromboembolism: Involvement of ADAMDEC1 Polymorphisms in Familially High Factor VIII Levels |
| Scharf RE |
- |
Experimental Hyperhomocysteinemia Has No Significant Effect on Global Hemodynamics or Regional Myocardial Blood Flow |
| |
- |
Modulation of Platelet Adhesion by Antithrombin |
| |
- |
Influence of Gender, Age, and Oral Contraception on Hemostatic Parameters Determined by Rotation Thrombelastography |
| Scharf C |
- |
Proteomics as a Tool for Assessment of Therapeutics in Transfusion Medicine: Evaluation of Prothrombin Complex Concentrates |
| Scharf RE |
- |
The 807C/T Polymorphism in the a-Subunit of Integrin a2b1 Modulates Platelet Adhesion onto Immobilized Collagen Under Arterial Flow Conditions |
| |
- |
Endogenous Myocardial FVIII:C, von Willebrand Factor (vWF) and Fibrinogen Are Independent of Regional Myocardial Blood Flow (RMBF) |
| |
- |
The IVS1-401 T-Allele of the Estrogen Receptor (ER)-a is an Independent Predictor of Late Fetal Loss |
| |
- |
Elevated Prothrombin Fragment F1 + 2 Levels during Pregnancy in Women with Previous Venous Thromboembolism |
| |
- |
Anticoagulation with Danaparoid in Two Pregnant Women with Valve Prosthesis and Heparin-Induced Thrombocytopenia Type II (HIT Typ II) |
| |
- |
New Approach for Evaluation of Quantitative Risk Factors of Venous Thromboembolism Using Individualized Reference Values |
| |
- |
Premature Onset of Fetal Loss Is Associated with the Polymorphism of Platelet Membrane Integrin a2b1 (a2807TT) |
| |
- |
Reeavaluation of 75 Patients with Previous Diagnosis of von Willebrand Disease |
| |
- |
The G20210A Prothrombin Gene Mutation and the Plasminogen Activator Inhibitor (PAI) 5G/5G Genotype Increase the Risk of Premature Onset of Severe Preeclampsia |
| |
- |
Closure Times Determined with a Platelet Function Analyzer are Closely Correlated to the Mean Transvalvular Gradient in Patients with Aortic-Valve Stenosis |
| Scharnagl H |
- |
Lipoprotein Pattern in Patients with Retinal Artery Occlusion or Retinal Vein Occlusion |
| Scharrer I |
- |
Evaluation of Thrombotic Events in Haemophiliacs Undergoing Major Orthopaedic Surgery without Thrombosis Prophylaxis |
| |
- |
Is the Rate of Clinical Manifestations of the Antiphospholipid Syndrome Associated to Cumulative Findings of Antiphospholipid Antibodies? |
| |
- |
The Additional Presence of Lupus Anticoagulants in 300 Patients with Anticardiolipin Antibodies Increases the Risk of Coincidental Venous and Arterial Thrombosis |
| |
- |
Clinical Manifestations of Patients with Dysfibrinogenemia |
| |
- |
Individual Efficacy Measurement of FVIII Replacement Therapy in Cell-based Monitoring Tests |
| |
- |
Home Treatment of Bleeding Episodes in Haemophiliacs With Inhibitors: Cost-Effectiveness of Three on-Demand Strategies in Germany |
| |
- |
ADAMTS 13 Activity and VWF : Ag Levels in Patients with Ischemic Stroke |
| |
- |
Clinical Significance of Antiphospholipid Antibodies in Haemophiliacs |
| |
- |
Inhibitor Development in PTP's: A Retrospective Study in Germany |
| |
- |
Mutations in the VKORC1 Gene Cause Warfarin Resistance, Warfarin Sensitivity and Combined Deficiency of Vitamin K Dependent Coagulation Factors |
| |
- |
Identification of Thrombin Antibodies in Patients with Antiphospholipid Syndrome |
| |
- |
Bleeding Events in Carriers Of Haemophilia A Dependent on the Factor VIII-Activity or the Age of the Carriers? |
| |
- |
The Relation of Laboratory and Clinical Features to the Response to Plasma Exchange Therapy in the Treatment of Acquired Thrombotic Thrombocytopenic Purpura (TTP) |
| |
- |
Tissue Factor Efficacy in Patients with Severe Hemophilia a Undergoing Total Knee Replacement |
| |
- |
Risk of Arterial Thrombosis in Carriers of a Familial Thrombophilic Defect |
| |
- |
Extensive Venous Malformation Associated with Coagulation Abnormality: Treatment with Peginterferon Alfa 2a |
| |
- |
Epitope Mapping of Inhibitory Antibodies and Inhibitor Elimination with Rituximab in Patients with Acquired Haemophilia |
| |
- |
Epitope Mapping of Inhibitors in Acquired Haemophilia A |
| |
- |
Prospective Investigations of the Predictive Value of hs-CRP in Patients with and without the Presence of Antiphospholipid Antibodies |
| |
- |
What Causes Patients with Acquired Thrombotic Thrombocytopenic Purpura to Relapse? |
| |
- |
Investigations of the Thrombin Generation Test in Patients with FV-L Mutation and Antiphospholipid Syndrome |
| |
- |
Rituximab in the Treatment of FXIII Inhibitor Possibly Caused by Ciprofloxacin |
| |
- |
Manifestations of the Antiphospholipid Syndrome in Patients with Malignancies |
| Schattner M |
- |
Role of Human Polymorphonuclear Neutrophils in Endothelial Cell Damage Induced by Shiga Toxin-1 and Inflammatory Agents |
| Schattner M |
- |
Effects of Leptospiral Proteins on Human Endothelial Cells |
| Schattner M |
- |
Regulation of Megakaryocyte Generation by Monocytes/Macrophages |
| |
- |
Cyclic AMP Protects Stem Cell (CD34+) Apoptosis |
| Schaub RG |
- |
The Activity of GPG-290, An Antagonist of vWF-mediated Platelet Capture, Can Be Rapidly Monitored Using the PFA-100 Assay |
| |
- |
WAY-197697, a P-selectin Antagonist, Reduces Atherosclerosis in Apolipoprotein E Deficient Mice |
| Schaub R |
- |
Prophylaxis using a Novel Oral Small Molecule Inhibitor to the P-selectin Receptor Promotes Thrombus Resolution in a Baboon Model of Venous Thrombosis |
| Schaub RG |
- |
Prevention of Canine Coronary Artery Thrombosis by the von Willebrand Factor Antagonist, GPG290 |
| Schaub R |
- |
Oral PAI-1 Inhibitor Decreases Thrombosis Without Anticoagulation in a Rat Stenosis Model of Venous Thrombosis |
| Schaub RG |
- |
A Novel P-Selectin Inhibitor, PSI-697, Demonstrates Positive Activity Following Oral Administration in Rodent Models of Vascular Inflammation |
| Schegolkova T |
- |
Heparin-induced Thrombocytopenia in Patients after Extracorporeal Circulation Surgery |
| Scheib H |
- |
Investigation of Molecular Mechanisms Regulating Fibrinogen Secretion |
| Scheifflinger F |
- |
TECHNOZYM® ADAMTS 13 Assays for Analyzing the vWF Cleaving Protease ADAMTS 13 |
| Scheiflinger F |
- |
Diagnosis of Acute Idiopathic Thrombotic Thrombocytopenic Purpura by Rapid Detection of ADAMTS 13 IgG Antibodies |
| |
- |
Murine and Human ADAMTS13 Swap Mutants Shed a New Light on the Molecular Mechanism of the ADAMTS13-VWF Interaction |
| |
- |
Quantification of ADAMTS13 Antigen Levels in Healthy Donors and Patients with Thrombotic Microangiopathies by a Newly Developed Sandwich ELISA |
| Scheiner T |
- |
Delayed FPA Release from Homophenotypic Aa 16 H (Fibrinogen Kingsport): Major b Fibrin Epitope Role in Clotting Times and Branching |
| Schellong S |
- |
Therapy of Isolated Calf Muscle Vein Thrombosis with Low-Molecular-Weight Heparin: Prospective Randomized Study |
| |
- |
Importance of the FV Level Screening for Individual Thrombotic Risk |
| |
- |
Follow-Up of Patients with Acute Venous Thromboembolism Treated with Ximelagatran for Prophylaxis of Recurrent Events |
| Scherrer F |
- |
Usefulness of Thromboelastography (ROTEM®) in Coagulation Management in Trauma Patient |
| Scherrmann JM |
- |
Pharmacokinetic Study of the Co-administration of a Von Willebrand Factor (VWF) Product Containing Low FVIII Level (WILFACTIN) with a Factor VIII Product |
| Schäfer A |
- |
Inhibition of Platelet Activation in Rats with Severe Congestive Heart Failure by Treatment with an Endothelial NO-Synthase Enhancer |
| |
- |
Rosuvastatin Reduces Platelet Activation in Heart Failure: Role of Nitric Oxide Bioavailability |
| |
- |
Inhibition of Platelet Activation in Diabetic Rats by Chronic Treatment with the Guanylyl Cyclase Activator HMR1766 |
| Schiavoni M |
- |
Pharmacokinetics, Efficacy and Safety of Solvent/Detergent (S/D) Treated Plasma in Patients with Rare Inherited Coagulation Disorders (RICDs) |
| |
- |
Immunotolerance Induction (ITI) with High Purity FVIII/VWF Concentrates in Inhibitors Patients with a High Risk of a Poor Response to ITI: A Prospective Surveillance |
| Schibi G |
- |
Evaluation of Pro-Angiogenic Activity of Factor XIII (FXIII) in Murine Models of Heart Transplantation and FXIII-Deficient Mice |
| Schick E |
- |
Kinetics of in vivo Activation of Protein C In Healthy Animals |
| Schiks B |
- |
Binding of Amyloid to the Fibronectin Type I Domain of tPA And Factor XII Induces Activation of the Fibrinolytic System and the Contact System |
| |
- |
Factor XII (fXII) Is Activated by Unfolded Proteins on the Surface of Negatively Charged Substances, Rather than by These Surfaces Themselves |
| |
- |
Activation of the Fibrinolytic System by Amyloid Cross-b Structure Results In reply to: Cell Detachment AND Processing of Neuroendocrine Factors |
| Schillinger U |
- |
Fibrin and b-chain Peptide (441461) for Tissue Engineering Improves Tolerability and Efficiency of Non-viral Gene Vector Formulations |
| Schillinger M |
- |
Complement Component C5a Predicts Future Cardiovascular Events in Patients with Advanced Atherosclerosis |
| Schinco PC |
- |
Immunotolerance Induction (ITI) with High Purity FVIII/VWF Concentrates in Inhibitors Patients with a High Risk of a Poor Response to ITI: A Prospective Surveillance |
| Schino M |
- |
APCC (FEIBA) Home Therapy. Long Term Use: An Italian Retrospective Survey in Hemophilia Patients with FVIII/IX Inhibitors |
| |
- |
APCC (FEIBA) Home Therapy. Long Term Use: An Italian Retrospective Survey in Hemophilia Patients with FVIII/IX Inhibitors |
| Schinzel H |
- |
Safety and Efficacy of Low-Molecular-Weight Heparin (Dalteparin) in Pregnant Women at Increased Risk of Venous Thromboembolism: A Prospective Stratified Multicentre Trial |
| Schlachterman A |
- |
Factor V Leiden as a Modifier of the Severe Hemophilia Phenotype in Murine Models |
| |
- |
Characterization and Gene Silencing of a Novel Gla-Containing Protein |
| Schlammadinger Á |
- |
Acquired FXIII Deficiency in a Patient with Systemic Lupus Erythematodes: Clinical Presentation and Management |
| Schlammadinger A |
- |
Severe Thrombotic Complications of Heparin-associated Thrombocytopenia and Thrombosis |
| |
- |
Severe Acquired Factor XIII Deficiency Caused by an Autoantibody against the B Subunit |
| Schlang G |
- |
Thromboembolic Risk Adapted Dosage of Low Molecular Weight Heparin in Chronically Anticoagulated Patients with Atrial Fibrillation Prior to Interventions with High Risk of Bleeding: Experience in 400 Patients |
| Schleef R |
- |
Initial Data on the Effects of Long-term Cigarette Mainstream Smoke Exposure and High Fat Diet in Apolipoprotein E-deficient Mice |
| Schlegel N |
- |
Molecular Basis of MYH9-Related Disorders in a Series of Ten Families |
| Schlegel N |
- |
Antiphospholipid Antibodies in 42 Neonates Born to Mothers with the Antiphospholipid Syndrome and Included in the European Forum Register |
| Schlenke P |
- |
The INTERCEPT Blood System for Plasma: Process Validation Studies of Coagulation Factor Activity and Yield in Three European Blood Centers |
| Schliamser L |
- |
ProC Global Assay in the Evaluation of Women at Risk for VTE While Using Hormonal Therapy |
| Schliamser L |
- |
Clinical Features of Cerebral Venous Thrombosis |
| Schlimm S |
- |
Circulating Inhibitor in an Elderly Female That Impairs the Action of Human But Not Rabbit Brain Thromboplastin |
| Schlitt A |
- |
Monocyte Subsets in Early Atherosclerosis Lessons Learnt at Home |
| Schmaier AH |
- |
Prolylcarboxypeptidase Activates Plasma Prekallikrein on Transfected CHO Cells |
| |
- |
Prolylcarboxypeptidase (PRCP): Characterization of Truncated Forms |
| Schmaier AH |
- |
Angiotensin Receptor 2 Over-Expression in Bradykinin B2 Receptor Knockout Mice Produces Thromboprotection |
| Schmalfeldt B |
- |
Analysis of the Differential Expression of uPA, PAI-1, and Tissue Kallikreins hk5, 6, 7, 8, 10, 11, 13 between Primary Ovarian Carcinoma Tissues and Corresponding Omentum Metastases |
| Schmidt B |
- |
The Effects of Supra-Normal Protein C Levels on Markers of Coagulation, Fibrinolysis and Inflammation in a Human Model of Endotoxemia |
| Schmidt T |
- |
Removal of PrPSc in the Manufacturing Process of OCTAPLAS and UNIPLAS |
| Schmidt EB |
- |
N-3 Polyunsaturated Fatty Acids Selectively Affect Circulating Microparticle Subpopulations in Patients with Myocardial Infarction |
| Schmidt M |
- |
Usefulness of a Particle Gel Immunoassay (PaGIA) for Rapid Diagnosis of Heparin-Induced Thrombocytopenia |
| Schmidt R |
- |
Targeting of the Direct FXa Inhibitor TAP via the Fusion of a Single-chain Antibody Directed Against a LIBS Epitope on GPIIb/IIIa Provides Effective Anticoagulation without Bleeding Time Prolongation |
| Schmidt EB |
- |
Plasma Lipids and Lipoproteins in Healthy Subjects are Closely Related to INR |
| Schmidt KA |
- |
Rituximab Treatment of FVIII Inhibitors in Congenital Hemophilia A (cHA) |
| Schmidt EB |
- |
Atorvastatin Treatment Affects Vitamin K-Dependent Coagulation Factors (INR) In Patients With Coronary Heart Disease |
| Schmidt T |
- |
Viral Safety of a Novel von Willebrand Factor and Factor VIII Concentrate (Wilate®): Virus Inactivation Capacities of Optimised Solvent/Detergent and Terminal Dry-Heat Treatment |
| |
- |
Viral Safety of a Prothrombin Complex Concentrate (Octaplex®): Combination of Solvent/Detergent (SD) Treatment with Nanofiltration |
| Schmidt H |
- |
Thromboembolic Risk Adapted Dosage of Low Molecular Weight Heparin in Chronically Anticoagulated Patients with Atrial Fibrillation Prior to Interventions with High Risk of Bleeding: Experience in 400 Patients |
| Schmidt AE |
- |
Role of Residue 193 in Development of the Oxyanion Hole in Serine Proteases: Kinetic Studies of the Effect of Side Chain Length and Charge in Factor XIa |
| Schmidt H |
- |
Venous Thromboembolism: Involvement of ADAMDEC1 Polymorphisms in Familially High Factor VIII Levels |
| Schmidt AE |
- |
Role of Residue 192 in Development of the Oxyanion Hole and in Macromolecular Specificity in Serine Proteases: Importance of Lys554 (192 in Chymotrypsin Numbering) in Factor XIa Catalysis |
| Schmitt J |
- |
Prevalence and Clinical Significance of Anti-b2-Glycoprotein-I-Antibodies in Patients with Venous Thrombosis |
| Schmitt J |
- |
Elevated Factor IX, XI and XII-Activities Are Associated with an Increased Risk for Venous Thrombosis |
| Schmitt M |
- |
Analysis of the Differential Expression of uPA, PAI-1, and Tissue Kallikreins hk5, 6, 7, 8, 10, 11, 13 between Primary Ovarian Carcinoma Tissues and Corresponding Omentum Metastases |
| Schmitz A |
- |
Thromboembolic Risk Adapted Dosage of Low Molecular Weight Heparin in Chronically Anticoagulated Patients with Atrial Fibrillation Prior to Interventions with High Risk of Bleeding: Experience in 400 Patients |
| Schmugge M |
- |
In Vitro Stability of Dilutions of the Recombinant Factor VIII Kogenate FS for Continuous Infusion Use |
| |
- |
Congenital Prothrombotic Disorders in Children with Venous and Arterial Thrombosis |
| Schmut O |
- |
Lipoprotein Pattern in Patients with Retinal Artery Occlusion or Retinal Vein Occlusion |
| Schmutzler-Baas A |
- |
Early Anticoagulation for Prevention and Therapy of Deep Venous Thrombosis In Patients Undergoing Craniotomy For Brain Tumor Risk of Postoperative Intra-cranial Hemorrhage in a Prospective Long-term Study |
| |
- |
Perioperative Prophylaxis Against Thromboembolism in Patients Undergoing Craniotomy for Brain Tumor: Analysis of Efficacy of Early Low Molecular Weight Heparin |
| Schneider MM |
- |
TAFIa Treatment of High Molecular Weight Fibrin Degradation Products Reduces the Ability of Plasminogen to Protect tPA from Inhibition by PAI-1 |
| Schneider S |
- |
Glykoprotein VI Mediates Platelet Adhesion to Vulnerable Human Atherosclerotic Plaque |
| |
- |
In vivo Relevance of Platelets and the Fibrinogen Receptor GPIIb-IIIa for Experimental Melanoma Metastasis |
| Schneider M |
- |
Factor V Leiden and Aprotinin in Cardiopulmonary Bypass |
| Schneppenheim R |
- |
The Incidence and Penetrance of Common VWF Gene Mutations in a Cohort of Type 1 VWD Patients: Results from the EU Funded MCMDM-1VWD Project |
| |
- |
Mutations Causing Type 3 Von Willebrand Disease in a Small Cohort of Greek Patients |
| |
- |
Assay of the von Willebrand Factor Propeptide (VWFpp) to Identify Type 1 von Willebrand Disease (VWD) Patients with a Decreased von Willebrand Factor (VWF) Survival Phenotype |
| |
- |
The Factor VIII/von Willebrand Factor Antigen (FVIII/VWF : Ag) Ratio in Determining VWF Defects in Patients with von Willebrand Disease Type 1: Results from the European Multicenter MCMDM-1VWD Study |
| |
- |
In vitro Expression of Ten Missense Mutations in the VWF C-Terminal Domain Identified in Patients Diagnosed with Type 1 VWD: Results from the MCMDM-1VWD Study |
| Schneppenheim R |
- |
A Baltic Origin of the Common ADAMTS13 Mutation 4143insA |
| Schneppenheim R |
- |
Collagen Binding (VWF : CB) Is Less Sensitive Than Ristocetin Cofactor Activity (VWF : RCo) in Suggesting Von Willebrand Factor (VWF) Molecular Defects in Patients with Von Willebrand Disease Type 1: Results From the European Multicenter MCMDM-1VWD Study |
| |
- |
Analysis of Bleeding Score in Type 1 VWD Families in the MCMDM-1 Study |
| |
- |
Association of FVIII/Von Willebrand Factor Measurements and PFA-100® with Bleeding Score in Type 1 Von Willebrand Disease (VWD) Families. The MCMDM-1 Study |
| Schneppenheim R |
- |
Tyr1605-Met1606 Flanking the Von Willebrand Factor Cleavage Site Are Not Required for Cleavage of VWF by ADAMTS13 |
| |
- |
A Rare Factor VIII Missense Variant as a Pitfall for Genetic Counseling |
| Schneppenheim R |
- |
Multimer Pattern in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD) |
| |
- |
Two Novel Type 1 Von Willebrand Disease Causing Mutations (G160W and N166I) in the Von Willebrand Factor Propeptide, Identified in the European Study MCMDM-1VWD, Are Responsible for Multimerization And Secretion Defects |
| |
- |
A Reduced VWF to FVIII Binding Capacity is not Uncommon in Patients With Type 1 Von Willebrand Disease: Results From the MCMDM-1VWD Study |
| |
- |
Gene Conversions Are a Common Cause of von Willebrand Disease |
| Schneppenheim R |
- |
Cysteine Mutations in the von Willebrand Factor D3 Domain Correlate with Multimerization Defects in Patients Previously Diagnosed with von Willebrand Disease Type 1 in Patients Entered in the European Multicentre Study MCMDM-1VWD |
| Schneppenheim R |
- |
Linkage Analysis of von Willebrand Disease Type 1 Phenotype, von Willebrand Factor Levels and Bleeding Symptoms with Von Willebrand Factor Gene Locus in the European Multicenter MCMDM-1VWD Study |
| |
- |
Mutation Profile in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD) |
| |
- |
Responsiveness to Desmopressin: Influence of Genotype in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD |
| |
- |
Abnormal Multimeric Pattern Is Not Associated with Increased Bleeding Symptoms in Index Cases of Families with Type 1 VWD. Results from the EU MCMDM-1 VWD Study |
| Schöni R |
- |
Clinical Evaluation of a New Functional Test for Detection of Activated Protein C Resistance (Pefakit® APC-R Factor V Leiden) at Two Centers in Europe and the USA |
| Schobess R |
- |
Long-Term Safety and Efficacy Data on Neonatal Thromboembolism Treated with Dalteparin or Enoxaparin: A Comparison of Once Daily Versus Twice Daily Administration |
| |
- |
Risk of Recurrent Venous Thromboembolism in Children with Cerebral Venous Thrombosis A Prospective Follow-Up Cohort Study |
| Schoenauer V |
- |
A Positive Family History of Venous Thromboembolism Does Not Predict A High Risk of Recurrence |
| Schoenmakers SHHF |
- |
FVIII-Dependent Propagation Phase Is of Minor Importance During Septic Peritonitis |
| Schoenwaelder SM |
- |
Distinct Roles for the Type I PI 3-Kinases, p110b and p110g, in ADP-Stimulated Platelet Activation |
| Scholz U |
- |
Measuring Thrombin Generation as a General Parameter in Relation to Single Coagulation Tests |
| |
- |
Influence of Platelet Transfusion on Thrombin Generation in Patients with Bone Marrow Transplantation |
| Scholz T |
- |
Effect of Beer, Dealcoholized Beer and Ethanol Consumption on Hemostasis in Humans |
| Scholz T |
- |
Individual Efficacy Measurement of FVIII Replacement Therapy in Cell-based Monitoring Tests |
| Scholz U |
- |
Influence of Factor IIa- and Factor Xa-Inhibitors on Thrombin Generation in Platelet-Rich Plasma |
| |
- |
Thrombin Generation as Parameter to Monitor Patients with Thrombophilia and Pregnancy |
| Scholz T |
- |
Tissue Factor Efficacy in Patients with Severe Hemophilia a Undergoing Total Knee Replacement |
| Schönauer V |
- |
Risk Factors for the Postthrombotic Syndrome (PTS) |
| |
- |
C-Reactive Protein 3'UTR (+1444) C>T Polymorphism in Patients with Spontaneous Venous Thromboembolism |
| Schoolmeester A |
- |
Non-helical Peptide Sequence SRHPRVGVYHVFDSA Binds Specifically to Human Integrin a2b1 |
| Schoolmeester A |
- |
Different Active Conformations Are Induced in the Collagen Receptor Integrin a2b1 by Outside Manipulation and Inside-out Signalling |
| |
- |
Functional Evidence for Three I-domain Activation States for Platelet a2b1 Integrin |
| Schoolmeester A |
- |
Crosstalk Between Integrins a2b1 and aIIbb3 during Platelet Activation |
| Schoormans S |
- |
The Role of Annexin A5 and Anti-Annexin A5 Antibodies in the Antiphospholipid Syndrome |
| |
- |
DDAVP Treatment Is Not Recommended in Patients with von Willebrand Disease Type 2N |
| Schoppmann A |
- |
Stability of CEPROTIN, Human Protein C Concentrate, for Use in Continuous Infusion |
| Schramm W |
- |
Quality of Life in Patients with Haemophilia An European Comparison Study (ESCHQoL) |
| |
- |
Comparison of B-Cell Epitope and Mutation Type in Haemophilia A Patients |
| Schreiber MA |
- |
Resuscitation with Lactated Ringers (LR) vs. Normal Saline (NS) Leads to a Hypercoagulable State in an Uncontrolled Hemorrhagic Shock Swine Model |
| Schreijer AJM |
- |
Incidence of Venous Thromboembolism Among Dutch Airline Pilots |
| |
- |
The Absolute Risk of Venous Thrombosis after Air Travel (WRIGHT Study) |
| Schreijer AJM |
- |
Coagulation in Aviation: Activation of the Coagulation System During Air Travel (The WRIGHT Volunteers Study) |
| Schreyer B |
- |
High Inter-Device Variation of the PFA-100 Platelet Function Analyzer |
| Schröder J |
- |
A Rare Factor VIII Missense Variant as a Pitfall for Genetic Counseling |
| Schroeder V |
- |
Identifying Hemostatic Modifier Loci Ameliorating FVII-Insufficiency Using Phenotypic Differences between Strains |
| Schroth P |
- |
Efficacy, Safety and Pharmacokinetic Properties of ADVATE rAHF-PFM in Previously Treated Patients (PTPs) Less Than 6 years of Age |
| Schroyens W |
- |
Characterisation and Classification of Von Willebrand Diseases |
| |
- |
Non-Invasive Diagnosis of Pulmonary Embolism Anno 2005 |
| |
- |
Safe Exclusion of Deep Vein Thrombosis (DVT) by a Normal Rapid ELISA D-Dimeer (<500 Ng/Ml) and by the Combination of a Negative Compression Ultrasonography and a D-Dimer of <1000 Ng/Ml in 1330 Consecutive Outpatients with Suspected DVT in the Primary Care Setting |
| Schött U |
- |
Principal Component Analysis to Evaluate Aprotinin Treatment in Abruptio Placentae Patients with Severe Bleeding |
| |
- |
Presentation of Laboratory and Sonoclot Variables Using Principal Component Analysis: Identification of Hypo- and Hypercoagulation in the HELLP Syndrome |
| |
- |
A Single Preoperative dose of Tranexamic Acid Reduces Blood Loss and Heterologous Blood Transfusion in Radical Retropubic Prostatectomy |
| |
- |
Evaluation of Low Molecular Weight Heparin Anticoagulation during Hemodialysis with Sonoclot Coagulation Analysis |
| |
- |
In vitro and in vivo Monitoring of Fondaparinux with a Viscoelastic Test |
| Schuff-Werner P |
- |
Thrombin Modulates Proangiogenic Cytokine Secretion and Cell Adhesion of Human Prostate Cancer Cells Via PAR-1 |
| Schuh K |
- |
Coagulation Factor XII is Essential for Arterial Thrombus Formation in Vivo |
| |
- |
Heparin-Binding Protein Increases Vascular Permeability by Bradykinin Release: A Novel Link Between Neutrophils and Vascular Inflammation |
| Schulman S |
- |
Experience of Surgery with Continuous Infusion at Karolinska University Hospital in Patients With Hemophilia A and B, von Willebrand'S Disease and FVII-Deficiency |
| |
- |
Prothrombotic Risk Assessment of Patients Receiving Ximelagatran for Secondary Prevention of Venous Thromboembolism |
| Schulman S |
- |
Prevention of Recurrent Venous Thromboembolism with What Agents and for How Long? |
| |
- |
Supplementation with Folic Acid or Vitamin C and E in Patients with Bleeding Disorders and Hepatitis C Treated with Pegylated Interferon and Ribavirin |
| |
- |
Prospective Evaluation of Low PAI-1 Activity as a Risk Factor for Hemorrhagic Diathesis |
| Schulman S |
- |
Treatment of Chronic Hepatitis C Infection in Patients with Hemophilia or Von Willebrand Disease with a Combination of Pegylated Interferon and Ribavirin |
| Schulte SJ |
- |
Evaluation of Glass versus Plastic Blood Collection Tubes Used in Coagulation Testing |
| |
- |
Sensitivity of Dilute Russell's Viper Venom Time (DRVVT) to Coagulation Factor Deficiency: Effect on Testing for Lupus Anticoagulant |
| Schulte V |
- |
Diverging Signaling Events Control the Pathway of GPVI Down-Regulation in vivo |
| Schulte V |
- |
Two-Phase Antithrombotic Protection after Anti-GPVI Treatment in Mice |
| Schulte am Esch II J |
- |
Platelet Activation Markers and Procoagulant Phenotype of Monocytes do Correlate with Markers of Reperfusion Injury Following Reperfusion after Orthotopic Liver Transplantation |
| Schultz MJ |
- |
Lung-Protective Mechanical Ventilation Attenuates Fibrin Generation in Healthy Lungs |
| Schultz C |
- |
Nitric Oxide Generation During Parenteral Administration Differentiates Argatroban from Lepirudin and Bivalirudin |
| |
- |
Interaction of BAY 59-7939 A Novel, Oral, Direct Factor Xa Inhibitor with Antiplatelet Agents: Monitoring and Therapeutic Applications |
| |
- |
Down-Regulation of Inflammatory Markers after Treatment with Topically Administered Mucopolysaccharide Polysulfate in Primates |
| Schultz MJ |
- |
Local Attenuation of the Protein C Pathway in Patients Developing Pneumonia |
| Schultz C |
- |
Ex vivo Evaluation of the Pharmacodynamic Effects of Defibrotide. Results from Various Clinical Trials |
| |
- |
Antithrombotic Mechanism of Action of BAY 59-7939 a Novel, Oral, Direct Factor Xa Inhibitor |
| |
- |
Argatroban Interactions with Low Molecular Weight Heparins: Pharmacologic Implications |
| |
- |
Modulation of Inflammatory Markers after Treatment with Topically Administered Mucopolysaccharide Polysulfate. Results of a Study in Primates |
| Schulz I |
- |
INR Results of the CoaguChek® PT Test Compare Well with INR Results of International Reference Thromboplastins |
| Schulz C |
- |
In vivo Relevance of Platelets and the Fibrinogen Receptor GPIIb-IIIa for Experimental Melanoma Metastasis |
| |
- |
Glykoprotein VI Mediates Platelet Adhesion to Vulnerable Human Atherosclerotic Plaque |
| |
- |
Fractalkine Mediates Leukocyte Recruitment to Inflammatory Endothelial Cells in Flowing Whole Blood |
| Schulz A |
- |
Severe Bleeding Caused by a Platelet Defect Leading to Enhanced Binding of Coagulation Factor XI (FXI) to Platelet GPIb-alpha |
| Schulz C |
- |
Reduced Platelet Adhesion, Attenuated Atherosclerosis and Increased Resistance to Focal Cerebral Ischemia in Mice Lacking GPIIb Integrin |
| Schumacher W |
- |
Evidence for the Anit-thrombotic Efficacy of Potato Carboxypeptidase Inhibitor in a Mouse Model of Ferric Chloride-Induced Venous Thrombosis |
| Schumacher W |
- |
Antithrombotic Activity of a Small Molecule Factor XIa Inhibitor in Rats with Limited Effects on Bleeding Time |
| Schumacher W |
- |
Development, Characterization and Application of Immunoassays for Mouse, Rat and Rabbit D-Dimer Using the Monoclonal Antibody FK03 in Animal Models of Thrombosis |
| Schumacher G |
- |
Carbohydrate-Based P-Selectin Antagonists: In vitro- and In Vivo Investigations of Structure-Activity Relationships |
| Schumock G |
- |
Barriers to Appropriate Anticoagulation with Warfarin in Orthopedic Surgery |
| Schurer J |
- |
Anticoagulant, Anti-inflammatory and Organoprotective Effects of BIBT 986, a Novel Dual Inhibitor of Thrombin and Factor Xa, on LPS-induced Disseminated Intravascular Coagulation and Septicemia in the Rat |
| Schürzinger K |
- |
Reduced Platelet Adhesion, Attenuated Atherosclerosis and Increased Resistance to Focal Cerebral Ischemia in Mice Lacking GPIIb Integrin |
| Schuster J |
- |
Intravenous DDAVP Associated Reduction in Fibrinogen Implications for Patients with Von Willebrand's Disease or Haemophilia A with Borderline Fibrinogen Levels Requiring Invasive Procedures |
| |
- |
IgE Mediated Anaphylaxis to Factor VIII |
| Schutgens R |
- |
The Clinical Probability Score and D-dimers Are Not Recommended in Elderly Patients Suspected for Having Deep Vein Thrombosis |
| Schutgens R |
- |
Stable Plasma D-dimer Concentrations after Prolonged Freezing |
| Schutgens REG |
- |
Fibrin Monomers in the Diagnosis of Deep Vein Thrombosis |
| Schved JF |
- |
A Spot Peptide Approach to Identify Binding Regions Between the TF-FVIIa Complex and its Macromolecular Substrates FIX and FX |
| |
- |
Prenatal Diagnosis in a Lebanese Family with Severe Factor VII Deficiency |
| Schved J-F |
- |
Secretion of Functional Plasma Coagulation Proteins in Long-term Primary Cultures of Human Hepatocytes |
| Schved JF |
- |
Factor V Leiden Mutation and Pregnancy Associated Venous Thromboembolism: A Meta-Analysis |
| |
- |
Influence of 10 Polymorphisms Located in Genes Coding for Factors Involved in Coagulation and Fibrinolysis on the Risk of Venous Thrombosis in Factor V Leiden Homozygotes: Study of 233 Subjects |
| |
- |
Fine Epitope Mapping of Human Monoclonal Antibodies Directed Against the B Domain of Factor VIII |
| Schwaab R |
- |
Comparison of B-Cell Epitope and Mutation Type in Haemophilia A Patients |
| |
- |
In Silico Design and in Vitro Validation of a Mimotope for Blocking a FVIII-inhibitor Antibody ESH8 |
| Schwammenthal Y |
- |
Aspirin Resistance in Acute Brain Ischemia: Association with Stroke Severity and Outcome |
| |
- |
Low rate of Responsiveness to Aspirin in Acute Brain Ischemia: Association with Stroke Severity and Clinical Outcome |
| Schwarte S |
- |
Does a F XIII Deficiency Induce a Bleeding Tendency? |
| Schwartz M |
- |
Successful Use of FEIBA to Control Postoperative Bleeding after Use of rFVIIa |
| Schwarz G |
- |
Viral Safety of a Novel von Willebrand Factor and Factor VIII Concentrate (Wilate®): Virus Inactivation Capacities of Optimised Solvent/Detergent and Terminal Dry-Heat Treatment |
| Schwarz M |
- |
Polymorphisms Known to Increase the Risk of Atherothrombosis Do Not Affect the Risk of Thrombembolism as Determined in Patients with Atrial Fibrillation |
| |
- |
A Unique Fusion Protein Combines Clot Targeting, Platelet Blockade and Direct Factor Xa Inhibition in One Molecule |
| |
- |
High Incidence of Symptomatic Venous Thromboembolism in Patients with Glioblastoma |
| Schwarz M |
- |
Design of Small Molecular Weight Activation-specific GPIIb/IIIa Inhibitors Based on the CDR3 Region of a Phage Display-derived Single-chain Antibody |
| Schwarz M |
- |
Targeting of the Direct FXa Inhibitor TAP via the Fusion of a Single-chain Antibody Directed Against a LIBS Epitope on GPIIb/IIIa Provides Effective Anticoagulation without Bleeding Time Prolongation |
| Schwarz HP |
- |
Protective Effect of Human Plasma-Derived Protein C in Septic Neonatal Mice |
| Schwarz T |
- |
Therapy of Isolated Calf Muscle Vein Thrombosis with Low-Molecular-Weight Heparin: Prospective Randomized Study |
| Schwarzman A |
- |
ABCA1 Transporter and Paraoxonase Gene Polymorphisms in Myocardial Infarction and Stroke |
| |
- |
The Study of Genetics Risk Factors Predisposing to Myocardial Infarction in Young Men |
| Schweigel J |
- |
In vitro Determination of Platelet Function in Whole Blood from Obese Children and Adolescents |
| Schweighoffer E |
- |
Syk Plays a Critical Role in Signalling Downstream of GPVI and Integrin aIIbb3, But Is not Required for Efficient G-Protein Mediated Platelet Activation |
| |
- |
Syk Plays an Essential Role Downstream of The Platelet Rhodocytin Receptor CLEC-2 |
| Schwieler JH |
- |
Inhibition of the Renin-Angiotensin System Does Not Reduce Platelet Activity at Rest or during Stress in Essential Hypertension |
| Sciuccati G |
- |
Low Molecular Weight Heparin (LMWH) Therapy in Neonates and Children with Venous Thromboembolism (VTE) |
| |
- |
Platelet Aggregation and ATP Release Values in Children and Adults |
| Scoditti E |
- |
Anti-Inflammatory and Anti-Angiogenic Effects of the Omega-3 Fatty Acid Docosahexaenoate (DHA, 22:6 n-3) Through ERK1/2-Mediated Inhibition of Cyclooxygenase (COX)-2 Expression |
| |
- |
Anti-Angiogenic Action of Peroxisome Proliferator-Activated Receptor(PPAR)g Ligands Through Cox-2-Mediated MMP-9 Expression and Release |
| Scorilas A |
- |
Analysis of the Differential Expression of uPA, PAI-1, and Tissue Kallikreins hk5, 6, 7, 8, 10, 11, 13 between Primary Ovarian Carcinoma Tissues and Corresponding Omentum Metastases |
| Scott DW |
- |
Induction of Tolerance by Gene Therapy with B-cells Expressing Ig Fusion Proteins: Pre-clinical Success in Naïve and Immune Hemophilia A Mice |
| Scott OM |
- |
Gait Alterations Exist in Children with Haemophilia after Relatively Few Haemarthroses and Despite Prophylaxis A 3D Motion Analysis Study |
| Scott BT |
- |
Evidence for Loci Pleotropically Influencing Inter-Related Clotting Factors |
| |
- |
Linkage Analysis Reveals No Evidence for Loci Other than the Factor VII Gene Influencing Factor VII Levels |
| Scott-Emuakpor A |
- |
The Older Hemophilia Patient with Inhibitors: Issues and Challenges |
| Scriven N |
- |
Assessment of Suspected Venous Thromboembolism in the UK: Findings from a Prospective Outpatient Treatment Registry (VERITY) |
| |
- |
Management of VTE in the Outpatient Setting: Findings from a UK Prospective Outpatient Treatment Registry (VERITY) |
| |
- |
Venous Thromboembolism Occurs Commonly Out-Of-Hospital in Patients Recently Immobilized through Surgery or Illness: Findings from the VERITY Outpatient Treatment Registry |
| Scudder L |
- |
PAR3 Expression and Functions Studied with Blocking, Cleavage Site-Specific Antibodies |
| Scully M |
- |
Successful Management of Pregnancy in Women with a History of Thrombotic Thrombocytopenic Purpura: A Role for ADAMTS 13 Monitoring |
| Scully MF |
- |
Hypertonic Stress Alters the Yield and Type of Microparticles Produced by Haemopoietic Cells |
| Scully MF |
- |
Preliminary Results of a Cross-Sectional Study of Mild Hemophilia A in Newfoundland and Labrador, Canada |
| Scully M |
- |
ADAMTS13 Gene Mutations and Polymorphisms in Acquired Thrombotic Thrombocytopenic Purpura (TTP) Patients |
| |
- |
Use of Recombinant Activated Factor VII (Novoseven) as Haemostatic Cover for Surgery in Congenital Factor VII Deficiency |
| Scully MF |
- |
Platelet-Derived Microparticles Bind Heparin with High Affinity |
| Scully M-F |
- |
Molecular Defect of Factor XIII A Subunit in Newfoundland Families with Factor XIII A Subunit Deficiency |
| Scully M |
- |
Determination of the Integrin Binding Properties of the Disintegrin-Like Loops of ADAM Proteins |
| |
- |
A Sequence Derived from Loop I of PDGF Inserted into Neurotoxin Dendroaspin Scaffold Has an Ability to Inhibit Cell Proliferation and Migration |
| Scully M |
- |
Treatment of HIV Associated Thrombotic Thrombocytopenic Purpura-Importance of Prompt Diagnosis |
| Scully M |
- |
Development of a Bifunctional Inhibitor with Anticoagulant and Anti-Platelet Activity |
| |
- |
Dendroaspin, a Disintegrin-Like Venom Protein, Inhibits the Protective Effect of Fibrinogen on the Apoptosis of A375 Cells |
| Scully M |
- |
Use of Rituximab in Acute Refractory Thrombotic Thrombocytopenic Purpura |
| Scully MF |
- |
Heterogeneity of Integrin Expression on Platelet Microparticles. Use of A Snake Venom Disintegrin as a Functional Probe |
| Scully M |
- |
The Sensitive Detection of Antibodies to von Willebrand Factor Cleaving Protease (ADAMTS-13) |
| Scully M |
- |
Six Children with Congenital Deficiency of ADAMTS-13: Clinical Features and Treatment |
| Söderberg M |
- |
A Normal D-dimer and a Low Clinical Probability Test Safely Excludes Venous Thromboembolism. A Follow-up D-dimer Adds No Further Information |
| |
- |
The Expression of von Willebrand Factor Antigen Differ Between Deep Vein Thrombosis and Pulmonary Embolism |
| Seaton BA |
- |
Prothrombin Fragment 1 and Annexin V Localize Differently after Laser Induced Vascular Injury in vivo |
| Sebbag L |
- |
MIP-1b and VE-Cadherin Are Implicated in Acute Rejection in Human Heart Transplantation |
| Sedano C |
- |
Hemostatic Abnormalities in Oncolgic Patients |
| |
- |
Vein Trombosis in Pediatric Patients |
| Sedding D |
- |
The Factor VII Activating Protease (FSAP) Is an Inhibitor of Neointimal Lesion Formation. Comparison with the Marburg I SNP (G511E) of FSAP |
| Seeger H |
- |
Removal of PrPSc in the Manufacturing Process of OCTAPLAS and UNIPLAS |
| Seeman T |
- |
A Multicentre Study on 50 Cases with Thrombotic Thrombocytopenic Purpura in the Czech Republic: Recurrent Mutation in ADAMTS13 Gene as a Cause of a Hereditary Thrombotic Thrombocytopenic Purpura |
| Sefranek V |
- |
Thrombophilia: Factor V Leiden in Patients with Cardiovascular Diseases in Slovak Population |
| [Scaron]efrna F |
- |
Special Hemocoagulative Examination at Invasive Meningococcal Disease |
| Segal H |
- |
Aspirin Non-Responsiveness in a Population-Based Study of Acute Vascular Events |
| |
- |
Screening for Aspirin Responsiveness after TIA and Stroke in the Oxford Vascular Study: Comparison of Two Point of Care Platelet Function Tests with Aggregometry |
| |
- |
A Comparison of the Incidence of PFA-100® Aspirin Non-Responders with 3.2% and 3.8% Citrated Blood (with and without Addition of in Vitro Aspirin) |
| Segers AEM |
- |
Outcomes in Obese Patients of Pulmonary Embolism (PE) and Deep Vein Thrombosis (DVT) Treatment with Fondaparinux or (LMW) Heparins: The Matisse Trials |
| Seghi F |
- |
Semi-Synthetic Sulfaminoheparosans Induce Tissue Factor Pathway Inhibitor Release by Human Umbelical Vein Endothelial Cells (HUVEC) |
| Seifried E |
- |
First Case of Compound Heterozygous Mutations in the Kininogen Gene Causing Severe High-Molecular-Weight Kininogen Deficiency |
| |
- |
A Novel Mutation (Asp36Tyr) in the Vitamin K Epoxide Reductase Complex Subunit 1 (VKORC1) Causes Moderately Increased Coumarin Doses |
| |
- |
Prevalence and Clinical Significance of Anti-b2-Glycoprotein-I-Antibodies in Patients with Venous Thrombosis |
| |
- |
Epitope Mapping of the Factor VIII-specific T Cell Response in E-17 Knockout Mice Using Peptide Pool Arrays |
| |
- |
Mutations in the VKORC1 Gene Cause Warfarin Resistance, Warfarin Sensitivity and Combined Deficiency of Vitamin K Dependent Coagulation Factors |
| |
- |
Arg485Pro Mutation in the Gamma-Glutamyl Carboxylase Contributes to Three Unrelated German VKCFD Type 1 Patients with Compound Heterozygous Mutations |
| |
- |
Elevated Factor IX, XI and XII-Activities Are Associated with an Increased Risk for Venous Thrombosis |
| |
- |
Both, COP I and COP II Coatomers Are Involved in the Anterograde ER to Golgi Transport of B-domain Deleted FVIII |
| Seiji M |
- |
Fatal Hemorrhagic Disorder and Vascular Intimal Carcinomatosis in Annexin II Expressing Transitional Cell Carcinoma |
| Seiler S |
- |
Antithrombotic Activity of a Small Molecule Factor XIa Inhibitor in Rats with Limited Effects on Bleeding Time |
| Seitova A |
- |
The Crystal Structure of Unliganded Thrombin Identifies Regions Involved in Allosteric Regulation by Thrombomodulin |
| Seitz R |
- |
A Multi-centre Assessment of the Chromogenic Method for Factor VIII:C Estimation in Plasma-derived and Recombinant Concentrates |
| Seitz Ch |
- |
Pharmacokinetics and Pharmacodynamics of the Direct Thrombin Inhibitor Dabigatran in Elderly Healthy Subjects |
| Sejima T |
- |
Intervention of Plasminogen Activator Inhibitor-1 in Nasal Allergy |
| Sek J |
- |
Comparing Bleed Frequency and Factor Concentrate Use Between Haemophilia A and Haemophilia B |
| Seki T |
- |
Regulation of Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) Gene Expression in Growth-Promoted Hepatocytes and Role of TAFI in Liver Regeneration |
| Seki T |
- |
Induction of Renal PAI-1 Gene Expression in a Rat Model of Type-2 Diabetic Nephropathy and Role of Albumin in PAI-1 Induction |
| Sekine Y |
- |
Circadian Oscillation of Thrombomodulin Gene Expression in Peripheral Tissues |
| Sekino T |
- |
Functional Analysis o Two Recombinant Missense Mutant Factor XI, F221S ad C212R |
| |
- |
HMG-CoA Reductase Inhibitors Reduce the Synthesis of Tissue Factor and Factor VII and Increase the Synthesis of Tissue Factor Pathway Inhibitor in Human Mononuclear Cells |
| Sekizuka T |
- |
Thrombomodulin Inhibits Tumor Cell Invasion Through Three Different Domains of the Molecule |
| Selemidis S |
- |
Nitric Oxide Modulates NADPH Oxidase Function through Haemoxygenase-1 Induction in Human Endothelial Cells |
| Selemidis S |
- |
Nitric Oxide Suppresses NADPH Oxidase-Dependent Superoxide Production in Human Endothelial Cells and Arteries |
| Seligsohn U |
- |
Mechanisms of Thrombin Generation Induced by High Concentrations of Recombinant Factor VIIa |
| |
- |
Further Characterization of the Mutation in Blade 2 of the aIIb b-Propeller That Causes Glanzmann Thrombasthenia in Palestinian Arabs |
| |
- |
Substitutions of Cysteine Residues in b3 Affect aIIbb3 Integrin Processing and Activation |
| |
- |
Concomitant Infusion of Low Doses of rFVIIa and FEIBA in Severe Hemophilia A Patients with an Inhibitor to Factor VIII Who Are Refractory to rFVIIa or FEIBA Has an Excellent Hemostatic Effect and Synergistically Enhances Thrombin Generation |
| |
- |
Identification and Characterization of 10 Novel Mutations Causing Factor XI Deficiency |
| |
- |
A Novel Mutation In Platelet Glycoprotein Iba Causing BernardSoulier Syndrome In A Bucharian Jewish Family |
| Seljeflot I |
- |
Markers of Vascular Inflammation Are Associated with the Degree of Atherosclerosis Assessed as Angiographic Score and Treadmill Walking Distance in Patients with Peripheral Arterial Occlusive Disease |
| Seljeflot I |
- |
Occult Bleeding During Long-term Treatment with Aspirin, Warfarin, or Both after Myocardial Infarction. A WARIS-II Subgroup Analysis |
| Seltmann M |
- |
Efficacy, Safety and Pharmacokinetic Properties of ADVATE rAHF-PFM in Previously Treated Patients (PTPs) Less Than 6 years of Age |
| Sembiring RJ |
- |
The Rise of Plasminogen Activator Inhibitor-1 Activity in Coronary Artery Bypass Grafting of Type 2 Diabetes Patients |
| Semeraro N |
- |
Platelets Abolish the Profibrinolytic Effect of Heparin but not That of Melagatran |
| |
- |
APC Resistance Caused by Prothrombin G20210A Mutation Does Not Affect the Fibrinolytic Activity of Activated Protein C |
| Semmache Y |
- |
Prolonged Extracorporeal Life Support (ECLS) in Patients with Severe Membrane Stabilizing Agent (MSA) Poisonings: Hemostatic Management Requires only Minimal Doses of Heparin |
| Sener A |
- |
The Role of Gamma-Glutamyltransferase Activity on Early Platelet Apoptotic Process |
| |
- |
The Effects of Clopidogrel and Nadroparine on Elevated Thrombolytic Risk and Apoptotic Process in Hypercholesterolemia |
| Senis Y |
- |
Syk Plays an Essential Role Downstream of The Platelet Rhodocytin Receptor CLEC-2 |
| Seno A |
- |
Regulation of Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) Gene Expression in Growth-Promoted Hepatocytes and Role of TAFI in Liver Regeneration |
| Senouf D |
- |
Effect of Statins on Clopidogrel Platelet Inhibition as Measured by ADP Induced Platelet Aggregation and RPFA-P2Y12 (Accumetrics) in Healthy Volunteers |
| Sentot S |
- |
Alloantigenic Polymorphisms of the bTerminal Domain Impair the Function of Platelet aIIbb3 Integrin |
| Serati M |
- |
Incidence of Deep Vein Thrombosis Following Gynecologic Laparoscopy: A Prospective Cohort Study |
| Serban M |
- |
Quality of Life in Patients with Haemophilia An European Comparison Study (ESCHQoL) |
| Serbic O |
- |
Pediatric Thrombosis |
| Serebryakova T |
- |
Coagulation and Anticoagulan Factors in Combined Action of Informational Overload and Weak Static Magnetic Field |
| Sergeenko N |
- |
Platelet Function in Patients with Cerebrovascular Pathology in Changes of Geomagnetic Field of Earth |
| Serino ML |
- |
Common Factor XIII Gene Polymorphisms in Venous Leg Ulcers |
| Seroski W |
- |
Telephone Consultation Provided by the Hemophilia Treatment Centre A Significant Part of the Service |
| Seroski W |
- |
A System to Track Coagulation Factor Concentrates Can Decrease Waste |
| Serra J |
- |
Management Study with the New HemosIL D-Dimer HS For Exclusion of Venous Thromboembolism (VTE) |
| |
- |
Clinical Management Study of Venous Thromboembolism (VTE) Using the HemosIL D-Dimer |
| Serre-Beinier V |
- |
Isolation, Characterization and Angiogenic Potential of Human Mesenchymal Stem Cell-Derived Endothelial-Like Progenitor Cells |
| Serrruys P |
- |
Transendocardial Autologous Bone Marrow Cell Transplantation in Patients with Advanced Ischemic Heart Disease A Multi-Center Feasibility Study |
| Sers[caron]a I |
- |
Ultrasonic and Magnetic Resonance Characteristics of Pulmonary Emboli Ex Vivo |
| Serve E |
- |
Factor X Gene Mutations Affecting the Gla Domain of the Protein |
| Sessa F |
- |
Successful Diagnosis in Pregnant Obligate Carriers of Hemophilia a of Fetal Sex Using Conventional Pcr Analysis of Maternal Plasma |
| Sestini I |
- |
C677T and A1298C MTHFR, A2756G MTR and 844ins68 CBS Gene Polymorphisms in Atrial Fibrillation |
| |
- |
Ischemic Complications in Nonvalvular Atrial Fibrillation Patients Despite Warfarin Therapy |
| |
- |
Managed Hemostasis Point-Of-Care Testing in a Large Hospital: A Three-Year Experience and the Assessment of Clotting Tests |
| |
- |
Systemic Sclerosis: Gene Expression Profiling by Microarray Technology of Endothelial Cells |
| Setiabudy R |
- |
The Relationship Between Hypercoagulable State and Sudden Sensory Neural Deafness |
| Setiati T |
- |
Plasma Levels of PAI-1 and Risk of Death from Dengue: No Association with the 4G/5G Promoter Polymorphism |
| Settles J |
- |
Gene Expression Abnormalities in Aspirin Hyper-responders |
| Setty BNY |
- |
Phosphatidylserine-Positive Erythrocytes Modulate Tissue Factor Activity in vivo and in vitro in Sickle Cell Disease |
| Setty BNY |
- |
Neonatal Thrombophilia: Novel Findings Related to the Red Cell Membrane and Red Cell-Endothelial Adhesion |
| Setty BNY |
- |
Confirmatory Evidence for the Presence and Functional Activity of a Phosphatidylserine Receptor (PSR) on Endothelial Cells |
| |
- |
Heparin Is a Multifaceted Anti-Adhesive Agent: Inhibition of Phosphatidylserine (PS)-Positive Erythrocyte Binding to Matrix Thrombospondin (TSP) |
| Severova TV |
- |
Home Treatment of Patients with Hemophilia Using Clotting Factor Concentrates VIII and IX Ahemphil A and Ahemphil B |
| |
- |
Diagnosis and Treatment of Von Willebrand's Disease |
| Seveso M |
- |
Long-Term Treatment with High-Dose Recombinant Human Antithrombin does not Prevent Acute Humoral Rejection in Primate Recipients of Porcine Xenografts |
| Sexauer C |
- |
Long-Term Clinical Experience with FEIBA VH in Hemophilia Patients with Inhibitors |
| Seyfarth H-J |
- |
Measuring Thrombin Generation as Marker of Hypercoagulation in Patients with Lung Cancer |
| Seyfert UT |
- |
Association between Platelet Function Analyzer 100 (PFA-100) Closure Times (CT), Bleeding Time (BT), Platelet Aggregation (PA), Blood Cell Counts, Fibrinogen, Factor VIII (FVIII) and Von Willebrand Factor (VWF) |
| |
- |
Reliability of Platelet Function Analyzer 100 (PFA-100) Closure Times (CT) Induced by Collagen/Epinephrine (CO/EPI) and by Collagen/ADP (CO/ADP) |
| Seyfert-Brand W |
- |
Application of Filtration Technologies for Prion Removal from Plasma Product Intermediates |
| seyfert-Brandt W |
- |
Efficient Reduction of Prions by the Manufacturing Process of Plasma-Derived Products |
| Séguin C |
- |
Isolation and Characterization of Human Bone-Derived Endothelial Cells (hBDECs) for the Study of Vascular Bone Disease States |
| Shafer SS |
- |
Factor Xa-Directed Inhibition in Plasma from Patients Undergoing Coumadin Treatment: Observations Relevant to Bridging Therapy |
| Shafi S |
- |
Injury-Inducible Yin Yang-1 Inhibits Vascular Smooth Muscle Cell Growth and Intimal Thickening by Repressing p21WAF1/Cip1 Transcription and Perturbing Cyclin D1-Cdk4-p21WAF1/Cip1 Assembly |
| Shaifta Y |
- |
Isolation of Megakaryocytic Cells over-Expressing TRPC Channels |
| Shaish A |
- |
Impaired Healing of Cutaneous Wounds in Factor XIII-Deficient Mice |
| Shaji RV |
- |
Molecular Characterization of Haemophilia B: 17 Novel Mutations in Patients of Indian Origin |
| Shakeel A |
- |
Unusual Thrombophilic Manifestations of Protein C Deficiency, Factor V Leiden and Antiphospholipid Syndrome From Sultanate of Oman |
| Shaklee P |
- |
A Multi-instrument Evaluation of a Chromogenic Factor X Assay for Monitoring Oral Anticoagulation Therapy |
| Shakoor S |
- |
The Effect of Coronary Distal Embolisation on Myocardial Blood Flow and Platelet Activation |
| Shang Y |
- |
Alteration of Protein Z in Malignant Tumors and Its Significance |
| Shang D |
- |
Apical Sorting of ADAMTS13 in Madin-Darby Canine Kidney (MDCK) Cells Depends on an Association with Detergent-Insoluble Sphingolipid and Cholesterol-Enriched Rafts |
| Shankar J |
- |
Adult Non-Twin Sib Concordance Rates for Non-Insulin Dependent Diabetes Mellitus (NIDDM) and Hypertension in Asian Indian Population |
| Shankar H |
- |
P2Y12 Receptor Mediated Thromboxane A2 Generation in Human Platelets Occurs in A GIRK Dependent Manner |
| Shankar H |
- |
Molecular Mechanism and Functional Implications of Thrombin-Mediated Tyrosine Phosphorylation of PKCd in Platelets |
| Shankar J |
- |
Heritability of Triglyceride and Relationship with Sac-1 Polymorphism in 3'-Untranslated Region (UTR) of Apolipoprotein CIII Gene: Linkage of Apolipoprotein CIII Locus (Chromosome 11 q23) and Association of Variant Allele with Coronary Artery Disease (CAD) |
| Shanley C |
- |
Fibrinolytic Peritoneal Response to Laparoscopic Surgery |
| |
- |
Validation of a Clinical Score (CS) Plus D-Dimer (DDi) Combination As a Diagnostic Strategy to Exclude Pulmonary Embolism (PE) |
| |
- |
Neonatal DIC by Enterovirus. Favorable Outcome with Maternal Plasma Transfusion |
| |
- |
Failure of the Outpatient Bleeding Risk Index to Predict Major Bleeding in Older Patients Receiving Coumarin for Atrial Fibrillation |
| Shann F |
- |
Developmental Haemostasis and Response to Heparin Therapy in Children |
| |
- |
Tissue Factor Pathway Inhibitor (TFPI) during Heparin Therapy in the Paediatric Intensive Care Unit (PICU) |
| Shao B |
- |
A Monoclonal Antibody Against Platelet GPVI Impaires the Interaction Between Platelet and Collagen |
| Shapiro A |
- |
Induction of Immune Tolerance Utilizing Third Generation Recombinant Factor VIII [Advate]: A Report of Two Cases |
| |
- |
Clinical Efficacy and Safety Evaluation of ADVATE Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method (rAHF-PFM) During Surgical and Invasive Procedures |
| |
- |
A Phase II/III Clinical Study for the Determination of the Efficacy and Safety of Protein C Concentrate in Subjects with Severe Congenital Protein C Deficiency Interim Study Analysis |
| |
- |
Efficacy, Safety and Pharmacokinetic Properties of ADVATE rAHF-PFM in Previously Treated Patients (PTPs) Less Than 6 years of Age |
| |
- |
A Missense Mutation in Exon 28 (C4120T) of the Von Willebrand Factor Gene is the Cause for Von Willebrand Disease in a Large Amish Pedigree |
| Shariat-Madar Z |
- |
Prolylcarboxypeptidase (PRCP): Characterization of Truncated Forms |
| |
- |
Prolylcarboxypeptidase Activates Plasma Prekallikrein on Transfected CHO Cells |
| Sharifi M |
- |
Regulation of Platelet Guanylyl Cyclase by Collagen: Evidence That Glycoprotein-VI Mediates Platelet Nitric Oxide Synthesis in Response to Collagen |
| Sharpe P |
- |
Comparative Structural Analysis of Recombinant Factor VIII (rFVIII): Defining Full-Length FVIII |
| |
- |
Molar Specific Activity of Factor VIII: An Alternative Means of Comparing FVIII Concentrates |
| Shattil SJ |
- |
Integrin As Scaffold |
| Shaun PJ |
- |
Importance of Temporal Flow Gradients and Integrin aIIbb3 Mechanotransduction for Shear-Activation of Platelets |
| Shaw GD |
- |
Prevention of Canine Coronary Artery Thrombosis by the von Willebrand Factor Antagonist, GPG290 |
| Shaw GD |
- |
A Novel P-Selectin Inhibitor, PSI-697, Demonstrates Positive Activity Following Oral Administration in Rodent Models of Vascular Inflammation |
| |
- |
The Activity of GPG-290, An Antagonist of vWF-mediated Platelet Capture, Can Be Rapidly Monitored Using the PFA-100 Assay |
| Shaw G |
- |
WAY-197697, a P-selectin Antagonist, Reduces Atherosclerosis in Apolipoprotein E Deficient Mice |
| |
- |
Prophylaxis using a Novel Oral Small Molecule Inhibitor to the P-selectin Receptor Promotes Thrombus Resolution in a Baboon Model of Venous Thrombosis |
| Shawn MJ |
- |
Role of FcRg and FXIII in Coated Platelet Formation and Platelet Procoagulant Activity in Mice |
| Shcherbak VA |
- |
Lymphocyte-Platelet Adhesion in Children with Chronic Gastritis |
| Shechter M |
- |
Statins Confer a Direct Anti-Platelet Effect in Patients with Acute Myocardial Infarction Treated with Aspirin and Clopidrogel: Ex-vivo and in-vitro Study Results |
| Sheffield WP |
- |
Fusion of the N-terminal Acidic Domain of Heparin Cofactor II to a1-PI M358R Increases the Rate of Thrombin Inhibition |
| Sheikh H |
- |
Risk Factors for Central Retinal Vein Occlusion |
| Shelat SG |
- |
Serologic Results in Suspected Heparin-Induced Thrombocytopenia |
| Shen F |
- |
A Monoclonal Antibody Against Platelet GPVI Impaires the Interaction Between Platelet and Collagen |
| Shen Y |
- |
Regulation of Platelet Receptors |
| Shen Y |
- |
Interaction of Calmodulin with the Platelet ADP Receptor P2Y1 |
| Shen Y |
- |
A Familial Platelet Function Disorder Associated with Abnormal Signaling Through the Glycoprotein VI Pathway |
| Shen M |
- |
The Pharmacogenetics and Inhibitor Risk (PIR) Study: Do the Multiple Forms of Wildtype Factor (F)VIII Contribute to the Development of Anti-FVIII Antibodies in Hemophilia a Patients during Coagulation Factor Replacement Therapy? |
| Shen MC |
- |
Genetic Frequencies of Single Nucleotide Polymorphisms in Predisposition to a Hypercoagulable State in Taiwan |
| Shen MJ |
- |
Drug-induced Thrombocytopenia: Mapping of the binding Site of the Rifampicin-dependent Antibody on GPIX |
| Shen M-C |
- |
An Unusual Clustering of S1506Lmutation in Type 2A von Willebrand Disease Seen in Taiwan |
| Shenkman B |
- |
High Rate of Unresponsiveness to Clopidogrel in Patients with Acute Coronary Syndrome (ACS) As Determined by the Impact-R [Cone And Plate(let) Analyzer] |
| Shenkman B |
- |
Low rate of Responsiveness to Aspirin in Acute Brain Ischemia: Association with Stroke Severity and Clinical Outcome |
| |
- |
Platelets Promote CD4+ Lymphocyte Adhesion to Extracellular Matrix and Fibronectin Under Flow: Role of Integrins, CD40 Ligand and P-Selectin Glycoprotein Ligand-1 |
| |
- |
Influence of Interleukins on CD 4+ T-lymphocyte Adhesion to Extracellular Matrix in Presence of Platelets under Flow Condition |
| |
- |
Aspirin Resistance in Acute Brain Ischemia: Association with Stroke Severity and Outcome |
| |
- |
A Novel Mutation In Platelet Glycoprotein Iba Causing BernardSoulier Syndrome In A Bucharian Jewish Family |
| |
- |
Statins Confer a Direct Anti-Platelet Effect in Patients with Acute Myocardial Infarction Treated with Aspirin and Clopidrogel: Ex-vivo and in-vitro Study Results |
| |
- |
Platelet Function of Preterm and Full Term Newborns Tested by The Cone and Plate(let) Analyzer Correlates with Gestational Age |
| Sheppard JI |
- |
Four Direct Thrombin Inhibitors (DTIs) Variably Increase the Prothrombin Time: A Consequence of Differing Therapeutic Molar Concentrations? |
| Sheppard C |
- |
Preliminary Results of a Cross-Sectional Study of Mild Hemophilia A in Newfoundland and Labrador, Canada |
| Shetty S |
- |
Thrombophilia Markers in Cases of Inflammatory Bowel Disease (IBD) |
| Shetty KR |
- |
Plasma Homocysteine and Coronary Artery Disease (CAD) in Asian Indians: An Unlikely Risk Factor |
| Shetty S |
- |
VWF1 Andvwf2 Alleles (Intron 40) Are Suitable Markers for Carrier Detection and Antenatal Diagnosis in VWD Families in Indian Population |
| Shetty S |
- |
Prevalence of type 2N von Willebrand Disease in Indian VWD patients |
| |
- |
Prevalence of Thrombophilic Mutations and Polymorphisms in Cases of Recurrent Pregnancy Loss (RPL) |
| Sheydina A |
- |
The Study of Genetics Risk Factors Predisposing to Myocardial Infarction in Young Men |
| Sheydina A |
- |
ABCA1 Transporter and Paraoxonase Gene Polymorphisms in Myocardial Infarction and Stroke |
| Shi GY |
- |
Pleiotropic Functions of Thrombomodulin Domains |
| Shi CS |
- |
Pleiotropic Functions of Thrombomodulin Domains |
| Shi G-y |
- |
Characterization Of Factor IX With Mutations At Residues 190 And 192 Of The Heavy Chain Of Defective Factor IX Found In Patients With Hemophilia B |
| Shi Q |
- |
Platelet-Derived Factor VIII (FVIII) Is Protected from Inhibitor Inactivation A Potential Approach for Gene Therapy of Hemophilia A with Inhibitors |
| Shi CS |
- |
Thrombomodulin Domain as an Angiogenic Factor |
| Shi GY |
- |
Thrombomodulin Domain as an Angiogenic Factor |
| Shi Q |
- |
Murine Hemophilia A is Phenotypically Corrected by Platelet-Expressed Factor VIII Even in the Absence of Detectable Plasma FVIII |
| Shi G-Y |
- |
Thromboxane A2 Null Mice Exhibit Resistance to Atherosclerosis and Neointima Formation in a Carotid Artery Ligation Model |
| Shi GY |
- |
Thrombomodulin Regulates Cell to Cell Junction Formation |
| Shi JM |
- |
The Association of Arterial Thrombosis and Polymorphisms of Platelet Glycoproteins and von Willebrand Factor in the Chinese Population |
| Shiach CR |
- |
Management of Injecting Drug Users (IDU) with Deep Vein Thrombosis (DVT): A Delphi Study |
| |
- |
Outreach Anticoagulation Project For Injecting Drug Users With Deep Vein Thrombosis: A Randomised Controlled Trial |
| |
- |
Anaemia in Injecting Drug Users (IDU) with Deep Vein Thrombosis (DVT) |
| Shibamiya A |
- |
The Marburg I SNP (G511E) of Factor VII Activating Protease (FSAP), Which Is Linked to Atherothrombosis, Exhibits Diminished Proteolytic Activity |
| Shibamiya A |
- |
Extracellular RNA Potentiates Factor VII Activating Protease (FSAP)Mediated Inhibition of Vascular Smooth Muscle Cell Proliferation Induced by Platelet-Derived Growth Factor-BB (PDGF-BB) |
| |
- |
Extracellular Nucleic Acids Serve as Novel Cofactors for Blood Coagulation Via Contact Pathway Activation |
| Shibano T |
- |
Pharmacological Characterization, Antithrombotic and Bleeding Effects of DU-176b, a Novel, Potent and Orally Active Direct Inhibitor of Factor Xa: A Wider Safety Margin of Antithrombotic and Bleeding Effects Compared to Heparin, LMWH and Warfarin |
| |
- |
Antithrombotic Effects of a Direct Factor Xa Inhibitor, DU-176b, and an Antithrombin Dependent Factor Xa Inhibitor, Fondaparinux, on an Ex vivo Capillary Perfusion Chamber Thrombosis Model in Rats |
| |
- |
Recombinant Factor VIIa Reverses Te Prolonged Bleeding Time Induced B A High Dose of DU-176b, a Novel Direct Factor Xa inhibitor, In Rats |
| |
- |
Hepatocytes are the Major Site of ADAMTS-13 Expression in Human Liver |
| |
- |
Antithrombotic Properties of DU-176b, a Novel Orally Active Factor Xa Inhibitor: Inhibition of both Arterial and Venous Thrombosis, and Combination Effects with Other Antithrombotic Agents |
| |
- |
Individual Variation of Platelet Functions after in vitro Incubation with Aspirin: Assessment of Aspirin Resistance in Healthy Subjects Using PFA-100® |
| Shibata M |
- |
Characterization of Recombinant Canine Factor VIII and Quantitative Determination of Factor VIII in Canine Plasma |
| Shibata H |
- |
Evaluation of Shape Change in Chilled Blood Platelet Using Light Scattering |
| |
- |
Platelet Thrombus Formation in Blood Vessel-Mimicking Microchannel |
| Shibata T |
- |
Measuring Concentration of Soluble Fibrinogen and Fibronectin Complexes (FG-FN) in Patient' Plasma with Various Diseases Using Two-Step Sandwich ELISA Method |
| Shibeko AM |
- |
Computer Simulation Model of Spatial Dynamics of Fibrin Clot Growth Under Conditions of Blood Flow |
| Shields DC |
- |
Unusual Haplotypic Associations with Marked GPIIIa Allelic Expression Bias in the Platelets of PlA2 Heterozygotes |
| |
- |
Accurate RNA Transcript Profiling of Platelets from Clinically Relevant, Small Blood Volumes |
| Shigeatsu E |
- |
A Multicenter, Prospective Validation of Disseminated Intravascular Coagulation Diagnostic Criteria for Critically Ill Patients: Comparing Current Criteria |
| Shigenaga T |
- |
Pharmacological Properties of YM-254890, a Specific Gaq/11 Inhibitor, on Thrombosis and Neointima Formation in Mice |
| Shih MH |
- |
The Antithrombotic Effect of the Fibrinogen-Binding Fragment of Staphylococcus Aureus Clumping Factor A |
| Shiku H |
- |
Proteinase 3 Expression on Neutrophil Membranes from Patients with Infectious Disease |
| |
- |
A Simple Technique to Determine Thrombopoiesis Level Using Immature Platelet Fraction (IPF) |
| Shiller E |
- |
The Occasions of Factor XII Deficiency in Children |
| Shiller EE |
- |
Family with Inherited f.X Deficiency. Case Report |
| Shilo V |
- |
Homocysteine, Genetic Venous Thrombosis Risk Factors in Patients on Maintenance Hemodialysis Underwent Vascular Access Thrombosis |
| Shilov IA |
- |
Study of the Methylenetetrahydrofolate Reductase Gene Promoter in Patients With Heterozygous C677T MTHFR Gene Polymorphism and Hyperhomocysteinemia |
| Shiltagh N |
- |
Obstetric Experience of Carriers of Haemophilia |
| Shim K |
- |
Platelet-VWF Complexes Are Preferred Substrates of ADAMTS13 Under Shear Stress |
| Shima M |
- |
Factor VIII Mimetic Antibody: (1) Establishment and Characterization of Anti-factor IX/Anti-factor X Bispecific Antibodies |
| Shima M |
- |
Factor VIII Mimetic Antibody: (2) In Vitro Assessment of Cofactor Activity in Hemophilia A |
| Shima MK |
- |
Mapping of B Cell Epitopes on the Factor VIII C2 Domain |
| Shimazu C |
- |
Increased Levels of Hepatocyte Growth Factor in Patients with DIC |
| Shimizu A |
- |
Individual Variation of Platelet Functions after in vitro Incubation with Aspirin: Assessment of Aspirin Resistance in Healthy Subjects Using PFA-100® |
| Shimoji T |
- |
CS-747 (Prasugrel, LY640315) Produces Potent and Sustained Platelet Inhibitory Effects in Dogs and Monkeys During Multiple Dosing That Are Enhanced by Co-administration of Aspirin |
| |
- |
Comparative Antiplatelet Effects of the Active Metabolites of CS-747 (Prasugrel, LY640315) and Clopidogrel |
| |
- |
Effective Inhibition of Platelet Aggregation and Release Reaction with Lack of Effect on Shape Change by CS-747 (Prasugrel, LY640315) and Its Active Metabolite |
| Shimomura I |
- |
Enhanced Platelet Aggregation and Thrombogenic Tendency in Adiponectin-Deficient Mice |
| Shin HS |
- |
Cardioprotective Effect of KR-32568, a Novel Sodium/hydrogen Exchanger-1 Inhibitor, in a Rat Model of Ischemia and Reperfusion Heart Injury |
| Shin L |
- |
Effect of Chemotherapeutic Agents on the Protein C Anticoagulant Pathway |
| Shin HS |
- |
Antiplatelet Activity of KR-32560, a Novel Selective Sodium/hydrogen Exchanger-1 Inhibitor |
| Shindo T |
- |
Significance of the Transcription Factor KLF5 in Cardiovascular Remodeling |
| Shinji O |
- |
Diabetic Microangiopathy is a Disease of Disturbance of the PDGF-BB/PKC Axis, But Not of Impaired Expression of Angiogenic Factors |
| Shinozawa K |
- |
Factor V Mutations, Arg2174Leu, a 5-bp Deletion and Val1813Met, Are Associated with Factor V Deficiency and A Bleeding Tendency |
| Shinozawa K |
- |
Four Novel Missense Mutations in Factor IX Gene Were Identified as Causes of Hemophilia B |
| Shintani N |
- |
Effects of Recombinant Antithrombin Expressed in Chinese Hamster Ovary Cells on Endotoxin- or Thromboplastin-Induced DIC in Rats and Concanavalin A-Induced Liver Injury in Mice |
| Shiokawa Y |
- |
Prevention of Postoperative Pulmonary Embolism in the Japanese Academic Medical Center |
| Shiomi T |
- |
Hepatocytes are the Major Site of ADAMTS-13 Expression in Human Liver |
| Shiozaki Y |
- |
Antithrombotic Properties of DU-176b, a Novel Orally Active Factor Xa Inhibitor: Inhibition of both Arterial and Venous Thrombosis, and Combination Effects with Other Antithrombotic Agents |
| Shiozaki H |
- |
Prevention of Postoperative Pulmonary Embolism in the Japanese Academic Medical Center |
| Shirafuji N |
- |
Increased Levels of Hepatocyte Growth Factor in Patients with DIC |
| Shiraga M |
- |
Negative Regulation of Platelet Function by a Secreted Cell Repulsive Protein, Semaphorin 3A |
| |
- |
Enhanced Platelet Aggregation and Thrombogenic Tendency in Adiponectin-Deficient Mice |
| Shirai H |
- |
Circadian Clock Genes are Involved in the Regulation of fibrinolytic Activities in Mice |
| |
- |
Circadian Oscillation of Thrombomodulin Gene Expression in Peripheral Tissues |
| Shivdasani RA |
- |
Regulation of Thrombopoiesis |
| Shmeleva V |
- |
Genetic Polymorphisms and Environmental Influences in Arterial Occlusive Diseases |
| |
- |
Hyperhomocysteinemia Is a Significant Risk Factor for Recurrent Early Pregnancy Loss in Russia |
| Shmilovich H |
- |
Comparative Analysis of Methods for Assessment of Circulating Endothelial Progenitor Cells Indicated Heterogeneity of Subpopulations at Various Stages of Differentiation |
| Söhne M |
- |
Brain Natriuretic Peptide in Hemodynamically Stable Acute Pulmonary Embolism |
| |
- |
Diagnostic Strategy Using a Modified Clinical Decision Rule and D-Dimer Test to Rule Out Pulmonary Embolism in Elderly in- and Outpatients |
| Shochat C |
- |
Endothelial Protein C Receptor (EPCR) Gene Polymorphisms and sEPCR Levels in Women with Recurrent Pregnancy Loss |
| Shopova S |
- |
Prophylaxis for Hemophilia A and B Present and Future |
| Shorey N |
- |
Comparison of Four D-Dimer Tests Combined with Clinical Probability Assessment to Exclude Deep Venous Thrombosis in Symptomatic Outpatients |
| |
- |
Combining Pretest Probability Score and Antigenic Assays in the Diagnosis of HIT A Viable Alternative to Functional Assays |
| Shrimati S |
- |
Prevalence of type 2N von Willebrand Disease in Indian VWD patients |
| Shrimpton CN |
- |
Relationship of Lipid Rafts and the Platelet Cytoskeleton |
| |
- |
Receptors, Rafts, and Microvesicles in Thrombosis and Inflammation |
| Shrum D |
- |
Use of FEIBA for Surgical Procedures in Patients with Severe Hemophilia A and B and Inhibitors |
| Shu A |
- |
Four Novel Missense Mutations in Factor IX Gene Were Identified as Causes of Hemophilia B |
| Shubilat T |
- |
A Thirteen Year Retrospective Study of Inherited Bleeding Disorders in the Jordanian Population |
| Shukla JS |
- |
Quality Systems in Automated Plateletpheresis in Hospital Based Blood Transfusion Services in North India |
| |
- |
Influence of Pre Donation Donor Factors on the Yield of Platelets Using Intermittent Flow Cell Separators |
| Shuman H |
- |
Kinetics of Fibrinogen Binding to aIIbb3 Binding Studied at the Single Molecule Level Using Optical Tweezers |
| Shu-Wha Lin S-w |
- |
Characterization Of Factor IX With Mutations At Residues 190 And 192 Of The Heavy Chain Of Defective Factor IX Found In Patients With Hemophilia B |
| Shvachko LP |
- |
Study on Secondary Structure and Properties of Human Gamma-Thrombin |
| Sié P |
- |
Microparticles from Smooth Muscle Cells Induce Endothelial Dysfunction, a Phenomenon Prevented by Glycoprotein IIb/IIIa Antagonists |
| Siani A |
- |
C-Reactive Protein and Its Determinants in European Populations at Different Risk of Cardiovascular Disease: Results from the IMMIDIET Project |
| |
- |
Association Between -675 4G/5G Polymorphism of the PAI-1 Gene and Obesity in Men: Longitudinal Findings of the Olivetti Heart Study |
| |
- |
Genetic and Environmental Regulation of Factor VII Levels: Results from the IMMIDIET Project |
| |
- |
Walking and Modulation of Cardiovascular Risk Factors in Three European Populations: Results from the IMMIDIET Project |
| |
- |
Comparison of Global Risk of Fatal Cardiovascular Disease in Three European Populations Using SCORE Equations: Results from the IMMIDIET Project |
| Siboni SM |
- |
Prospective Study on Acute Thrombotic Microangiopathy (TMA) after Bone Marrow Transplantation (BMT): Role of ADAMTS13, VWF:Ag and High Molecular Weight von Willebrand Factor (HMW : VWF) |
| Siboni SM |
- |
Molecular Characterization in an Italian Patient with Plasminogen Deficiency And Ligneous Conjunctivitis |
| Sickmann A |
- |
Glycosylation Site Analysis of Human Platelet Proteins |
| |
- |
An Approach to Elucidate the Platelet Membrane Proteome |
| Siddiqui FA |
- |
CD40 and CD40 Ligand (CD40L) in Primary Hemostasis and Antibody-Mediated Platelet Activation |
| Siddiqui AJ |
- |
Therapeutic Endogenous Ligand/Receptor Induction of the VEGF-Angiopoietin System after Intramyocardial Gene Transfer during Myocardial Ischemia |
| Sidelmann JJ |
- |
Lupus Anticoagulant (LA) is Significantly Associated with Inflammation Among Patients Suspected for Deep Vein Thrombosis (DVT) |
| Sidelmann JJ |
- |
Reduced Fibrin Compaction and Increased Fibrin Formation Rate in Patients with End-Stage Renal Disease |
| SidelmannMünsterMünster JJAMBH |
- |
Alterations of the Tissue-Factor Induced Pathway of Coagulation during Acute Deep Vein Thrombosis (DVT): Significant Increase in Tissue-Factor Pathway Inhibitor (TFPI) |
| Sié P |
- |
Screening of Factor V Leiden (FVL) and Risk-Assessment of Venous Thrombosis in Non-FVL-Carriers: Comparison of Different Methods for Activated Protein C Resistance (APCR) Measurement |
| Siegbahn A |
- |
IL-10 Inhibits TF mRNA and the Surface Expression of TF in Platelets-monocytes Aggregates In Stimulated Whole Blood |
| Siegbahn A |
- |
Elevated Levels of Interleukin-10 and the IL-10 -819 C/T SNP Are Predictors of Poor Prognosis in Patients with Acute Coronary Syndrome |
| Siegbahn A |
- |
Activation of MAP Kinase Pathway in Monocytes by TF/FVIIa is Required for TNF-a Production but not for PDGF-BB Induced Chemotaxis |
| |
- |
Higher Coagulation Activity and anti-Xa levels During Dalteparin Treatment in Women with Unstable Coronary Artery Disease |
| |
- |
The Impact of Tissue Factor Single Nucleotide Polymorphisms on Risk, Outcome and Plasma levels in Acute Coronary Syndrome |
| |
- |
The -3459 A > GSNP in the CD40L Gene Predicts Plasma Concentrations and Outcome in Patients with Acute Coronary Syndrome (FRISC-II) |
| |
- |
Gender Related Differences in Coagulation Activity in Unstable Coronary Artery Disease Patients and Apparently Healthy Individuals |
| |
- |
Persistently Reduced D-dimer Levels by the Oral Direct Thrombin Inhibitor Ximelagatran Indicate Reduced Risk of New Ischemic Events after Myocardial Infarction |
| Siegbahn A |
- |
The TF 5466 a/G SNP is a Novel Regulator of Tissue Factor Expression |
| Siegbahn A |
- |
Tissue Factor Regulation, RhoA Localization, and Induction of Apoptosis in Human Cancer Cell Lines upon Simvastatin Treatment |
| Siegel JE |
- |
The Variability of Platelet Function Testing |
| Siegemund A |
- |
Identifying the Bleeding Tendency in Patients with Hypo- and Dysfibrinogenemia |
| Siegemund T |
- |
Identifying the Bleeding Tendency in Patients with Hypo- and Dysfibrinogenemia |
| Siegemund A |
- |
Analytical Evaluation of a Fully Automated Chromogenic Assay for the Determination of Endogenous Thrombin Potential (ETP) |
| Siegemund T |
- |
Measuring Thrombin Generation as a General Parameter in Relation to Single Coagulation Tests |
| Siegemund A |
- |
Measuring Thrombin Generation as a General Parameter in Relation to Single Coagulation Tests |
| Siegemund A |
- |
Measuring Thrombin Generation as Marker of Hypercoagulation in Patients with Lung Cancer |
| Siegemund T |
- |
Measuring Thrombin Generation as Marker of Hypercoagulation in Patients with Lung Cancer |
| Siegemund T |
- |
Thrombin Generation as Parameter to Monitor Patients with Thrombophilia and Pregnancy |
| Siegemund A |
- |
Thrombin Generation as Parameter to Monitor Patients with Thrombophilia and Pregnancy |
| Siegemund T |
- |
Influence of Factor IIa- and Factor Xa-Inhibitors on Thrombin Generation in Platelet-Rich Plasma |
| Siegemund A |
- |
Influence of Factor IIa- and Factor Xa-Inhibitors on Thrombin Generation in Platelet-Rich Plasma |
| |
- |
Individual Efficacy Measurement of FVIII Replacement Therapy in Cell-based Monitoring Tests |
| Siegemund T |
- |
Influence of Platelet Transfusion on Thrombin Generation in Patients with Bone Marrow Transplantation |
| Siegemund A |
- |
Influence of Platelet Transfusion on Thrombin Generation in Patients with Bone Marrow Transplantation |
| Siegert G |
- |
In vitro Determination of Platelet Function in Whole Blood from Obese Children and Adolescents |
| Siegert G |
- |
Importance of the FV Level Screening for Individual Thrombotic Risk |
| Siegmund B |
- |
ADVOY: First Experiences with an Internet Based Electronic System for Documentation of Haemophilia Therapy of Patients in Home Treatment |
| Siejka A |
- |
Thalidomide Affects Early Phases of VEGF Stimulated Angiogenesis in Human Endothelial Cells |
| Sieri S |
- |
Genetic and Environmental Regulation of Factor VII Levels: Results from the IMMIDIET Project |
| Sierko E |
- |
Heterogeneous Expression of Components of Protein C (PC) System in Human Colon Cancer Tissue |
| Sierko E |
- |
Immunohistochemical Localization of Protein Z (ZP) and Protein Z-Dependent Protease Inhibitor (ZPI) in Situ in Human Malignant Tumors |
| Siess W |
- |
Glykoprotein VI Mediates Platelet Adhesion to Vulnerable Human Atherosclerotic Plaque |
| Siguret V |
- |
We Still Need to Organize French Anticoagulation Clinics |
| |
- |
A Multi-Rule Expert System to Manage OAT in Most Real-Life Clinical Situations |
| Siigur E |
- |
Snake Venom Apoptotic L-Amino Acid Oxidase (LAAO) Inhibits Platelet Aggregation |
| Siigur J |
- |
Snake Venom Apoptotic L-Amino Acid Oxidase (LAAO) Inhibits Platelet Aggregation |
| Siigur E |
- |
A Heterodimeric Metalloprotease from Vipera Lebetina Venom Induces Human Endothelial Cell Apoptosis |
| Siigur J |
- |
A Heterodimeric Metalloprotease from Vipera Lebetina Venom Induces Human Endothelial Cell Apoptosis |
| Siitonen SM |
- |
Generation of Activated Protein C and Phagocyte Activation Associated with Immmunosuppression Using Anti-Thymocyte Globulin for Kidney Transplantation |
| Sikirica MV |
- |
Monitoring International Normalized Ratio (INR) in Patients with Chronic Non-Valvular Atrial Fibrillation: Relationships between INR and Adverse Outcomes? |
| [Scaron]ikurová L |
- |
Increased Aspirin Hydrolysis in Plasma of Patients with Type 2 Diabetes Mellitus: A New Mechanism of Aspirin Resistance? |
| Silacci P |
- |
Egr-1: A Key Mediator of Oscillatory Shear Stress Induction of Tissue Factor Promoter |
| Silaraks S |
- |
Changes in Thrombogenic Markers but not Factor XIII in Left Atrium of Thai Patients with Mitral Stenosis |
| Silence K |
- |
Active Von Willebrand Factor Is present in Plasma of Patients with Von Willebrand Disease Type 2B Or ADAMTS-13 Deficiency |
| Silingardi M |
- |
Clinical Experience with Optional Vena Cava Filters: Results of a Prospective Observational Multicenter Study |
| |
- |
Prevalence of Thrombophilic Abnormalities in Patients with Deep Vein Thrombosis or Pulmonary Embolism |
| |
- |
Duration of Anticoagulant Treatment and Recurrence of Venous Thromboembolism in Patients with and without Thrombophilia |
| |
- |
A Randomized Trial Comparing 1 mg Oral Vitamin K with Placebo for the Treatment of Warfarin-associated Coagulopathy in Patients with Mechanical Heart Valves |
| Siljander PR-M |
- |
Distinct Signals in Procoagulant Adherent Platelets Compared to Aggregated Platelets |
| Siljander P |
- |
Functional Evidence for Three I-domain Activation States for Platelet a2b1 Integrin |
| Siljander PRM |
- |
Disclosure of Microdomain Structure and Function in Arterial Thrombi of Heterogeneous Composition |
| Siljanovski N |
- |
Implantation of Total Hip Prosthesis in a Hemophilic Patient Is Antithrombotyc Prophylaxis Necessary? |
| Sillat T |
- |
A Heterodimeric Metalloprotease from Vipera Lebetina Venom Induces Human Endothelial Cell Apoptosis |
| Sillesen H |
- |
Catheter Directed Thrombolysis of Acute Iliofemoral Deep Venous Thrombosis Is Effective and Preserves Venous Valve Function. Results from a Prospective One-centre Study of 60 Cases |
| Silva DM |
- |
Antithrombotic Effect of Bothrojaracin, a Bothrops jararaca Snake Venom-Derived (Pro)thrombin Inhibitor |
| Silva W |
- |
Identification of Gene Defects in Brazilian Patients with Types 2B, 2M and 3 of von Willebrand Disease |
| Silva HF |
- |
Incidence of Factor VIII Inhibitor in Hemophilia A in Ceara Brazil |
| Silva MAM |
- |
Incidence of Factor VIII Inhibitor in Hemophilia A in Ceara Brazil |
| Silvanova E |
- |
Thrombophilia: Factor V Leiden in Patients with Cardiovascular Diseases in Slovak Population |
| Silver L |
- |
Screening for Aspirin Responsiveness after TIA and Stroke in the Oxford Vascular Study: Comparison of Two Point of Care Platelet Function Tests with Aggregometry |
| |
- |
A Comparison of the Incidence of PFA-100® Aspirin Non-Responders with 3.2% and 3.8% Citrated Blood (with and without Addition of in Vitro Aspirin) |
| |
- |
Aspirin Non-Responsiveness in a Population-Based Study of Acute Vascular Events |
| Sim Y |
- |
Plasma proCPU (TAFI) Concentrations and Clot Lysis Time Are Not Different in a Chilean Population of Young Healthy Individuals Subgrouped According to the Naturally Occurring 325 Thr/Ile Polymorphism |
| |
- |
Patients with Mucocutaneous Bleeding and Hereditary Disorders of Primary Haemostasis Have Higher Plasma proCPU Levels But a Similar Distribution of the 325 Thr/Ile Polymorphism Compared to Age and Sex Matched Healthy Controls |
| Simanek R |
- |
High Incidence of Symptomatic Venous Thromboembolism in Patients with Glioblastoma |
| [Scaron]imek |
- |
Changes of Coagulation after Single i.v. Bolus 0.75 mg Per kg of Low Molecular Weight Heparin Enoxaparin During PCI A Pharmacokinetic Study |
| Simes RJ |
- |
Low-Dose Aspirin for Secondary Prophylaxis of Vein Thrombosis A Prospectively Planned Meta-Analysis |
| Simionescu M |
- |
Cardiomyogenic Differentiation Induced by in vitro Manipulation of Adult Stem Cells |
| |
- |
VCAM-1 as Target for Immunoliposome-Mediated Drug Delivery to Activated Endothelial Cells |
| Simioni P |
- |
Clinical and Molecular Characterization of Three Italian Patients with Severe Factor V Deficiency and Bleeding Disorder (Parahaemophilia): Report of a Novel Homozygous Mutation (FV: Asp524His) |
| |
- |
Different Thromboprophylaxis Approaches in Patients Undergoing Knee Arthroscopy (KANT Study): A Prospective Randomized Study |
| |
- |
Is There a Role of Thrombophilia in the Progression of Carotid Plaques and/or in the Onset of Cerebrovascular Ischemic Events in Asymptomatic Patients? Results of a Prospective Study (CAST Study) |
| Simioni P |
- |
Venous Thromboembolism (VTE) in Patients with Antiphospholipid Antibodies Against Protein C and/or Protein S: A Case-Control Study |
| |
- |
Cerebral Sinovenous Thrombosis in Children |
| Simioni P |
- |
Thrombin Generation and Activated Protein C Resistance in Factor V Leiden Pseudo-homozygous Patients |
| |
- |
Soluble Endothelial Protein C Receptor Levels (sEPCR) and Thrombotic Manifestations in Carriers of Dysfunctional Protein C Variants |
| |
- |
Increased Risk of Recurrent Venous Thromboembolism in Patients with Deep-Vein Thrombosis Who Are Carriers of the Factor V Leiden or Prothrombin Gene Mutation. A Meta-Analysis |
| Simioni P |
- |
Soluble Endothelial Protein C Receptor (sEPCR) Levels, A3 Haplotype of EPCR Gene and the Risk of Thrombosis in Carriers of Antithrombin (AT), Protein C (PC) and Protein S (PS) Defects |
| Simioni M |
- |
Hereditary Protein C Deficiency: Prevalence and Risk of Venous Thromboembolism in the General Population. Preliminary Results from the Vita Study |
| Simioni P |
- |
Long-Term Treatment with High-Dose Recombinant Human Antithrombin does not Prevent Acute Humoral Rejection in Primate Recipients of Porcine Xenografts |
| Simioni P |
- |
FV Leiden Mitigates Bleeding Tendency in Recessive Type 1 von Willebrand Disease |
| |
- |
The G20210A Prothrombin Variant (PT-G20210A) and the Risk of Thromboembolism and Foetal Loss in Pregnant Women: A Retrospective Cohort Study |
| Simioni P |
- |
A Common Pathogenetic Link between Venous Thrombosis and Atherosclerosis: Increased Prevalence of Small, Dense LDL |
| Simioni P |
- |
Risk of Recurrent Venous Thromboembolism Associated with Inherited Deficiency of Natural Anticoagulants |
| Simmers T |
- |
Pharmacokinetics and Pharmacodynamics of the Oral Direct Thrombin Inhibitor Dabigatran in a Dose Finding Trial in Atrial Fibrillation |
| Simmet Th |
- |
The Annexin II Heterotetramer is a Receptor for the Plasmin-Induced Signaling in Human Peripheral Monocytes |
| Simon A |
- |
Direct Flow Cytometry Counting of Circulating Endothelial Progenitor Cells in Whole Blood and Relationship with Cardiovascular Risk Factors |
| Simon M |
- |
Monitoring of Heparinization during Extracorporeal Circulation (ECC) with the New Anti-Factor Xa (FXa) Point-of-Care (POC) Clotting Assay Heptest-POC-Hi |
| Simoneau G |
- |
Interaction between Paracetamol and Warfarin: A Double-Blind Placebo-Controlled Randomised Study |
| Simonneau G |
- |
Effect of Age on the Performance of a Diagnostic Strategy Based on Clinical Probability, Spiral CT and Venous Compression Ultrasonography: The ESSEP Study |
| Simons SM |
- |
Amblyomma Cajennense Tick: The Transcriptome, Expression and Biochemical Characterization of a Factor Xa Recombinant Inhibitor |
| Simpson J |
- |
Both, COP I and COP II Coatomers Are Involved in the Anterograde ER to Golgi Transport of B-domain Deleted FVIII |
| Simpson DF |
- |
Oxidative Modification of Low-density Lipoprotein (LDL) and OxLDL/b2GPI Complexes in Patients with Infectious Endocarditis: Possible Role in Aortic Valve Disease |
| |
- |
Circulating oxLDL/b2GPI Complexes, Autoantibodies and Intima-media Thickness in Patients with Systemic Lupus Erythematosus: Possible Role in Autoimmune-mediated Atherosclerosis |
| Sinauridze E |
- |
Comparison of Activated Platelets with Platelet-derived Microparticles in Procoagulant Activity |
| Sinauridze E |
- |
Effects of Plasma Dilution with Crystalloid or Colloid Solutions on Blood Coagulation |
| Sinclair CJ |
- |
Anti-D Compared to IVIg for the Treatment of Immune Thrombocytopenic Purpura: A Systematic Review |
| Sing H |
- |
Diagnosing and Treating Haemorrhagic Disorders in a Developing Country |
| Singelyn FJ |
- |
Extended Thromboprophylaxis with Fondaparinux (Arixtra®) after Major Orthopedic Lower Limb Surgery: The EXPERT Study |
| |
- |
Use of Neuraxial Catheter for Anesthesia/Analgesia in Major Orthopedic Lower Limb Surgery Patients Treated With Prophylactic Doses of Fondaparinux (Arixtra®) in Routine Practice: The EXPERT Study |
| Singer AU |
- |
Crystal Structure of CIB1, an Endogenous Inhibitor of Platelet Integrin aIIbb3 Activation: Delineation of a New Family of Calcium-Binding Proteins |
| Singh S |
- |
Ristocetin Cofactor (VWF:Rco) Assay A Comparison of a Rapid Automated Method on ACL10000 Coagulometer and Conventional Aggregometry |
| |
- |
Data From APTT Clot Curves of Automated Photo-Optical Coagulometers Correlates Better with Heterogeneity of Clinical Presentation in Severe Hemophilia A than FVIII: C Levels |
| Singh RK |
- |
Increased Levels of Procoagulant Factors Associated with Increased Potential for Thrombin Generation in Patients with Premature Myocardial Infarction |
| Sinha P |
- |
A Concept for Preoperative Management of Patients with Impaired Primary Hemostasis |
| |
- |
A Concept for Preoperative Identification of Patients with Impaired Primary Hemostasis |
| Sinha D |
- |
Macromolecular Substrate-Binding Exosites on Both the Heavy and the Light Chain of Factor XIa Mediate the Formation of the Michaelis Complex Required for Factor IX-Activation |
| Sinigaglia F |
- |
HGF Activates Its Met Receptor on Human Platelets and Inhibits Platelets Aggregation |
| |
- |
Study of the Role of Membrane Lipid Rafts in Estrogen Signaling in Human Platelets |
| Sint R |
- |
Von Willebrand Factor-mediated Sorting of Endothelial Secretory Proteins |
| Siotia AK |
- |
Utility of a Whole-Blood Single-Platelet Counting Assay in Monitoring the Effects of Tirofiban |
| Sioufi J |
- |
How Useful is the Monitoring of (Low Molecular Weight) Heparin Therapy by Anti-Xa assay? The Laboratory Perspective |
| |
- |
Towards Harmonisation of D-dimer Assays |
| Siqueira LH |
- |
Molecular Analysis of Two Unrelated Patients with Bernard-Soulier Syndrome Identification of Novel Mutation in Glycoprotein Ib Alpha Gene |
| Sirachainan N |
- |
Acute and Long Term Management for Patients with Severe Protein C Deficiency |
| Siragusa S |
- |
Clinical Experience with Optional Vena Cava Filters: Results of a Prospective Observational Multicenter Study |
| |
- |
Successful Treatment of Acquired Haemophilia with FEIBA® and Retuximab® |
| |
- |
Thrombophilia in Young Adults with Ischemic Stroke Not Related to Cardiovascular Risk Factors |
| Siragusa S |
- |
Residual Vein Thrombosis Assessment Establishes the Optimal Duration of Oral Anticoagulants in Patients with Idiopathic or Provoked Deep Vein Thrombosis: a Randomized, Controlled Trial |
| Siragusa S |
- |
Thrombophilia in Women with Unexplained Fetal Loss |
| Siragusa S |
- |
Objective Assessment of Pulmonary Embolism Can Be Deferred without Risk |
| Siret L |
- |
A Comparison of Two Manufacturing Processes for an Antithrombin Concentrate |
| Sirotkina O |
- |
Inherited Thrombophilias in the Patients with Prosthetic Heart Valves |
| |
- |
Pharmacogenetics of WarfarinCytochrome Cyp2c9 and Vitamin K Epoxide Reductase Gene Polymorphisms in Russian Population |
| Sirotkina O |
- |
The New Single Nucleotide Polymorphisms of Adp Receptor P2y12 Gene Affected Platelet Aggregation and Myocardial Infarction Development Were Found in Russia |
| |
- |
The 4g/5g Polymorphism of the Pai-1 Gene is Associated with Cerebrovascular Disease Development in Childhood and Juvenile Period |
| Sitalakshmi S |
- |
Coagulation Markers as Predictors of Disease Progression in Cancer |
| Sitaru AG |
- |
Platelet CD40L in Chorioamnionitis |
| Sitruk-Ware R |
- |
Comparative Effects of a Contraceptive Vaginal Ring Delivering Nestorone® and Ethinyl Estradiol, and a Combined Oral Contraceptive Containing Levonorgestrel, on Lipids and Inflammation Markers of Arterial Disease |
| |
- |
Comparative Effects of a Contraceptive Vaginal Ring Delivering Nestorone® and Ethinyl Estradiol, and a Combined Oral Contraceptive Containing Levonorgestrel on Risk of Venous Thromboembolism Evaluated through Haemostasis Variables and Sex Hormone Binding Globulin |
| Sittinger K |
- |
A Novel Mutation (Asp36Tyr) in the Vitamin K Epoxide Reductase Complex Subunit 1 (VKORC1) Causes Moderately Increased Coumarin Doses |
| |
- |
Arg485Pro Mutation in the Gamma-Glutamyl Carboxylase Contributes to Three Unrelated German VKCFD Type 1 Patients with Compound Heterozygous Mutations |
| Sivin I |
- |
Comparative Effects of a Contraceptive Vaginal Ring Delivering Nestorone® and Ethinyl Estradiol, and a Combined Oral Contraceptive Containing Levonorgestrel on Risk of Venous Thromboembolism Evaluated through Haemostasis Variables and Sex Hormone Binding Globulin |
| |
- |
Comparative Effects of a Contraceptive Vaginal Ring Delivering Nestorone® and Ethinyl Estradiol, and a Combined Oral Contraceptive Containing Levonorgestrel, on Lipids and Inflammation Markers of Arterial Disease |
| Siwaporn S |
- |
Vitamin K Status in Mothers and Their Newborn Babies: Role of Dietary Phylloquinone Intake |
| Sjøland JA |
- |
Reduced Fibrin Compaction and Increased Fibrin Formation Rate in Patients with End-Stage Renal Disease |
| Sjøland JA |
- |
Lupus Anticoagulant (LA) is Significantly Associated with Inflammation Among Patients Suspected for Deep Vein Thrombosis (DVT) |
| Sjörin E |
- |
Functional Analysis of the Factor Ix Egf-Like Domain Mutation Ile66thr Associated with Mild Hemophilia B |
| |
- |
Novel Mutations in the Factor VIII Gene in Sweden |
| Skarnes W |
- |
Essential Role of Junctional Adhesion Molecule-A in bFGF-Induced Angiogenesis |
| Skibowska A |
- |
Determination of Known Risk Factors of Thromboembolism in Laryngeal and Non-small Cell Lung Cancer Patients |
| Skok M |
- |
Haemostasis Is Regulated through Nicotinic Acetylcholine Receptors |
| |
- |
PAR3 Expression and Functions Studied with Blocking, Cleavage Site-Specific Antibodies |
| Skok M |
- |
The Effect of Fibrin Degradation Products on Neuroendocrine Cells |
| Skokowski J |
- |
Concentration of TF and TFPI in Non-Small Cell Lung Cancer |
| |
- |
AT, TAT and F1+F2 in Radically Operated Non-small Cell Lung Cancer Patients |
| |
- |
Concentration of TAFI and D-Dimers in Radically Operated Non-Small Cell Lung Cancer Patients |
| |
- |
Correlation Between Selected cloTting Factors Parameters and Apoptosis of Peripheral T Lymphocytes in Non-Small Cell Lung Cancer |
| |
- |
Determination of Known Risk Factors of Thromboembolism in Laryngeal and Non-small Cell Lung Cancer Patients |
| |
- |
Expression of the Death Receptor Fas (CD95) on Peripheral T Lymphocytes in Correlation with Selected Clotting System Parameters in Non-Small Cell Lung Cancer |
| Skolnick BE |
- |
No Influence of Antiplatelet Therapy on the Outcome of Acute Intracerebral Haemorrhage Treated with Recombinant Activated Factor VII |
| |
- |
Effects of Recombinant Activated Factor VII on Perilesional Oedema in Patients with Acute Intracerebral Haemorrhage |
| Skov Madsen J |
- |
Occurrence of Venous Thrombosis (VT) Is Not Increased in Women Taking Postmenopausal Hormonal Replacement Therapy (HRT) in the Danish Osteoporosis Prevention Study (DOPS) |
| Skovlund S |
- |
Assessment of Treatment Satisfaction in Patients with Haemophilia Development and Validation of the First Disease-Specific Questionnaire (Hemo-SatA) |
| Skrzipczyk HJ |
- |
Otamixaban, a Direct Factor Xa Inhibitor, More Potently Inhibits Experimental Coronary Thrombosis than Bivalirudin, a Direct Thrombin Inhibitor |
| Skurzynski, Sz1 |
- |
Refolding Characteristics of Recombinant Beta3(109-352) Fragment and Formation of a Functionally Active A-Domain |
| Slaby JA |
- |
Rituximab Treatment of FVIII Inhibitors in Congenital Hemophilia A (cHA) |
| Slatter D |
- |
GPVI-Dependent Binding of Murine Platelets to a Series of Triple-Helical Peptides Derived from Human Type III Collagen |
| Slavik L |
- |
Clinical Phenotype of Hemophilia and Prothrombotic Gene Mutation |
| Slavik L |
- |
Prevalence of Inherited Thrombophilia in Severe OHSS |
| |
- |
Determination of Platelet Derived Microparticles in Patients with Autoimmune Thrombocytopenia (AITP) |
| Slavkovic B |
- |
Pediatric Thrombosis |
| [Scaron]lechtová MUDr.J |
- |
The Monitoring FEIBA Therapeutic Effect in a Haemophiliac with an Inhibitor by the Method of Thrombelastography |
| [Scaron]lechtová J |
- |
Syndrome Kasabach-Merritt and Severe Postoperative Bleeding |
| |
- |
Special Hemocoagulative Examination at Invasive Meningococcal Disease |
| |
- |
Clinical and Laboratory Risk Factors in a Group of Patients with Venous Thromboembolism |
| Slezáková E |
- |
Our Experiences with the Determination of ProC Global Test and with the Interpretation of Results |
| Slingerland RJ |
- |
Role of Platelet Aggregation Testing in Acute Stent Thrombosis |
| Säll T |
- |
Genetic Variation of VWD Type I in Sweden: Tracing the Evolutionary History of the von Willebrand Factor Gene Region |
| Sloane DA |
- |
A Historical Comparison of Danaparoid (with or without Coumarin) Versus Ancrod (with or without Coumarin), or Coumarin Alone, for the Treatment of Heparin-Induced Thrombocytopenia (HIT): Evidence That Treatment Experience Can Influence Choice of Anticoagulant Rather Than Approval Status |
| Slofstra S |
- |
Low Molecular Weight Heparin Attenuates Multiorgan Failure in DIC |
| Slofstra SH |
- |
TF:FVIIa-Induced CREB Activation Occurs Via a Mechanism That Is Distinct from That Involved in TF:FVIIa-Induced STAT5 Activation |
| Slungaard A |
- |
NF-kB Activation Mediates Deep Vein Thrombosis: Inhibition by the NF-kB Inhibitor Andrographolide and Its Derivatives |
| Small DS |
- |
Superior Inhibition of Platelet Aggregation Following a Loading Dose of CS-747 (Prasugrel, LY640315) Versus Clopidogrel: Correlation with the Pharmacokinetics of Active Metabolite Generation |
| |
- |
Effect of Ketoconazole on the Pharmacokinetics and Pharmacodynamics of CS-747 (Prasugrel, LY640315) and Clopidogrel in Healthy Subjects |
| Smejkal P |
- |
Project HemIS (Haemophilia Information System): Multicentric Information System of Patients with Haemophilia |
| Smerling C |
- |
Functional Evidence for Three I-domain Activation States for Platelet a2b1 Integrin |
| Smet de MD |
- |
Hereditary Thrombophilia is not a Risk Factor for Idiopathic Retinal Vein Thrombosis |
| Smethurst PA |
- |
Affinity Maturation of Blocking Human Antibodies Against Human Glycoprotein VI |
| |
- |
Functional Differences in the Response of Platelets to Collagen That Are Linked to Glycoprotein VI Genotype Are Also Associated with Differences in Platelet Gene Expression Profiles |
| Smethurst PA |
- |
Surfaces of Glycoprotein VI Involved in Collagen Binding and Receptor Clustering |
| |
- |
GPVI Deficiency Associated with Unexpected Severe Bleeding in a 33 year Old Patient with Moderate Thrombocytopenia and Autoantibodies Against the Ig-like Domains |
| Smid M |
- |
Changes in Fibrinolysis Activity after Angiotensin II Receptor Blockade in Patients Undergoing Renal Artery Angiography |
| Smid WM |
- |
Low CD4/CD8 Ratios In HIV Negative Haemophilia Patients Cause High HCV Viraemia |
| |
- |
Metabolic Arrest Suppresses Platelet Binding to and Phagocytosis by Macrophages |
| Smid M |
- |
Activation of the Contact Factor System and Its Predictive Role in Coronary Heart Disease and Ischemic Stroke; Follow Up from the Second Northwick Park Heart Study |
| Smirnov M |
- |
HemosIL ThromboPath: A Chromogenic Assay Sensitive to Major Prothrombotic Risk Factors Affecting the Protein C Pathway |
| Smit JJJ |
- |
Role of Platelet Aggregation Testing in Acute Stent Thrombosis |
| Smit AA |
- |
Alternative Clinical Diagnoses with Spiral CT in Patients with Suspected Pulmonary Embolism |
| Smith T |
- |
Regular Plasma Infusion Allows Successful Pregnancy despite Thrombotic Thrombocytopaenic Purpura Relapse in First Trimester |
| Smith A |
- |
Multi Modal Management of Purpura Fulminans due to Homozygous Protein C Deficiency |
| Smith VC |
- |
Molecular Characterization of a 4.4 Mbp Deletion of the X Chromosome in a Male with Hemophilia B |
| Smith MP |
- |
A Postmarketing Study of the Safety and Efficacy of ReFacto® in Haemophilia a Patients |
| Smith L |
- |
The Application of New Diagnostic Guidelines in Type 1 von Willebrand Disease to Patients Previously Diagnosed Under the UK 1995 Guidelines. A Single Centre Paediatric Experience |
| Smith B |
- |
Betaine, a Novel Anticoagulant with Combined Nitric Oxide and Tissue Factor Pathway Release Potential. Implications in the Management of Peripheral Vascular Diseases |
| Smith A |
- |
Which Haemostatic Variables Add to the Prediction of Cardiovascular Events by Conventional Risk Factors? The Caerphilly Study |
| |
- |
Adenovirus-Mediated VEGF Gene Therapy Enhances Venous Thrombus Resolution |
| Smith LJ |
- |
Biodistribution of a Covalent Antithrombin-Heparin Complex |
| Smith A |
- |
Chromogenic and Clot Based Protein C Assays Contribute to the Management Of Homozygous Protein C Deficient Patients |
| Smith SMG |
- |
Monitoring of P2Y12 Receptor Antagonist Efficacy |
| Smith LJ |
- |
Reaction of Clot-Bound Thrombin with a Covalent Antithrombin-Heparin Complex Results in an Anticoagulant Surface |
| Smith J |
- |
Nanoparticle Tethered Biosensors for Autoregulated Gene Therapy in Hyperoxic Endothelium |
| Smith SMG |
- |
The PAR-1 IVSn-14 A/T Polymorphism Influences TRAP-Induced Platelet Calcium Mobilisation and Platelet Procoagulant Responses |
| Smith A |
- |
Monocyte Recruitment and Increased Urokinase (uPA) Activity are Important for Thrombus Resolution |
| Smith P |
- |
Evidence for the Anit-thrombotic Efficacy of Potato Carboxypeptidase Inhibitor in a Mouse Model of Ferric Chloride-Induced Venous Thrombosis |
| |
- |
The Proximal C-terminal Domains of ADAMTS13 Determine the Recognition and Cleavage of Peptidyl Substrate VWF73 and Macromolecular Substrate von Willebrand Factor |
| Smith MP |
- |
A Comparison of the PK/PD of Tinzaparin in Pregnant Women and in Non-Pregnant Healthy Volunteers |
| Smith A |
- |
Adenovirus Urokinase (uPA) Gene Transfection Mediates Monocyte Fibrinolysis |
| Smith D |
- |
Early FVIII Exposure and Subsequent Inhibitor Development in Children with Severe Haemophilia A |
| Smith KA |
- |
Identification of the Region of FXIIIA Responsible for Binding to the Alpha Chain of Fibrin(ogen) |
| Smith B |
- |
Use of Recombinant Activated Factor VII (Novoseven) as Haemostatic Cover for Surgery in Congenital Factor VII Deficiency |
| Smith G |
- |
A Multi-centre Assessment of the Chromogenic Method for Factor VIII:C Estimation in Plasma-derived and Recombinant Concentrates |
| Smith E |
- |
Prothrombin Binding to Phospholipid Membranes A Proposed Mechanism |
| Smith G |
- |
There Is No Correlation between HPA-1a Antibody Concentration and Clinical Severity of Neonatal Thrombocytopenia in 200 Pregnancies with HPA Alloimmunisation |
| Smith CW |
- |
Adhesion Molecules and Leukocyte Migration in the Context of Corneal Wound Healing |
| Smits PC |
- |
Transendocardial Autologous Bone Marrow Cell Transplantation in Patients with Advanced Ischemic Heart Disease A Multi-Center Feasibility Study |
| Smoktunowicz M |
- |
Diving and Decompression Have Significant Effect on the Activation of Fibrinolysis |
| |
- |
The Effect of Continuous-flow Automated Plateletpheresis on Fibrinolytic Activity of Donor's Plasma |
| Smolarczyk K |
- |
Adhesive Properties and Fibrinolytic Response of Endothelial Cells Containing PAI-1 in the Complex with Alpha 1-Acid Glycoprotein Accumulated on Their Surface |
| Smolarczyk K |
- |
Binding Sites for PAI-1 Are Exposed in Fibrin But Not in Fibrinogen |
| Smythe MA |
- |
Identifying the Incidence of Heparin Induced Thrombocytopenia |
| |
- |
An Evaluation of Heparin Platelet Factor 4 Antibody Testing |
| Smythe MA |
- |
An Evaluation of Unfractionated Heparin Use to Assess the Magnitude of Risk For Heparin Induced Thrombocytopenia |
| [Scaron]nábl I |
- |
Project HemIS (Haemophilia Information System): Multicentric Information System of Patients with Haemophilia |
| Sánchez-Luceros A |
- |
Ultralarge Multimers of Von Willebrand Factor (VWF) And ADAMTS13 Activity In Plasma From BALB/C And C57Bl/6J Mice At Physiological Conditions |
| Snelling H |
- |
Characterisation of the Anticoagulant Properties of a Phospholipase A2 from the Venom of the Australian King Brown Snake (Pseudechis australis) |
| Snetkov V |
- |
Isolation of Megakaryocytic Cells over-Expressing TRPC Channels |
| Snir A |
- |
Tissue Factor Is Expressed and Active on Cultured Human Trophoblast Cell Surface; Possible Regulation by Angiogenic Stimuli |
| Snoeck DP |
- |
In Type 2 Diabetes, P-Selectin- But Not CD63 -Exposing Microparticles Are Elevated in the Postprandial State |
| |
- |
The Phospholipid Composition of Cell-derived Microparticles Changes in the Postprandial State |
| Soares AL |
- |
Natural Anticoagulation Evaluation in Type 2 Diabetes |
| |
- |
Factor V Leiden: An Important Risk Factor for Venous and Arterial Thrombosis in Brazilian Patients |
| Soares AL |
- |
Type 2 Diabetes: Endothelium Lesion and Fibrinolytic System Markers Assessment |
| |
- |
Methylenetetrahydrofolate Reductase (MTHFR) Gene Polymorphism and Plasma Levels of Homocysteine in Patients with Type 2 Diabetes |
| Sobezyk D |
- |
TFPI Degradation by Neutrophil Proteases: Potential Implications in Acute Myocardial Infarction |
| Sobocka MB |
- |
Phosphorylation of the Extracellular Domain of the F11R/JAM-1 and Its Role in Platelet Aggregation |
| Sobocki T |
- |
Phosphorylation of the Extracellular Domain of the F11R/JAM-1 and Its Role in Platelet Aggregation |
| Sobreira ACM |
- |
Incidence of Factor VIII Inhibitor in Hemophilia A in Ceara Brazil |
| Socher I |
- |
A Short Tandem Repeat Polymorphism Leads to Differential Expression of the Neonatal Fc Receptor |
| Soeda T |
- |
Factor VIII Mimetic Antibody: (1) Establishment and Characterization of Anti-factor IX/Anti-factor X Bispecific Antibodies |
| Soff GA |
- |
Tissue Factor: Lack of the Cytoplasmic Tail Results in Generation of Functional Microparticle-Associated Tissue Factor |
| Soff G |
- |
Fondaparinux Use in Heparin-Induced Thrombocytopenia |
| Sofi F |
- |
Inherited and Acquired Thrombophilic Risk Factors in Atherosclerotic Disease |
| Sofi F |
- |
Interaction of Choline/Betaine Metabolysm and Homocysteine Plasma Levels |
| |
- |
Protein Z Plasma Levels in Different Phases of Activity of Coronary Atherosclerosis |
| Sofi F |
- |
Influence of the Enos Gene Polymorphisms on the Homocysteine Plasma Levels in Healthy Subjects |
| |
- |
ACE DD Genotype: A Predisposing Factor to Abdominal Aortic Aneurysm |
| |
- |
Asymmetric Dimethyl Arginine (ADMA), Homocysteine and Semicarbazide-Sensitive Amine Oxidase Activity (SSAO): New Markers of Oxidative Stress in Acute Coronary Syndromes |
| |
- |
Protein Z Decreases During Follow-up of Patients with Acute Coronary Syndromes |
| Sogorb F |
- |
Synergism between Functional Hemostatic Polymorphisms and Risk of Premature Myocardial Infarction |
| |
- |
Factor XIII Val34Leu Polymorphism Showed an Adverse Pharmacogenetic Effect on the Thrombolytic Therapy for Acute Myocardial Infarction |
| Sohne M |
- |
Pentraxin 3 in Patients with Pulmonary Embolism |
| |
- |
C-reactive Protein in Combination with Clinical Decision Rule and D-Dimer to Safely Rule out Pulmonary Embolism |
| |
- |
Clinical Usefulness of Prothrombin Fragment 1+2 in Patients with Suspected Pulmonary Embolism |
| Söhne M |
- |
Prognostic Value of Echocardiography and Chest Computed Tomography in Patients with Pulmonary Embolism |
| Sohne M |
- |
Alternative Clinical Diagnoses with Spiral CT in Patients with Suspected Pulmonary Embolism |
| Sohne M |
- |
D-Dimer Test in Cancer Patients with Suspected Acute Pulmonary Embolism |
| Söhne M |
- |
What Is the Real Contribution of Standardized Pre-test Clinical Probability Scores and D-dimer Assays to the Diagnostic Management of Deep Vein Thrombosis? Systematic Review of Clinical Outcome Studies |
| Sohne M |
- |
The Distribution Of Central, Segmental And Sub-Segmental Pulmonary Emboli In Multi- And Single-Row Helical CT |
| Soisamrong A |
- |
Spontaneous Subgaleal Hemorrhage in a Girl with Adrenaline Receptor Defect |
| Sokolowski J |
- |
Thrombin Activatable Fibrinolysis Inhibitor (TAFI) in Patients with Obliterative Atherosclerosis |
| |
- |
von Willebrand Factor and Thrombomodulin in Patients with Thromboangiitis Obliterans |
| Sokolowski J |
- |
Thrombin Activatable Fibrinolysis Inhibitor (TAFI) in Patients with Acute Myeloid Leukaemia (AML) |
| Solano C |
- |
Queensland Health Pathology Service Statewide Coagulation Quality Control Database: the First Three Years Experience |
| Solarin K |
- |
Neonatal Thrombophilia: Novel Findings Related to the Red Cell Membrane and Red Cell-Endothelial Adhesion |
| Solazzo V |
- |
More Carotid Atherosclerosis in HCV Positive Italian Patients? |
| Soldà G |
- |
Type II Mutation (Glu117stop) Causes Factor XI Deficiency by Inducing Allele Specific mRNA Degradation |
| Soldera C |
- |
How von Willebrand Factor Survival Contributes to Determining von Willebrand Disease Phenotype |
| Solgaard S |
- |
Measuring Fragment 1 + 2 in Spot Urine to Determine the Thrombotic Potential after Hip Arthroplasty |
| Solimeno LP |
- |
Ten Year Experience of TKR in Hemophilic Patients: The Surgical Unsolved Problems |
| Solomon PJ |
- |
Expression Profiling Reveals Functionally Important Genes and Coordinately Regulated Signalling Pathway Genes During in vitro Angiogenesis |
| Solovey A |
- |
Therapeutic Inhibition of Endothelial Tissue Factor Expression by Nitric Oxide and Other Agents in Sickle Transgenic Mice |
| Solpov A |
- |
Platelets Promote CD4+ Lymphocyte Adhesion to Extracellular Matrix and Fibronectin Under Flow: Role of Integrins, CD40 Ligand and P-Selectin Glycoprotein Ligand-1 |
| Solpov DA |
- |
Influence of Interleukins on CD 4+ T-lymphocyte Adhesion to Extracellular Matrix in Presence of Platelets under Flow Condition |
| Soltani S |
- |
Laboratory Assessment of von Willebrand Disorder (VWD): Reassessment of ABO-Blood Group, Gender and Age on Laboratory Parameters and the Potential Influence on a Diagnosis of Mild VWD and the Potential Association with Risk of Thrombosis |
| Soltysik RC |
- |
Evolving Risk for Thromboembolism in Spinal Cord Injury |
| Solymoss S |
- |
Thrombophilia Is Not a Risk Factor for Peripheral Intravenous Infusion-Associated Thrombophlebitis |
| |
- |
The VEINES-QOL/Sym Questionnaire Is a Valid and Reliable Measure of Quality of Life in Patients with Deep Venous Thrombosis |
| |
- |
Heparin Levels with Subcutaneously (sc) Low-Molecular-Weight-Heparin (LMWH) and Unfractionated Heparin (UFH): Results from a Randomized Trial |
| |
- |
Acute Treatment of Venous Thromboembolism (VTE) with Fixed-Dose, Weight-Adjusted, Unfractionated Heparin (UFH) Given Subcutaneously (sc) without Laboratory Monitoring: Randomized Comparison with Low-Molecular-Weight-Heparin (LMWH) |
| Sommeijer D |
- |
Diabetes Mellitus Does Not Increase Thrombogenicity of the Arterial Vessel Wall in Atherosclerotic LDLr-/- Mice |
| |
- |
Pravastatin Reduces Levels of the Glycoprotein IIIa Subunit from the Fibrinogen Receptor on Platelet-Derived Microparticles in Patients with Type 2 Diabetes |
| Sommeijer DW |
- |
Soluble Tissue Factor: A Marker of Microvascular Disease in Patients with Type 2 Diabetes |
| Sommeijer DW |
- |
Analysis of Blood Coagulation in Mice: Pre-analytical Conditions and Comparison of a Home-made Assay for Thrombin-antithrombin Complexes with Two Commercial Assays |
| Sommerbrodt C |
- |
Prevalence of Acquired and Hereditary Thrombophilic Disorders in Women with Pregnancy Loss |
| Sømod L |
- |
Prolonged Thromboprophylaxis with Dalteparin May Improve Survival in Patients Operated on for Abdominal Cancer |
| Sondek J |
- |
Crystal Structure of CIB1, an Endogenous Inhibitor of Platelet Integrin aIIbb3 Activation: Delineation of a New Family of Calcium-Binding Proteins |
| Sone M |
- |
Targeted Disruption of Mouse Ortholog of the Human MYH9 Responsible for Macrothrombocytopenia with Different Organ Involvement: Hematological, Nephrological, and Otological Studies of Heterozygous KO Mice |
| Song K |
- |
A Novel Fibrinogen Variant (Fibrinogen Seoul II: AaGln328Pro) with Impaired Fibrin Aa-chain Cross-linking |
| Song K |
- |
Measurement of Plasma Selectin Levels in Patients with Antiphospholipid Syndrome |
| Song J |
- |
Measurement of Plasma Selectin Levels in Patients with Antiphospholipid Syndrome |
| Song Y |
- |
Simultaneous and Coordinate Activation of Human Platelet PAR-1 and PAR-4 by Sub-Nanomolar Thrombin |
| Song C |
- |
Serum Amyloid A (SAA) Induces Monocyte Tissue Factor |
| Song H |
- |
The Development of Transplanted Rat Prostate Tumors in vivo Is Impaired by Reduced Tissue Factor Expression |
| Sonne S |
- |
Measuring Fragment 1 + 2 in Spot Urine to Determine the Thrombotic Potential after Hip Arthroplasty |
| Sonnet P |
- |
TIIICBP: The Platelet Receptor for Type III Collagen is Present into Platelet Membrane Lipid Microdomains (Rafts) |
| |
- |
Strong Antithrombotic Effect of the Type III Collagen-Related Octapeptide (KOGEOGPK) in the Mouse |
| Sonni P |
- |
Successful Diagnosis in Pregnant Obligate Carriers of Hemophilia a of Fetal Sex Using Conventional Pcr Analysis of Maternal Plasma |
| |
- |
The COX-2 G/C-765 Polymorphism Modulates the Occurrence of Cerebrovascular Ischemia |
| Sonoda M |
- |
The Rap1 Activation Mechanism in Platelets: It is Related to the Release Reaction Mediated Through the Collagen Receptor Glycoprotein (GP) VI |
| Sood R |
- |
Thrombophilia-Associated Fetal Loss: Epistasis of Fetal and Maternal Factors |
| Sood N |
- |
Intravenous DDAVP Associated Reduction in Fibrinogen Implications for Patients with Von Willebrand's Disease or Haemophilia A with Borderline Fibrinogen Levels Requiring Invasive Procedures |
| Sood SK |
- |
Inhibition of Tissue Factor Procoagulant Activity by GRP78/BiP, an Endoplasmic Reticulum Chaperone |
| Soosaipillai A |
- |
Analysis of the Differential Expression of uPA, PAI-1, and Tissue Kallikreins hk5, 6, 7, 8, 10, 11, 13 between Primary Ovarian Carcinoma Tissues and Corresponding Omentum Metastases |
| Sorarù M |
- |
Risk Factors for CVC-Associated Thrombosis in Cancer Patients: Analysis of the ETHIC Study |
| Sørensen KW |
- |
In vitro Characterization of Increased Factor V 1 Form by Factor V R2 Haplotype |
| Sorensen B |
- |
Visualization of Dynamic Fibrin Formation from APTT Recordings Reflects More Heterogeneity in Patients with Severe Haemophilia A Than Conventional APTT Values |
| Sorensen E |
- |
Neurologic Injury during Ventricular Assist Device (VAD) Support: Association with Rebound Hypercoagulability after Heparin Withdrawal |
| Sørensen BB |
- |
Recombinant FVIIa Acts in a Tissue Factor Independent Way in a Mouse Model of Hemophilia A |
| Sorensen E |
- |
Correlation Between Thromboelastographic and Whole Blood Aggregometrical Aspirin-Resistance Values and Neurological Events in Ventricular-Assist Device (VAD) Patients |
| Sorensen BB |
- |
Factor VIIa Binding and Internalization in Hepatocytes |
| Sorg N |
- |
Epitope Mapping of the Factor VIII-specific T Cell Response in E-17 Knockout Mice Using Peptide Pool Arrays |
| Soria JM |
- |
Effect of F7 Gene Promoter Polymorphisms on Factor VII Antigenic Levels |
| Soria JM |
- |
A Genome Search for Genetic Determinants That Influence Plasma Fibrinogen Levels |
| |
- |
The ABO Blood Group Genotype and Factor VIII Levels as Independent Risk Factors for Venous Thromboembolism |
| Soriani A |
- |
Integrin As Scaffold |
| Soriano AO |
- |
Endothelial Microparticle Binding to Neutrophils Is an Important Determinant of Neutrophil Activation In Vivo in Different Clinical Conditions |
| Soriano C |
- |
Characterization of Factor VIII Autoantibodies with Complex Reaction Kinetics is Improved by Heat Inactivation of the Test Plasma to Remove Residual Factor Activity |
| Soroczynska M |
- |
Correlation Between Selected cloTting Factors Parameters and Apoptosis of Peripheral T Lymphocytes in Non-Small Cell Lung Cancer |
| |
- |
Expression of the Death Receptor Fas (CD95) on Peripheral T Lymphocytes in Correlation with Selected Clotting System Parameters in Non-Small Cell Lung Cancer |
| Soskov GI |
- |
Family with Inherited f.X Deficiency. Case Report |
| |
- |
The Long-term Future of Patients Had Had Henoch-Schonlein Purpura in Childhood |
| Soulat L |
- |
Are Diagnostic Algorithms for Suspected Pulmonary Embolism Applicable in French Emergency Departments? |
| Soulières D |
- |
Use of D-Dimer (DD) in The Management of Suspected Deep Venous Thrombosis and Pulmonary Embolism in the Emergency Room: Prospective Observations Over 1 year |
| Souri M |
- |
Cardiac Involvement in Pathologic Findings of Factor XIII Knockout Mice |
| Sousa MO |
- |
Methylenetetrahydrofolate Reductase (MTHFR) Gene Polymorphism and Plasma Levels of Homocysteine in Patients with Type 2 Diabetes |
| |
- |
Increased Plasma Levels of Lipoprotein(a) Correlate with Severity of Angiographically Defined Coronary Artery Disease |
| |
- |
Type 2 Diabetes: Endothelium Lesion and Fibrinolytic System Markers Assessment |
| |
- |
Natural Anticoagulation Evaluation in Type 2 Diabetes |
| Souto JC |
- |
A Genome Search for Genetic Determinants That Influence Plasma Fibrinogen Levels |
| |
- |
Risk of Arterial Thrombosis in Carriers of a Familial Thrombophilic Defect |
| Souza GC |
- |
807C/T Polymorphism in the Platelet Glycoprotein Ia Gene in Patients with Ischemic Stroke (IS) of Undetermined Etiology |
| Sovershaev M |
- |
Intersubject Variability in Intracellular and Surface Tissue Factor Distribution in LPS-Stimulated Monocytes |
| Spaargaren-van Riel CC |
- |
The Prothrombin G19911A Is a Functional Non-coding Polymorphism |
| Spagnotto M |
- |
Clinical Evaluation of Thromboembolic Samples with the New HemosIL D-Dimer HS and the HemosIL D-Dimer Assays on the ACL TOP |
| |
- |
Evaluation of the New ACL TOP Coagulation Analyser from IL |
| Spandorfer J |
- |
Low-Molecular-Weight Heparin or Unfractionated Heparin as Bridging Therapy in Patients on Long-term Oral Anticoagulants: Results from the REGIMEN Registry |
| Spannagl M |
- |
Assessment of Cyclooxygenase, ADP Receptor and GpIIb/IIIa Receptor Blockade by Impedance Aggregometry Using the Multiplate Analyzer |
| |
- |
Mortality Prediction Using Coagulation Parameters in Patients with Sepsis: The New Overt DIC Scoring System in Comparison with APACHE II and LOD Score |
| |
- |
Safety and Efficacy of Low-Molecular-Weight Heparin (Dalteparin) in Pregnant Women at Increased Risk of Venous Thromboembolism: A Prospective Stratified Multicentre Trial |
| Spartali A |
- |
Drug induced inhibition of platelet function and immune hemolytic anemia (CASE REPORT) |
| |
- |
Linear and Cyclic RGD Peptides Containing Salicylic Acid Derivatives and Their Antiplatelet Activity In Vitro |
| Spath B |
- |
Platelet Microparticles (PMP) Are Increased in Patients with Localized Prostate Cancer and Correlate with Plasma Tissue Factor (TF) Antigen Levels |
| |
- |
Experimental Metastasis and Tumor Cell-Induced Coagulopathy in Mice with Hemophilia A and the Effect of FVIII Replacement Therapy |
| Speer CP |
- |
Platelet CD40L in Chorioamnionitis |
| Speers A |
- |
Tissue Factor Synthesis and Expression by Human Proximal Tubular Cells: the Source of Increased Urinary Tissue Factor Secretion in Disease? |
| Speidl WS |
- |
Complement Component C5a Predicts Future Cardiovascular Events in Patients with Advanced Atherosclerosis |
| Speijer D |
- |
Proteomic Analysis of High-Density Lipoprotein |
| Spek CA |
- |
Antithrombotics Inhibit Tumor Metastasis |
| |
- |
FVIII-Dependent Propagation Phase Is of Minor Importance During Septic Peritonitis |
| |
- |
Alternatively Spliced Soluble Tissue Factor in Mice |
| |
- |
TF:FVIIa-Induced CREB Activation Occurs Via a Mechanism That Is Distinct from That Involved in TF:FVIIa-Induced STAT5 Activation |
| |
- |
Effect of Modified Normothrombotic Heparin on Cancer Progression and Metastasis |
| |
- |
Coagulation Factors VIIa and Xa Promote Apoptosis in Human Tumor Cells in Association with CREB Activation |
| Spek C |
- |
Low Molecular Weight Heparin Attenuates Multiorgan Failure in DIC |
| Spek CA |
- |
Impaired Thrombus Formation after Sterile Inflammation Induced by Endotoxin in a Murine Carotid Artery Thrombosis Model |
| Speller T |
- |
Clotting Factor Prophylaxis in Boys with Haemophilia; Experience from a Single Australian Centre |
| Spencer HT |
- |
High-Level Expression of Porcine Factor VIII from Genetically-Modified Bone Marrow-Derived Cell Types |
| Spencer F |
- |
Observed Rates of Clinically Apparent Venous Thromboembolism and Death Due to Pulmonary Embolism Among Unselected Hospitalized Acutely Ill Medical Patients Compared to Rates Predicted from Clinical Trials |
| |
- |
Early Use of Low-Molecular-Weight or Unfractionated Heparin in Patients with Non-ST-Segment Elevation Myocardial Infarction and Unstable Angina. The Global Registry of Acute Coronary Events |
| Spencer-Manzon M |
- |
Increased Platelet Activation in Cystic Fibrosis: A Role for cAMP/Adenylate Cyclase But Not for Mead Acid or Platelet CFTR |
| Speziale P |
- |
Fibronectin-Binding Protein (FnBP) Mediates Staphylococcus Aureus-Induced Platelet Aggregation |
| Spiel A |
- |
Platelet Hyperfunction and Low Response to Aspirin Predict Re-events in Patients With Acute Coronary Syndromes During Long Term Follow Up |
| Spiel A |
- |
The Effects of Supra-Normal Protein C Levels on Markers of Coagulation, Fibrinolysis and Inflammation in a Human Model of Endotoxemia |
| Spiel A |
- |
Effects of the Pan-Selectin Antagonist Bimosiamose (TBC1269) on LPS Induced Coagulation |
| Spiezia L |
- |
Venous Thrombosis in Women on Oral Contraceptives: A Study of 201 Cases |
| |
- |
Cerebral Venous Thrombosis: The Padua Experience |
| |
- |
Oral Contraceptives in the Management of Rare Coagulation Bleeding Disorders |
| Spijkers PP |
- |
von Willebrand Factor D'-D3-domains comprise an adhesion site for leukocytes |
| Spike J |
- |
Accuracy of a Whole Blood D-Dimer Assay (SimplifyTM) for Deep Vein Thrombosis, When Performed Using Venous Whole Blood and Frozen Plasma in a Cohort Patients with Suspected Deep Vein Thrombosis |
| |
- |
The Accuracy of the Wells Pretest Probability Assessment Model for Proximal Deep Vein Thrombosis When Applied by Emergency Department Doctors in South Australia |
| Spohn G |
- |
A Novel Mutation (Asp36Tyr) in the Vitamin K Epoxide Reductase Complex Subunit 1 (VKORC1) Causes Moderately Increased Coumarin Doses |
| Spotts G |
- |
Efficacy, Safety and Pharmacokinetic Properties of ADVATE rAHF-PFM in Previously Treated Patients (PTPs) Less Than 6 years of Age |
| Spranger S |
- |
12-Year Old Boy with Deep Venous Thrombosis (DVT) and Pulmonary Thromboembolism (PTE) |
| Spranger T |
- |
Cerebral Venous Sinus Thrombosis in a 12 year Old Boy with Transient Antiphospholipid Antibodies |
| |
- |
Orthopedic Outcome in Patients With Severe Hemophilia Under Prophylactic TreatmentBenefit of an Early Long-term Prophylaxis? |
| Spreafico M |
- |
Relationship between CYP2C9 and VKORC1 Polymorphisms and Anticoagulant Dose Requirement |
| Spreafico M |
- |
Molecular Characterization in an Italian Patient with Plasminogen Deficiency And Ligneous Conjunctivitis |
| Sprenger HG |
- |
Effects of Highly Active Antiretroviral Therapy on the Risk of Venous and Arterial Thromboembolism in Male and Female HIV Positive Patients |
| Sprigg N |
- |
Effects of Granulocyte-Colony Stimulating Factor on Platelet and Leukocyte Function in Whole Blood in vitro |
| Spronk HMH |
- |
Activation of the Contact Factor System and Its Predictive Role in Coronary Heart Disease and Ischemic Stroke; Follow Up from the Second Northwick Park Heart Study |
| |
- |
A Hypercoagulable State in Myeloperoxidase Deficient Mice |
| |
- |
Laboratory Markers of Cardiovascular Disease in Systemic Lupus Erythematosus: Evidence of a Latent Hypercoagulable State |
| |
- |
Analysis of Blood Coagulation in Mice: Pre-analytical Conditions and Comparison of a Home-made Assay for Thrombin-antithrombin Complexes with Two Commercial Assays |
| |
- |
Activity and Localization of Tissue Factor and Factor VII in Organs of Normal and Endotoxemic Mice |
| |
- |
Soluble Tissue Factor: A Marker of Microvascular Disease in Patients with Type 2 Diabetes |
| |
- |
Changes in Fibrinolysis Activity after Angiotensin II Receptor Blockade in Patients Undergoing Renal Artery Angiography |
| |
- |
Plasminogen Activator Inhibitor-1 Plasma Levels Increase after Myocardial Ischemia/Reperfusion Injury in Mice |
| |
- |
ASIS Blocks Tissue Factor Activity in the Heart after Ischemia/Reperfusion Injury in Mice |
| Spyropoulos AC |
- |
Low-Molecular-Weight Heparin or Unfractionated Heparin as Bridging Therapy in Patients on Long-term Oral Anticoagulants: Results from the REGIMEN Registry |
| Spyropoulos AC |
- |
Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients in Intensive Care Units |
| |
- |
Does Body Weight Influence Physician Practices for Providing Venous Thromboembolism Prophylaxis to Acutely Ill Medical Patients? Findings from IMPROVE |
| |
- |
Observed Rates of Clinically Apparent Venous Thromboembolism and Death Due to Pulmonary Embolism Among Unselected Hospitalized Acutely Ill Medical Patients Compared to Rates Predicted from Clinical Trials |
| Squizzato A |
- |
Incidence of Deep Vein Thrombosis Following Gynecologic Laparoscopy: A Prospective Cohort Study |
| |
- |
Abdominal Obesity and the Risk of Recurrent Deep Vein Thrombosis |
| Sørensen B |
- |
Haemostatic Potential of a Novel Analogue of rFVIIa Versus rFVIIa on Dynamic Whole Blood Clot Formation in Blood from Patients with Severe Haemophilia A |
| |
- |
Visualization of the Continuous APTT Coagulation Signature Methods and Correlations to Continuous Thrombin Generation |
| |
- |
Recombinant Factor VIIa Mechanism of Action Based on Dynamic Whole Blood Coagulation Studies |
| Srikanth S |
- |
Angiotensin Receptor 2 Over-Expression in Bradykinin B2 Receptor Knockout Mice Produces Thromboprotection |
| Srivastava A |
- |
Alanine Mutagenesis Demonstrates Functional Importance of Four Amino Acids Within the Disintegrin Eristostatin: Implications for Its Anti-Platelet and Anti-Cancer Properties |
| |
- |
Molecular Characterization of Haemophilia B: 17 Novel Mutations in Patients of Indian Origin |
| Srivastava A |
- |
Successful Surgical Haemostasis in Patients with von Willebrand Disease with Koate®DVI |
| Srivastava A |
- |
Ristocetin Cofactor (VWF:Rco) Assay A Comparison of a Rapid Automated Method on ACL10000 Coagulometer and Conventional Aggregometry |
| |
- |
Data From APTT Clot Curves of Automated Photo-Optical Coagulometers Correlates Better with Heterogeneity of Clinical Presentation in Severe Hemophilia A than FVIII: C Levels |
| |
- |
Thrombin Generation in Haemophilia A Patients Does Not Necessarily Correlate with Levels of Factor VIII Detected Using Standard Factor VIII Potency Assays: A Comparative Analysis of Pre- and Post-Infusion Patients Plasmas Using Fluorogenic and Clotting Thrombin Generation Tests |
| St Pierre L |
- |
Characterisation of the Anticoagulant Properties of a Phospholipase A2 from the Venom of the Australian King Brown Snake (Pseudechis australis) |
| Stacker SA |
- |
Molecular Pathways for Lymphangiogenesis and Their Role in Human Disease |
| Stadler M |
- |
Terminal Dry-Heat (TDH) Treatment, As Part of the Octanate® Production Process, Contributes to the High Virus Safety Preserving the Structural and Functional Properties of the Concentrate |
| |
- |
Viral Safety of a Novel von Willebrand Factor and Factor VIII Concentrate (Wilate®): Virus Inactivation Capacities of Optimised Solvent/Detergent and Terminal Dry-Heat Treatment |
| |
- |
Protein-Biochemical Characterisation of Wilate®: Determination of the Upper Residual Moisture Limit during Terminal Dry-Heat Treatment |
| |
- |
Characterisation of the Novel, High Purity, Double Virus Inactivated von Willebrand Factor and Factor VIII Concentrate Wilate |
| Staelens S |
- |
Determination of Interacting Residues within the VWF A3-Domain and the Antithrombotic Antibody 82D6A3 by Docking, Cocrystallisation and Mutagenesis |
| |
- |
Humanisation of an Antithrombotic Anti-von Willebrand Factor (VWF) Monoclonal Antibody, 82D6A3, by Variable Domain Resurfacing |
| Staes A |
- |
Protein Profiling of Human Blood Platelets from Young and Aged Individuals |
| Staff of Haemostasis Laboratory |
- |
Prevalence of Acquired Haemophilia A in the Malaysian Population |
| Stafford A |
- |
Fibrinolytic Activity Is Enhanced after Major Orthopedic Surgery |
| Stafford DW |
- |
The Vitamin K Cycle |
| Stafford P |
- |
There Is No Correlation between HPA-1a Antibody Concentration and Clinical Severity of Neonatal Thrombocytopenia in 200 Pregnancies with HPA Alloimmunisation |
| Stähle H |
- |
Pharmacokinetics and Pharmacodynamics of the Direct Thrombin Inhibitor Dabigatran in Elderly Healthy Subjects |
| |
- |
Effect of Food and Pantoprazole on the Bioavailability of the Direct Thrombin Inhibitor Dabigatran in Healthy Subjects |
| Stain A |
- |
Results from the Canadian Hemophilia Dose Escalation Prophylaxis Trial: An Update |
| Stain M |
- |
Risk Factors for the Postthrombotic Syndrome (PTS) |
| Stain M |
- |
A Positive Family History of Venous Thromboembolism Does Not Predict A High Risk of Recurrence |
| Stain AM |
- |
Time In-Situ as a Risk Factor for Central Venous Catheter Associated Thrombosis (CVC-Clot) in Severe Hemophiliacs (SH) |
| Stakiw JL |
- |
A Case of Non-Resolving Hemophilia B Leyden in a 40 year Old Male (Factor IX promoter +13 A to G) |
| Sta[scaron]ko J |
- |
Beta-Thromboglobulin, Platelet Factor 4 and Soluble P-Selectin in Hemodialysis Patients with EPO Therapy |
| S[breve]talc A |
- |
New Direct Thrombin Inhibitors Build on Azaphenylalanine Scaffold Antithrombotic Effect in Two Rat Venous Thrombosis Models |
| [Scaron]talc J |
- |
Warfarin and Plasma Concentrations of Some Metalloproteinases in Patients with Popliteal Arterial Aneurysm |
| Stalenhoef AF |
- |
A Genome-Wide Linkage Scan for Homocysteine Levels Identifies Three Regions of Interest |
| Stalenhoef AFH |
- |
The Effect of Statin Therapy on Coagulation and Fibrinolysis in Patients with Heterozygous Familial Hypercholesterolemia |
| Stamm S |
- |
Inhibition of thrombin generation by Otamixaban (XRP0673), a direct and selective factor Xa inhibitor |
| Stancheva A |
- |
Rotation Thrombelstography Monitoring during Liver Transplantation |
| Standeven KF |
- |
Functional Characterization of the FXIII Cross Linking Sites in the Fibrinogen g-Chain |
| Stangier J |
- |
Pharmacokinetics and Pharmacodynamics of the Direct Thrombin Inhibitor Dabigatran in Elderly Healthy Subjects |
| |
- |
Effect of Food and Pantoprazole on the Bioavailability of the Direct Thrombin Inhibitor Dabigatran in Healthy Subjects |
| |
- |
Pharmacokinetics and Pharmacodynamics of the Oral Direct Thrombin Inhibitor Dabigatran in a Dose Finding Trial in Atrial Fibrillation |
| Stanica RM |
- |
Antithrombotic Effect of the Peptide YMESRADR, Corresponding to Residues 313320 of the Platelet aIIb Subunit in a Rabbit Model of Carotid Artery Thrombosis |
| Stankiewicz C |
- |
Determination of Known Risk Factors of Thromboembolism in Laryngeal and Non-small Cell Lung Cancer Patients |
| Stankovic S |
- |
Implantation of Total Hip Prosthesis in a Hemophilic Patient Is Antithrombotyc Prophylaxis Necessary? |
| Stanojevic M |
- |
Homocysteine Levels and MTHFR C677T Genotypes in Patients with Myocardial Infarction under Age 45 years |
| Stapleton M |
- |
Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1) Negatively Influences Thrombus Formation in Vivo |
| Starke R |
- |
Investigation of Relationship between ADAMTS-13, Von Willebrand Factor Antigen and Collagen-Binding Activity in Patients with Type 1 Von Willebrand Disease |
| |
- |
Treatment of HIV Associated Thrombotic Thrombocytopenic Purpura-Importance of Prompt Diagnosis |
| Starke R |
- |
Plasma Prion Protein (PrPC) in Patients with Vascular Diseases |
| Starke R |
- |
Successful Management of Pregnancy in Women with a History of Thrombotic Thrombocytopenic Purpura: A Role for ADAMTS 13 Monitoring |
| |
- |
Investigation of Relationship of von Willebrand Factor Antigen Clearance with ADAMTS-13 Activity and Tyr1584Cys Polymorphism in Type 1 von Willebrand Disease |
| |
- |
Use of Rituximab in Acute Refractory Thrombotic Thrombocytopenic Purpura |
| Starke R |
- |
The Sensitive Detection of Antibodies to von Willebrand Factor Cleaving Protease (ADAMTS-13) |
| Starke R |
- |
Characterisation of Anti-ADAMTS13 Autoantibodies from a Patient with Thrombotic Thrombocytopenic Purpura (TTP) |
| Staroverov I |
- |
Relation of Changes in D-dimer and Factor VIIa Levels after Treatment with Heparins to Clinical Outcomes of Unstable Angina |
| Stasiak M |
- |
Analysis of the Interaction of Platelet Collagen Receptors with Collagen Type I |
| Stasiak M |
- |
Expression of GPVI Is Modulated in Endothelial Cells by Different Agonists |
| Stassen JM |
- |
Effect of Recombinant Factor VIIa or Activated Prothrombin Complex Concentrate on the Bleeding Time in Anaesthetized Rats during Anticoagulant Treatment with the Direct Thrombin Inhibitor Dabigatran |
| |
- |
In Vitro Pharmacological Characterization of BIBT 986, A Novel Synthetic Active Site Dual Inhibitor of Thrombin and Factor Xa |
| |
- |
Humanisation of an Antithrombotic Anti-von Willebrand Factor (VWF) Monoclonal Antibody, 82D6A3, by Variable Domain Resurfacing |
| |
- |
In vivo Anticoagulant, Antithrombotic and Anti-inflammatory Efficacy of BIBT 986, a Novel Synthetic Active Site Dual Inhibitor of Thrombin and Factor Xa |
| Stas[scaron]ko J |
- |
Plasma TFPI Levels in Patients Undergoing Regular Hemodialysis and Treated with Erythropoietin |
| Staton J |
- |
Hormonal Regulation of the Anticoagulant Protein S |
| Staton JM |
- |
Protein Z Gene Polymorphisms, Protein Z Concentration and Ischaemic Stroke |
| Staton J |
- |
Enhanced Antiplatelet Effect of Clopidogrel in Patients with Aspirin Resistance: A Randomized Crossover Trial |
| Staubach P |
- |
Treatment with Pasteurized C1 Inhibitor Concentrate in Abdominal Pain Attacks of Patients with Hereditary Angioedema |
| Staus A |
- |
Razaxaban, a Novel Direct Factor Xa Inhibitor, Enhanced the Antithrombotic Effects of Aspirin and Clopidogrel But Not Their Bleeding Time Effects in Rabbits |
| |
- |
Evaluation of a Novel Direct Factor VIIa Inhibitor in Rabbit Models of Arterial Thrombosis and Hemostasis |
| Stavljeni[cacute] Rukavina A |
- |
Factor XIII Val34Leu Polymorphism in Croatian Population |
| Stavropoulos G |
- |
Linear and Cyclic RGD Peptides Containing Salicylic Acid Derivatives and Their Antiplatelet Activity In Vitro |
| Stearns-Kurosawa DJ |
- |
Proteinase 3 Expression on Neutrophil Membranes from Patients with Infectious Disease |
| Stebbing Y |
- |
Intravenous DDAVP Associated Reduction in Fibrinogen Implications for Patients with Von Willebrand's Disease or Haemophilia A with Borderline Fibrinogen Levels Requiring Invasive Procedures |
| Steen LH |
- |
Platelet and Inflammatory Alterations Associated with Late Restenosis in Patients Undergoing Angioplasty and Brachytherapy |
| Stefanin C |
- |
Evaluation of the New ACL TOP Coagulation Analyser from IL |
| |
- |
Clinical Evaluation of Thromboembolic Samples with the New HemosIL D-Dimer HS and the HemosIL D-Dimer Assays on the ACL TOP |
| Stefaniuk K |
- |
A New Double Virus Inactivated 4-Factor Prothrombin Complex Concentrate (4F PCC) |
| Stefano PL |
- |
Clotting Profile by Sonoclot Analysis Is Different in Patients Undergoing Off-Pump and On-Pump Coronary-Artery Bypass Surgery |
| Stefanska E |
- |
Severe Hemophilia in Poland Focus on Hemophilic Arthropathy |
| Stefanski E |
- |
Lack of Occult HBV Infection in Polish Haemophilia Patients |
| Steffen LM |
- |
Dietary Vitamin B6 and Folate Intake is Inversely Related to Risk of Developing Venous Thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology (LITE) |
| Steffensen FH |
- |
Patient Outcome during Oral Anticoagulant Therapy Using an Electronic Decision Support System |
| Steg PG |
- |
Enhanced Shear-Induced Platelet Aggregation in Patients Who Experienced Subacute Stent Thrombosis: A Case-Control Study |
| |
- |
Early Use of Low-Molecular-Weight or Unfractionated Heparin in Patients with Non-ST-Segment Elevation Myocardial Infarction and Unstable Angina. The Global Registry of Acute Coronary Events |
| Stegnar M |
- |
Increased Haemostasis Potential Persists in Young Patients with Previous Ischemic Cerebrovascular Event |
| |
- |
Methyl-Methacrylate Bone Cement Surface Does Not Promote Platelet Aggregation or Plasma Coagulation in vitro |
| Stegnar M |
- |
New Direct Thrombin Inhibitors Build on Azaphenylalanine Scaffold Antithrombotic Effect in Two Rat Venous Thrombosis Models |
| Steidl L |
- |
Prevalence of the Metabolic Syndrome in Patients with Provoked or Unprovoked Deep Vein Thrombosis and in Controls |
| |
- |
Abdominal Obesity and the Risk of Recurrent Deep Vein Thrombosis |
| |
- |
Incidence of Deep Vein Thrombosis Following Gynecologic Laparoscopy: A Prospective Cohort Study |
| Steigerwald U |
- |
Multicenter Evaluation of BCS® XP A Further Development of the Widespread BCS® Coagulation Analyzer |
| Stein SF |
- |
Treatment and Management of Women with Bleeding Disorders and Menorrhagia (WBDM) Study: Laboratory Diagnosis |
| Stein U |
- |
Follow-Up of Patients with Acute Venous Thromboembolism Treated with Ximelagatran for Prophylaxis of Recurrent Events |
| Stein SF |
- |
Multi-Site Comparison of Platelet Function Testing |
| Stein PD |
- |
Fatal Vascular Outcomes Following Major Orthopedic Surgery |
| Stein SF |
- |
Quality of Life (QoL) Evaluation in Women with Menorrhagia and Inherited Bleeding Disorders |
| Steinbacher T |
- |
Antithrombotic Activity of a Small Molecule Factor XIa Inhibitor in Rats with Limited Effects on Bleeding Time |
| Steinbrüchel D |
- |
Platelet Activation and Interaction of rFVIIa (NovoSeven®) with COAT Platelets Following Cardiopulmonary Bypass |
| Steiner T |
- |
Effects of Recombinant Activated Factor VII on Perilesional Oedema in Patients with Acute Intracerebral Haemorrhage |
| Steiner M |
- |
Thrombin Modulates Proangiogenic Cytokine Secretion and Cell Adhesion of Human Prostate Cancer Cells Via PAR-1 |
| Steiner T |
- |
No Influence of Antiplatelet Therapy on the Outcome of Acute Intracerebral Haemorrhage Treated with Recombinant Activated Factor VII |
| Steiner B |
- |
Cardiovascular Interventions and Surgery in Patients with Haemophilia and Von Willebrand Disease |
| Steinlechner B |
- |
Anticoagulant and Anti-inflammatory Effects of Recombinant Human Antithrombin in Man after LPS Challenge |
| Steitz B |
- |
Superparamagnetic Iron Oxide Uptake as Imaged By Magnetic Resonance Is Mediated by the Integrin Receptor MAC-1 (CD11b/CD18) Possible Implications on Imaging of Atherosclerotic Plaques |
| Stella M |
- |
Recurrent Venous Thromboembolic Events during Treatment with Combined Oral Contraceptives in Hereditaria Dystrophic Epidermolysis Bullosa |
| Stemberger A |
- |
Fibrin and b-chain Peptide (441461) for Tissue Engineering Improves Tolerability and Efficiency of Non-viral Gene Vector Formulations |
| Stemmelin G |
- |
Failure of the Outpatient Bleeding Risk Index to Predict Major Bleeding in Older Patients Receiving Coumarin for Atrial Fibrillation |
| |
- |
Neonatal DIC by Enterovirus. Favorable Outcome with Maternal Plasma Transfusion |
| |
- |
Fibrinolytic Peritoneal Response to Laparoscopic Surgery |
| |
- |
Validation of a Clinical Score (CS) Plus D-Dimer (DDi) Combination As a Diagnostic Strategy to Exclude Pulmonary Embolism (PE) |
| Stenberg LM |
- |
Precursors of Novel Gla-Containing Conotoxins Contain a Carboxy-Terminal Recognition Site that Directs g-Carboxylation by g-Glutamyl Carboxylase |
| Stenflo J |
- |
Precursors of Novel Gla-Containing Conotoxins Contain a Carboxy-Terminal Recognition Site that Directs g-Carboxylation by g-Glutamyl Carboxylase |
| |
- |
APC-PCI Complex Concentration and Association with Factor V Leiden in Patients with Deep Vein Thrombosis |
| Stenhoff J |
- |
Analysis of Gas6 in Human Platelets and Plasma |
| Sten-Linder M |
- |
Prospective Evaluation of Low PAI-1 Activity as a Risk Factor for Hemorrhagic Diathesis |
| Stennicke HR |
- |
Activation Hypothesis for Coagulation Factor VIIa |
| Stepanian A |
- |
Two Novel Type 1 Von Willebrand Disease Causing Mutations (G160W and N166I) in the Von Willebrand Factor Propeptide, Identified in the European Study MCMDM-1VWD, Are Responsible for Multimerization And Secretion Defects |
| Stephen KCL |
- |
Systemic Prognostic Haemostatic Marker Levels for Disease Outcome within Five Years from Ovarian Cancer |
| Stephen KCL |
- |
Systemic Pre-Operative Haemostatic Marker Levels and Their Association with Disease Outcome from Uterine Cervix and Endometrial Cancers Within 2 years |
| Stephens D |
- |
Time In-Situ as a Risk Factor for Central Venous Catheter Associated Thrombosis (CVC-Clot) in Severe Hemophiliacs (SH) |
| Stephensen D |
- |
Ultrasound Diagnosis of Acute Joint Pain May Lead to More Effective and Efficient Use of Haemophilia Therapy |
| |
- |
Gait Alterations Exist in Children with Haemophilia after Relatively Few Haemarthroses and Despite Prophylaxis A 3D Motion Analysis Study |
| Stephenson JJ |
- |
The Relationship Between INR Time-In-Range and Risk of Stroke and Major Bleeds in Chronic Non-Valvular Atrial Fibrillation Warfarin Utilizers |
| Stephenson DA |
- |
Modulation of Monocyte Function by Activated Protein C, a Natural Anticoagulant |
| Stepien H |
- |
Thalidomide Affects Early Phases of VEGF Stimulated Angiogenesis in Human Endothelial Cells |
| Steppich B |
- |
TFPI Degradation by Neutrophil Proteases: Potential Implications in Acute Myocardial Infarction |
| Stern MP |
- |
A Quantitative Trait Locus on Chromosome 12q14.1 Influences Plasminogen Levels in the San Antonio Heart Family Study (SAFHS) |
| Sternby NH |
- |
Prevalence and Risk of Pulmonary Embolism in Patients with Intracardiac Thrombosis. A Population-Based Study |
| |
- |
Does the PE Risk in Abdominal Cancer Reflect Location, Spread or Tumour Type? Observations from a Population-Based Autopsy Study |
| |
- |
The Risk of Proximal DVT and Pulmonary Embolism (PE) in Patients with Objectively Verified Arterial Thrombosis. A Population-Based Autopsy Study |
| Sterner M |
- |
The Haplotype Structure of the von Willebrand Factor (VWF) Gene Promoter Indicates Balancing Selection |
| Steven RL |
- |
Role of FcRg and FXIII in Coated Platelet Formation and Platelet Procoagulant Activity in Mice |
| Steven WP |
- |
Lactadherin Detects and Blocks Phosphatidylserine in vivo on Stimulated Platelets |
| Stevens B |
- |
Long-Term Clinical Experience with FEIBA VH in Hemophilia Patients with Inhibitors |
| Stevenson W |
- |
Molecular Dissection of Platelet Production Via Random Mutagenesis |
| Stewart KA |
- |
Inactivation of Factor V during Sepsis-Induced Disseminated Intravascular Coagulation: Reconciliation of Total Factor V Activity with Its Cleavage and Inactivation as Assessed by SDS-PAGE and Immunoblotting |
| Stewart A |
- |
Development, Characterization and Application of Immunoassays for Mouse, Rat and Rabbit D-Dimer Using the Monoclonal Antibody FK03 in Animal Models of Thrombosis |
| Stewart D |
- |
Supplemental Alpha-2-Antiplasmin Prevents Plasmin-Induced Hemorrhage |
| Stewart A |
- |
Antithrombotic Activity of a Small Molecule Factor XIa Inhibitor in Rats with Limited Effects on Bleeding Time |
| Stewart KA |
- |
The Mechanism of Alpha-1-Protease Inhibitor Inactivation During Sepsis-Induced Disseminated Intravascular Coagulation |
| Stewart D |
- |
Magnesium Sulfate in Doses Up to 8-Fold Greater than Physiologic Concentration does Not Affect TPA-Mediated Clot Lysis: An in vitro Study |
| Sticchi E |
- |
Ischemic Complications in Nonvalvular Atrial Fibrillation Patients Despite Warfarin Therapy |
| |
- |
ACE DD Genotype: A Predisposing Factor to Abdominal Aortic Aneurysm |
| |
- |
Influence of the Enos Gene Polymorphisms on the Homocysteine Plasma Levels in Healthy Subjects |
| |
- |
eNOS Gene Affects Blood Viscosity and Red Cell Deformability: Role of eNOS T-786C, G894T and 4a/4b Polymorphisms |
| Stieltjes N |
- |
Pharmacokinetic Study of the Co-administration of a Von Willebrand Factor (VWF) Product Containing Low FVIII Level (WILFACTIN) with a Factor VIII Product |
| |
- |
WILFACTIN: Efficacy and Safety Evaluation of WILFACTIN (a Triple Secured Von Willebrand Factor Product with a Low Factor VIII Content) in Women with Severe Von Willebrand Disease during Gynaecological/Obstetrical Events |
| Stier-Brück I |
- |
ADAMTS 13 Activity and VWF : Ag Levels in Patients with Ischemic Stroke |
| Stigendal L |
- |
Long-term Prophylaxis in VWD. The Swedish Experience |
| |
- |
Treatment of Chronic Hepatitis C Infection in Patients with Hemophilia or Von Willebrand Disease with a Combination of Pegylated Interferon and Ribavirin |
| |
- |
Case Report on Successful Use of Activated Prothrombincomplex Concentrate FEIBA® in Orthopedic Surgery on Two Patients with Factor VIII Inhibitors |
| Stiles MK |
- |
Bleeding Events with and without Thienopyridines in Patients with Unstable Angina or Non-ST-Segment Elevation Myocardial Infarction. The Global Registry of Acute Coronary Events |
| Stiles C |
- |
A System to Track Coagulation Factor Concentrates Can Decrease Waste |
| Stiller V |
- |
Prospective Evaluation of Low PAI-1 Activity as a Risk Factor for Hemorrhagic Diathesis |
| Stine KC |
- |
Use of FEIBA for Surgical Procedures in Patients with Severe Hemophilia A and B and Inhibitors |
| Stine KC |
- |
Surgical Procedures in Patients with Inhibitors to Factor VIII: A Case Series |
| Stinn W |
- |
Initial Data on the Effects of Long-term Cigarette Mainstream Smoke Exposure and High Fat Diet in Apolipoprotein E-deficient Mice |
| Stinson JC |
- |
A Comparison of the PK/PD of Tinzaparin in Pregnant Women and in Non-Pregnant Healthy Volunteers |
| Stirling D |
- |
Endothelial Progenitor Cells Are Mobilized Following Coronary Angiography |
| Stirling D |
- |
36 Novel Factor VIII Mutations in the Scottish Hemophilia a Population |
| Stirling D |
- |
Blood Leukocyte mRNA Expression of CD34 and VEGFR-2 Is Reduced, But Ve-cadherin and CD14 mRNA Expression Is Increased Following Elective Abdominal Aortic Aneurysm Repair |
| Stirzaker RA |
- |
Abnormal Megakaryocyte Maturation, Abortive Platelet Shedding and inflammatory Disease Caused By Mutations in the Cytoskeletal Regulator Aip1 |
| St-Louis J |
- |
Spurious Decrease of Inhibitor Levels in Plasma Containing rFVIIa |
| St-Louis J |
- |
Clinical and Laboratory Response to rFVIIa and APCC in a Rare Case of Severe Congenital Factor VII Deficiency with an Inhibitor |
| Stobel U |
- |
The Molecular Structure of the Antigen in Heparin-induced Thrombocytopenia |
| Stobierska-Dzierzek B |
- |
Anticoagulant Effects of Statins and Angiotensin-Converting Enzyme Inhibitors in Stable Patients with Coronary Artery Disease: Results of a Randomized Double Blind Study |
| Stocker R |
- |
New Insights on Oxidative Stress in the Artery Wall |
| Stockinger H |
- |
Podoplanin-Induced Platelet Aggregation is Responsible For Separation of Blood and Sprouting Lymphatic Vessels during Embryonic Development |
| Stockschlaeder M |
- |
Reeavaluation of 75 Patients with Previous Diagnosis of von Willebrand Disease |
| Stodulski D |
- |
Determination of Known Risk Factors of Thromboembolism in Laryngeal and Non-small Cell Lung Cancer Patients |
| Stoffman JM |
- |
An Unusual Factor VIII Inhibitor Developing in a Patient with Mild Hemophilia A |
| |
- |
Pilot Study of a New Hemostasis Screening Test (HST) Developed by Modification of the Activated Partial Thromboplastin Time (aPTT) |
| |
- |
Shortcomings of the Activated Partial Thromboplastin Time (aPTT) As a Routine Screening Test of Hemostasis |
| Stogowska B |
- |
Effects of Long-Term Simvastatin Treatment on Some Hemostatic Parameters in Hyperlipidemic Patients with Ischemic Heart Disease |
| Stojakovic T |
- |
Lipoprotein Pattern in Patients with Retinal Artery Occlusion or Retinal Vein Occlusion |
| Stojanovic A |
- |
Implantation of Total Hip Prosthesis in a Hemophilic Patient Is Antithrombotyc Prophylaxis Necessary? |
| Stoldt V |
- |
The 807C/T Polymorphism in the a-Subunit of Integrin a2b1 Modulates Platelet Adhesion onto Immobilized Collagen Under Arterial Flow Conditions |
| |
- |
Modulation of Platelet Adhesion by Antithrombin |
| |
- |
Endogenous Myocardial FVIII:C, von Willebrand Factor (vWF) and Fibrinogen Are Independent of Regional Myocardial Blood Flow (RMBF) |
| Stoll H |
- |
Cranial Epidural Bleeding in a Child with Congenital Afibrinogenaemia, Management and Long-Term-Prophylaxis with a Fibrinogen Concentrate |
| |
- |
Antiphospholipid Antibodies in Children Reference Values in Healthy Controls and Frequency in Children with aPTT Prolongation, Thrombosis or Stroke |
| |
- |
Treatment of Acute Angioedema Attack with Icatibant in a Patient with Hereditary Angioedema due to C1-Inhibitor-Deficiency |
| |
- |
Epitope Mapping During FVIII Inhibitor Eimination With Rituximab Reveals Conformational Epitopes on FVIII and Identifies Small Molecules Blocking Inhibitor and Targeting B Cells |
| Stoll P |
- |
Targeting of the Direct FXa Inhibitor TAP via the Fusion of a Single-chain Antibody Directed Against a LIBS Epitope on GPIIb/IIIa Provides Effective Anticoagulation without Bleeding Time Prolongation |
| Stoll H |
- |
Pharmacokinetics of C1 Esterase Inhibitor, Human (Pasteurized) in Subjects with Hereditary Angioedema |
| Stolla M |
- |
Fractalkine Mediates Leukocyte Recruitment to Inflammatory Endothelial Cells in Flowing Whole Blood |
| Stolz H |
- |
Multicenter Evaluation of BCS® XP A Further Development of the Widespread BCS® Coagulation Analyzer |
| Stone P |
- |
Reversal of the Inhibitory Effect of Monclonal Antiphospholipid Antibodies on Trophoblast Proliferation by Unfractionated Heparin, Low Molecular Weight Heparins (Enoxaparin and Dalteparin) and a Synthetic Pentasaccharide, Fondaparinux |
| Stonebraker J |
- |
Using a Cohort Model to Anticipate the Future Therapeutic Needs of the Hemophilia A Patient Population |
| Stoneman VEA |
- |
Apoptotic Mechanisms Underlying High-Risk Plaque |
| St-Onge C |
- |
The Whole Blood Platelets Aggregation Test for HIT Diagnosis |
| Storelli C |
- |
Anti-Inflammatory and Anti-Angiogenic Effects of the Omega-3 Fatty Acid Docosahexaenoate (DHA, 22:6 n-3) Through ERK1/2-Mediated Inhibition of Cyclooxygenase (COX)-2 Expression |
| |
- |
Anti-Angiogenic Action of Peroxisome Proliferator-Activated Receptor(PPAR)g Ligands Through Cox-2-Mediated MMP-9 Expression and Release |
| |
- |
Homocysteine (Hcy) Stimulates Endothelial Vascular Cell Adhesion Molecule(VCAM)-1 Via Nuclear Factor(NF)-kB Activation Induced by an Increase of Reactive Oxygen Species (ROS): Protective Role by Natural Antioxidants |
| Storey RF |
- |
Incomplete P2Y12 Receptor Blockade by Clopidogrel Is Not Due to the Presence of an Internal Pool of P2Y12 Receptors |
| |
- |
Monitoring of P2Y12 Receptor Antagonist Efficacy |
| Storey RF |
- |
Utility of a Whole-Blood Single-Platelet Counting Assay in Monitoring the Effects of Tirofiban |
| Storey RF |
- |
The PAR-1 IVSn-14 A/T Polymorphism Influences TRAP-Induced Platelet Calcium Mobilisation and Platelet Procoagulant Responses |
| |
- |
Evidence of Partial P2Y12 Receptor Antagonism Despite Excess Clopidogrel in Mice |
| Storm G |
- |
Intracellular Assembly of Factor VIII and von Willebrand Factor |
| Storozhevykh T |
- |
PARs (Protease Activated Receptors) Activation by Thrombin and Factor Xa Protects Hippocampal Neurons against Glutamate-induced Apoptosis |
| Storozhilova A |
- |
Homocystein and Hemostatic Variables in Young Postinfarction Patients |
| Storti S |
- |
Leukocyte Activation in Myeloproliferative Disease |
| Stott DJ |
- |
Plasma Fibrinogen and Viscosity and Risk of Cognitive Decline in Elderly Patients with Vascular Risk Factors or Disease |
| Straczek C |
- |
Interactions between Prothrombotic Mutations and Hormone Therapy in Relation to the Risk of Venous Thromboembolism: Impact of the Route of Estrogen Administration |
| Strandberg K |
- |
APC-PCI Complex Concentration and Association with Factor V Leiden in Patients with Deep Vein Thrombosis |
| Stranden E |
- |
Markers of Vascular Inflammation Are Associated with the Degree of Atherosclerosis Assessed as Angiographic Score and Treadmill Walking Distance in Patients with Peripheral Arterial Occlusive Disease |
| Strano A |
- |
Ex vivo Evaluation of the Pharmacodynamic Effects of Defibrotide. Results from Various Clinical Trials |
| Strassel C |
- |
Mice Lacking the Platelet Glycoprotein Ib Beta Intracellular Domain Display Resistance to Thrombosis But Normal Bleeding Times |
| Strasser EF |
- |
Comparative Study of Fibrinolysis Test Systems with A Special Focus on Variable Sample Handling (Different Transport Modalities/Arterial and Venous Catheterization) |
| Sträter R |
- |
Recurrent Stroke: The Role of Prothrombotic Disorders |
| |
- |
Risk of Recurrent Venous Thromboembolism in Children with Cerebral Venous Thrombosis A Prospective Follow-Up Cohort Study |
| Strauch K |
- |
Venous Thromboembolism: Involvement of ADAMDEC1 Polymorphisms in Familially High Factor VIII Levels |
| Strauss BH |
- |
The Effect of Coronary Distal Embolisation on Myocardial Blood Flow and Platelet Activation |
| Strauss R |
- |
Heparin Abrogates the Positive Effect of High-dose Antithrombin III in Severe Sepsis (KyberSept Study) |
| Strazzullo P |
- |
Association Between -675 4G/5G Polymorphism of the PAI-1 Gene and Obesity in Men: Longitudinal Findings of the Olivetti Heart Study |
| Street A |
- |
Towards Harmonisation of D-dimer Assays |
| |
- |
How Useful is the Monitoring of (Low Molecular Weight) Heparin Therapy by Anti-Xa assay? The Laboratory Perspective |
| Strehl A |
- |
Crucial Role of Glycoprotein VI in Thrombus Formation and Coagulation during Venous and Arterial Thrombosis |
| Strehl A |
- |
Inhibition of Protein Kinase C Results in an Altered Thrombus Phenotype with Suppressed Platelet Aggregation and Increased Platelet Procoagulant Activity |
| Strevens MJ |
- |
Seven Novel Candidate Mutations in Exon 27 and 28 of von Willebrand Gene in Patients with Type 1, Type 2 M and Unclassified von Willebrand Disease |
| Stricker H |
- |
Variation in Coagulation Inhibitors During Prolonged Sitting: Possible Pathogenetic Mechanisms for Travel-associated Thrombosis |
| Strickland D |
- |
Identification of Coagulation Factor VIII A2 Domain Residues Forming the Binding Epitope for Low-Density Lipoprotein Receptor-Related Protein |
| Strickland DK |
- |
Beyond Endocytosis: LRP Function in Cell Migration, Proliferation and Vascular Permeability |
| Strickland D |
- |
Identification of Regions in Low-Density Lipoprotein Receptor-Related Protein Responsible for Interaction with A2 and A1/A3-C1-C2 Portions of Coagulation Factor VIII |
| |
- |
The A2 Domain of Coagulation Factor VIII Shares Residues Critical for Interaction with Three Members of LDL Receptor Superfamily LRP, VLDL and Megalin Receptors |
| |
- |
Identification of Factor VIII Binding Sites for Very Low Density Lipoprotein Receptor |
| Stroes ESG |
- |
Acute Hyperglycemia Perturbs Endothelial Glycocalyx and Induces a Prothrombotic State in Healthy Volunteers |
| Strukova S |
- |
PARs (Protease Activated Receptors) Activation by Thrombin and Factor Xa Protects Hippocampal Neurons against Glutamate-induced Apoptosis |
| [Scaron]truncová V |
- |
Special Hemocoagulative Examination at Invasive Meningococcal Disease |
| Strunz CMC |
- |
Oral Anticoagulation Laboratory Control: Comparison between Two Differents Methods |
| Struve S |
- |
Pregnancy of a Libanese Woman with Homozygous Protein C deficiency |
| Strzelecka A |
- |
Plasminogen Activator Inhibitor-1 Plasma Levels Increase after Myocardial Ischemia/Reperfusion Injury in Mice |
| |
- |
ASIS Blocks Tissue Factor Activity in the Heart after Ischemia/Reperfusion Injury in Mice |
| Strzelecki O |
- |
Severe Hemophilia in Poland Focus on Hemophilic Arthropathy |
| Stuart MJ |
- |
Neonatal Thrombophilia: Novel Findings Related to the Red Cell Membrane and Red Cell-Endothelial Adhesion |
| Stuart MJ |
- |
Phosphatidylserine-Positive Erythrocytes Modulate Tissue Factor Activity in vivo and in vitro in Sickle Cell Disease |
| |
- |
Heparin Is a Multifaceted Anti-Adhesive Agent: Inhibition of Phosphatidylserine (PS)-Positive Erythrocyte Binding to Matrix Thrombospondin (TSP) |
| Stuart-Smith SE |
- |
Putative Prothrombotic Polymorphisms in Patients with Antiphospholipid Antibodies |
| Stuckless S |
- |
Preliminary Results of a Cross-Sectional Study of Mild Hemophilia A in Newfoundland and Labrador, Canada |
| Stumpf S |
- |
Screening of Phage Displayed Random Peptide Libraries Reveals Conformational Epitopes of Inhibitors in a Haemophilia B Patient |
| Stumpf U |
- |
Tissue Factor Efficacy in Patients with Severe Hemophilia a Undergoing Total Knee Replacement |
| Sturgeon SA |
- |
Specific Role of the GPVI/FcRg Complex in Promoting Thrombus Formation Following Superficial But Not Deep Arterial Injury |
| Sturk A |
- |
Congenital Deficiency of Factor XIII Caused by Two Missense Mutations in a Dutch Family |
| |
- |
Inhibition of Microparticle Release from Endothelial Cells Induces Apoptosis |
| |
- |
Microparticles From Preeclamptic Patients Do Not Affect Transcription of Inflammation-related Genes in Endothelial Cells |
| |
- |
Synovial Microparticles in Arthritic Patients Support Coagulation and Inflammation |
| |
- |
Cell-derived Microparticles Contain Caspase 3 in Vitro and in Vivo |
| |
- |
Complement Activation on the Surface of Cell-Derived Microparticles in Rheumatoid Arthritis |
| |
- |
P-selectin- and CD63-Exposing Platelet Microparticles Reflect Platelet Activation in Peripheral Arterial Disease and Myocardial Infarction |
| |
- |
Microparticle-associated P-selectin Is a Marker of Platelet Activation in Preeclampsia |
| |
- |
The Phospholipid Composition of Cell-derived Microparticles Changes in the Postprandial State |
| |
- |
In Type 2 Diabetes, P-Selectin- But Not CD63 -Exposing Microparticles Are Elevated in the Postprandial State |
| Sturm D |
- |
The Role of Dalteparin for Perioperative Prophylaxis of Thromboembolism in Breast Cancer Patients |
| Sturn D |
- |
Inhibition of Monocyte-induced Procoagulant Activation with Antithrombin |
| Styles LA |
- |
Is the Novel Genetic Mutation, Prothrombin C20209T, an Independent Risk Factor for Stroke among African-Americans with Sickle Cell Anemia? |
| Su J |
- |
A Novel Deletion Mutation of Von Willebrand Factor Associated with Type 3 Von Willebrand Disease |
| Su ZJ |
- |
Expression Profiling Reveals Functionally Important Genes and Coordinately Regulated Signalling Pathway Genes During in vitro Angiogenesis |
| Su J |
- |
Expression of Tissue Factor Pathway Inhibitor-2 by Retrovirus and Its Effects in Rat Glioma Cells Migration and Invasion |
| Su RJ |
- |
Neuro-microenvironment and Neurotrophic Factors Support ex vivo Expansion of Megakaryocytic Progenitor Cells |
| Su Y-C |
- |
The Assembly of the Factor-X Activating Complex on Activated Platelets is Down-regulated by the Formation of Lipid Rafts that Remove the Substrate (Factor X) and the Cofactor (Factor VIIIa) from the Enzyme (Factor IXa) |
| Su J |
- |
A2 Domain of Human Von Willebrand Factor Expressed in E. Coli and Its Use in Quantitative Measurement of ADAMTS13 Activity |
| Su K-I |
- |
Thromboxane A2 Null Mice Exhibit Resistance to Atherosclerosis and Neointima Formation in a Carotid Artery Ligation Model |
| [Scaron]ubrt I |
- |
Clinical and Laboratory Risk Factors in a Group of Patients with Venous Thromboembolism |
| Suchoverchova A |
- |
Homocystein and Hemostatic Variables in Young Postinfarction Patients |
| Sucker C |
- |
Influence of Gender, Age, and Oral Contraception on Hemostatic Parameters Determined by Rotation Thrombelastography |
| |
- |
Closure Times Determined with a Platelet Function Analyzer are Closely Correlated to the Mean Transvalvular Gradient in Patients with Aortic-Valve Stenosis |
| |
- |
Reeavaluation of 75 Patients with Previous Diagnosis of von Willebrand Disease |
| Suckow M |
- |
Identifying Hemostatic Modifier Loci Ameliorating FVII-Insufficiency Using Phenotypic Differences between Strains |
| Suckow Mark |
- |
The Development of Transplanted Rat Prostate Tumors in vivo Is Impaired by Reduced Tissue Factor Expression |
| Suckow M |
- |
Cancer Procoagulant Enhances Tumor Cell Adhesion to the Extracellular Matrix |
| Suda T |
- |
Hematopoietic Stem Cells and Their Niche |
| Sudic D |
- |
Effects of Acute Hyperglycaemia on Platelet and Leukocyte Activation: Involvement of Multiple Mechanisms |
| Sueishi K |
- |
Paracrine Loop between VEGF-C/Flt-4 and PDGF-BB/PDGFR-Beta Systems Contributes Therapeutic Angiogenesis Using FGF-2 Gene Transfer in Ischemic Hind Limbs |
| Suffritti C |
- |
TAFI 325/Ile Genotype in Old Population of Northern Italy |
| Sugawara J |
- |
Age-Related Effects of Regular Physical Activity on Coagulation Factors in Men |
| Sugidachi A |
- |
CS-747 (Prasugrel, LY640315), a Novel Antiplatelet Agent, Inhibits Arterial Thrombosis Through Selective Blockade of Platelet P2Y12 Receptors |
| Sugidachi A |
- |
Active Metabolites of CS-747 (Prasugrel, LY640315) and Clopidogrel Show Similar in vitro P2Y12 Receptor Blockade But Greater in vivo Potency of CS-747 |
| Sugidachi A |
- |
CS-747 (Prasugrel, LY640315) Produces Potent and Sustained Platelet Inhibitory Effects in Dogs and Monkeys During Multiple Dosing That Are Enhanced by Co-administration of Aspirin |
| |
- |
Comparative Antiplatelet Effects of the Active Metabolites of CS-747 (Prasugrel, LY640315) and Clopidogrel |
| |
- |
Effective Inhibition of Platelet Aggregation and Release Reaction with Lack of Effect on Shape Change by CS-747 (Prasugrel, LY640315) and Its Active Metabolite |
| Sugiyama N |
- |
Pharmacological Characterization, Antithrombotic and Bleeding Effects of DU-176b, a Novel, Potent and Orally Active Direct Inhibitor of Factor Xa: A Wider Safety Margin of Antithrombotic and Bleeding Effects Compared to Heparin, LMWH and Warfarin |
| |
- |
Antithrombotic Properties of DU-176b, a Novel Orally Active Factor Xa Inhibitor: Inhibition of both Arterial and Venous Thrombosis, and Combination Effects with Other Antithrombotic Agents |
| Sugo T |
- |
Phenotype Correction of Hemophilia a Mice with Adeno-associated Virus (AAV) Vectors Carrying the B domain Deleted Canine Factor VIII Gene |
| |
- |
Phenotype Correction of Hemophilia A Mice with Adeno-associated Virus (AAV) Vectors Carrying the B domain Deleted Canine Factor VIII Gene |
| |
- |
Aspirin Resistance Detected with Aggregometry Can Not Be Explained by Failure to Suppress Cyclooxygenase Activity: Possible Involvement of Other Signaling Pathway(s) in Cardiovascular Events of Aspirin-treated Patients |
| |
- |
Intervention of Plasminogen Activator Inhibitor-1 in Nasal Allergy |
| Suhartono H |
- |
Viral Safety of a Prothrombin Complex Concentrate (Octaplex®): Combination of Solvent/Detergent (SD) Treatment with Nanofiltration |
| |
- |
Viral Safety of a Novel von Willebrand Factor and Factor VIII Concentrate (Wilate®): Virus Inactivation Capacities of Optimised Solvent/Detergent and Terminal Dry-Heat Treatment |
| |
- |
Characterisation of the Novel, High Purity, Double Virus Inactivated von Willebrand Factor and Factor VIII Concentrate Wilate |
| Suiter TM |
- |
Human Thrombospondin-1 in Twelve Von Willebrand Factor/FVIII Coagulation Factor Concentrates |
| Sukanya C |
- |
Coagulation Defects in Thai Adolescents with Menorrhagia |
| |
- |
Homocysteine and Thrombosis in Thai Children: A Case-Control Study |
| Sukhoverkhova AS |
- |
Study of the Methylenetetrahydrofolate Reductase Gene Promoter in Patients With Heterozygous C677T MTHFR Gene Polymorphism and Hyperhomocysteinemia |
| Sukhu K |
- |
Thrombin Potential in Severe Haemophilia A and B Patients |
| Sukumaran D |
- |
Ristocetin Cofactor (VWF:Rco) Assay A Comparison of a Rapid Automated Method on ACL10000 Coagulometer and Conventional Aggregometry |
| [Scaron]uláková T |
- |
A Multicentre Study on 50 Cases with Thrombotic Thrombocytopenic Purpura in the Czech Republic: Recurrent Mutation in ADAMTS13 Gene as a Cause of a Hereditary Thrombotic Thrombocytopenic Purpura |
| Sulistya AB |
- |
The Relationship Between Hypercoagulable State and Sudden Sensory Neural Deafness |
| Sulowicz W |
- |
Effect of TGN 255, a Novel Intravenous Direct Thrombin Inhibitor, on the Prolongation of ACT in Patients Undergoing Haemodialysis |
| Sultan I |
- |
Anti-phospholipid Antibody Syndrome in the Neonatal Period: Report of a Rare Case |
| Sulzer I |
- |
ADAMTS13 Is Present in Human Platelets and Strongly Expressed on COAT-Platelets |
| Sumi H |
- |
Nattokinase and Vitamin K2 Production Using Sake Cake, in Particular Distilled Cake, as the Fermented Material |
| |
- |
Plasminogen Activator Releasing Activity in Coffee |
| Sumi T |
- |
Detection of von Willebrand Factor and Tissue Factor in Platelets-Fibrin Rich Coronary Thrombi Causing Acute Myocardial Infarction |
| Summerhayes R |
- |
Tissue Factor Pathway Inhibitor (TFPI) during Heparin Therapy in the Paediatric Intensive Care Unit (PICU) |
| |
- |
Developmental Haemostasis and Response to Heparin Therapy in Children |
| |
- |
Tissue Factor Pathway Inhibitor (TFPI) Contributes to the Early Anticoagulant Effect of Unfractionated Heparin (UFH) during Haemodialysis |
| |
- |
Heparin Monitoring During Haemodialysis in Children |
| Sun L |
- |
Decreased Platelet Expression of MYL9 (Myosin Light Chain Regulatory Polypeptide) and Other Genes with Platelet Dysfunction and CBFA2 (AML1) Mutation: Insights From Platelet Expression Profiling |
| Sun W-q |
- |
Regulation of Tissue Factor Expression in Brain Microvascular Endothelial Cells by PLA Nanoparticles Loading NF-KappaB Decoy Oligonucleotides |
| Sun J |
- |
The Detection of the Platelet Activation by Flow Cytometry in the Patients with Pre-eclampsia |
| Sun B |
- |
The Importance of PDE3A in the Regulation of Platelet Aggregation |
| Sun C |
- |
A Novel Anti-LIBS mcAb (3C7) Is Specific for the Complex of Integrin aIIbb3 and Inhibits Platelets Aggregation and Adhesion |
| Sun D |
- |
Mechanism of HKa-induced Endothelial Cell Apoptosis |
| Sun MF |
- |
Role of Residue 192 in Development of the Oxyanion Hole and in Macromolecular Specificity in Serine Proteases: Importance of Lys554 (192 in Chymotrypsin Numbering) in Factor XIa Catalysis |
| |
- |
Role of Residue 193 in Development of the Oxyanion Hole in Serine Proteases: Kinetic Studies of the Effect of Side Chain Length and Charge in Factor XIa |
| Sun B |
- |
GPVI-Deficient Mice Lack Collagen Responses and are Protected Against Experimentally-Induced Pulmonary Thromboembolism |
| Sun G |
- |
The Impact of Factor XIII Polymorphisms, FXIIIa T204P, P506L and Factor XIIIb Polymorphism H95A, on Myocardial Infarction |
| Sundaresan P |
- |
Distinct Signals in Procoagulant Adherent Platelets Compared to Aggregated Platelets |
| Sung RYT |
- |
The Effect of Chinese Danggui and PDGF on Thrombopoiesis in Irradiated Mice |
| Suongto U |
- |
Changes in Thrombogenic Markers but not Factor XIII in Left Atrium of Thai Patients with Mitral Stenosis |
| Supari F |
- |
The Rise of Plasminogen Activator Inhibitor-1 Activity in Coronary Artery Bypass Grafting of Type 2 Diabetes Patients |
| Suppiej A |
- |
Cerebral Sinovenous Thrombosis in Children |
| Surdhar GK |
- |
Seven Novel Candidate Mutations in Exon 27 and 28 of von Willebrand Gene in Patients with Type 1, Type 2 M and Unclassified von Willebrand Disease |
| Suresh S |
- |
The Lupus Ratio Test for Detection of Lupus Anticoagulants: Evaluation of Two Fully Automated aPTT-based Procedures That Use Commercially Available Reagents |
| Surrenti C |
- |
Asymmetric Dimethyl Arginine (ADMA), Homocysteine and Semicarbazide-Sensitive Amine Oxidase Activity (SSAO): New Markers of Oxidative Stress in Acute Coronary Syndromes |
| |
- |
Influence of the Enos Gene Polymorphisms on the Homocysteine Plasma Levels in Healthy Subjects |
| |
- |
Interaction of Choline/Betaine Metabolysm and Homocysteine Plasma Levels |
| Sürücü O |
- |
Factor VII Activating Protease (FSAP) Inhibits Angiogenesis in vivo |
| Susen S |
- |
Plasma Levels of Tissue Factor and von Willebrand Factor Predict Long Term Clinical Outcome after Percutaneous Coronary Revascularization |
| Sushkova N |
- |
A Novel P-Selectin Inhibitor, PSI-697, Demonstrates Positive Activity Following Oral Administration in Rodent Models of Vascular Inflammation |
| Suslina Z |
- |
The Evaluation of Disfunction of Endothelium in Patients with Atherosclerosis of Carotid System and Reversible Neurological Deficit |
| |
- |
Haemorheology and Haemostasis in Ischemic Cerebrovascular Diseases |
| Suslina Z |
- |
Hemorheology, Hemostasis in Patients with Arterial Hypertension |
| |
- |
Hemorheology, Hemostasis and Antiaggregate Activity of Endothelium in Patients with Hypertensive Small Deep Infarcts |
| Sutherland JS |
- |
Fusion of the N-terminal Acidic Domain of Heparin Cofactor II to a1-PI M358R Increases the Rate of Thrombin Inhibition |
| Suthida C |
- |
Vitamin K Status in Mothers and Their Newborn Babies: Role of Dietary Phylloquinone Intake |
| Sutomo K |
- |
The Rise of Plasminogen Activator Inhibitor-1 Activity in Coronary Artery Bypass Grafting of Type 2 Diabetes Patients |
| Suttnar J |
- |
A Multicentre Study on 50 Cases with Thrombotic Thrombocytopenic Purpura in the Czech Republic: Recurrent Mutation in ADAMTS13 Gene as a Cause of a Hereditary Thrombotic Thrombocytopenic Purpura |
| Suttorp M |
- |
In vitro Determination of Platelet Function in Whole Blood from Obese Children and Adolescents |
| Suzuki T |
- |
Factor V Mutations, Arg2174Leu, a 5-bp Deletion and Val1813Met, Are Associated with Factor V Deficiency and A Bleeding Tendency |
| Suzuki K |
- |
Mechanism of Lipopolysaccharide-induced Decrease of Plasma Protein S: Its Expression in Hepatocytes and Sinusoidal Endothelial Cells Is Mediated by NFkB Activation |
| Suzuki H |
- |
Hemostatic Effects of Polymerized Albumin Particles Carrying Recombinant Glycoprotein Iba as Platelet Substitutes in vitro and in vivo |
| Suzuki M |
- |
Hepatocytes are the Major Site of ADAMTS-13 Expression in Human Liver |
| Suzuki Y |
- |
Protein S Suppresses Invasive Potential of THP-1 Cells by Lowering Binding Capacity of Plasminogen on Cell Surface |
| Suzuki K |
- |
Protein C Inhibitor Plays a Role as a Potent Regulator of Activated Hepatocyte Growth Factor Activator |
| Suzuki H |
- |
Hemostatic Effects of Polymerized Albumin Particles Carrying Fibrinogen-g Chain Dodecapeptide as Platelet Substitutes in vitro and in vivo |
| Suzuki T |
- |
Significance of the Transcription Factor KLF5 in Cardiovascular Remodeling |
| Suzuki N |
- |
Active Metabolites of CS-747 (Prasugrel, LY640315) and Clopidogrel Show Similar in vitro P2Y12 Receptor Blockade But Greater in vivo Potency of CS-747 |
| |
- |
CS-747 (Prasugrel, LY640315) Produces Potent and Sustained Platelet Inhibitory Effects in Dogs and Monkeys During Multiple Dosing That Are Enhanced by Co-administration of Aspirin |
| Suzuki T |
- |
Factor VIII Mimetic Antibody: (1) Establishment and Characterization of Anti-factor IX/Anti-factor X Bispecific Antibodies |
| |
- |
Regulation of Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) Gene Expression in Growth-Promoted Hepatocytes and Role of TAFI in Liver Regeneration |
| Suzuki N |
- |
Effective Inhibition of Platelet Aggregation and Release Reaction with Lack of Effect on Shape Change by CS-747 (Prasugrel, LY640315) and Its Active Metabolite |
| |
- |
Comparative Antiplatelet Effects of the Active Metabolites of CS-747 (Prasugrel, LY640315) and Clopidogrel |
| Suzuki T |
- |
Four Novel Missense Mutations in Factor IX Gene Were Identified as Causes of Hemophilia B |
| Suzuki-Inoue K |
- |
Signaling Mediated by Glycoprotein Ib-IX-V/VWF Interaction Mainly Takes Place in GEMs In Human Platelets |
| |
- |
Platelet GPIb-IX-V-Dependent Signaling |
| |
- |
Syk Plays an Essential Role Downstream of The Platelet Rhodocytin Receptor CLEC-2 |
| Suzuki-Inoue K |
- |
Identification of CLEC-2 as a Novel Signalling Receptor for Rhodocytin in Platelets |
| Suzuki-Inoue K |
- |
Laminin Stimulates Spreading of Platelets Through a6b1-dependent Activation of GPVI |
| Svae TE |
- |
Viral Safety of a Novel von Willebrand Factor and Factor VIII Concentrate (Wilate®): Virus Inactivation Capacities of Optimised Solvent/Detergent and Terminal Dry-Heat Treatment |
| Svae TE |
- |
Characterisation of the Novel, High Purity, Double Virus Inactivated von Willebrand Factor and Factor VIII Concentrate Wilate |
| Sveinbjørnsson B |
- |
Heparin Induces Release of Osteoprotegerin (OPG) |
| |
- |
Serum Osteoprotegerin in Young Survivors of Myocardial Infarction |
| Svendsen MS |
- |
The Effect of rFVIIa on Thrombin Generation, Whole Blood Clot Formation, and Resistance to Fibrinolysis under Conditions Mimicking Hemophilia A |
| Svennefalk M |
- |
Experience of Surgery with Continuous Infusion at Karolinska University Hospital in Patients With Hemophilia A and B, von Willebrand'S Disease and FVII-Deficiency |
| Svensson P |
- |
Risk of Arterial Thrombosis in Carriers of a Familial Thrombophilic Defect |
| Svensson PJ |
- |
Patient Preference and Willingness-To-Pay Among Different Oral Anticoagulant Treatment Options |
| Svensson D |
- |
Human Aortic Endothelial Cells Inhibit Thrombin Generation in vitro and Augment Inhibition by Melagatran |
| Svensson P |
- |
APC-PCI Complex Concentration and Association with Factor V Leiden in Patients with Deep Vein Thrombosis |
| Svetlikov A |
- |
The Role of Low Doses Anti-TNF In Improvement of Immune Function in PAD Patients after Late Thrombosis |
| Svirin P |
- |
The Occasions of Factor XII Deficiency in Children |
| Svirin PV |
- |
Family with Inherited f.X Deficiency. Case Report |
| |
- |
Ulcerous Colitis in Children with Hemophilia A |
| Swarup S |
- |
Two Isoforms of Factor X Is Produced in the Liver of Pseudonaja Textilis |
| |
- |
Gene Structures of Two Functionally Diverse Prothrombin Activators, Trocarin D and Coagulation Factor X, in Tropidechis Carinatus Snake |
| |
- |
Two Parallel Prothrombin Activator Systems in Eastern Brown Snakes |
| Swenson S |
- |
Contortrostatin: A Potent Inhibitor of Cancer Growth and Angiogenesis |
| Swiatkowska M |
- |
Activation of NF-kB by Reactive Oxygen Species Mediates Induction of PAI-1 Expression in Vascular Endothelial Cells |
| Swift P |
- |
Venous Function and Clinical Outcome Following Deep Vein Thrombosis |
| |
- |
Risk Factor Assessment in the Management of Patients with Suspected Deep Venous Thrombosis |
| Swillo RE |
- |
Prevention of Canine Coronary Artery Thrombosis by the von Willebrand Factor Antagonist, GPG290 |
| Sylvén C |
- |
Therapeutic Endogenous Ligand/Receptor Induction of the VEGF-Angiopoietin System after Intramyocardial Gene Transfer during Myocardial Ischemia |
| Syrjälä M |
- |
Different Monitoring Methods for in Vitro and in Vivo Lepirudin, a Direct Thrombin Inhibitor: Diluted Thrombin Time (dTT), Activated Partial Thromboplastin Time (aPTT) and Ecarin Clotting Time (ECT) |
| Syrovets T |
- |
The Annexin II Heterotetramer is a Receptor for the Plasmin-Induced Signaling in Human Peripheral Monocytes |
| Syvänen A-C |
- |
The Impact of Tissue Factor Single Nucleotide Polymorphisms on Risk, Outcome and Plasma levels in Acute Coronary Syndrome |
| Szabó G |
- |
Protective Effects of GYKI-66476 and GYKI-66430 in Experimental Models of Disseminated Intravascular Coagulation (DIC) |
| Szabó T |
- |
Modeling VWF Catabolism Predicts the Multimer Pattern and Subunit Degradation in VWD Vicenza, Type 1, Type 2A, and Healthy Controls after DDAVP Infusion |
| |
- |
Three Novel Missense Mutations and Their Functional Consequences in Two Severe Inherited Factor X Deficiencies |
| Szabo K |
- |
Reduced Expression of ABCA1 and A Novel Missense Mutation That Results in Altered Protein Trafficking Underlie Scott Syndrome |
| Szadkowski C |
- |
Preoperative Fibrin Monomer in Elective Surgery Predicts Intraoperative Blood Loss and Hospitalization Time: Results from a Confirmatory Study |
| Szántó T |
- |
Comparison of Platelet Deposition on Collagen in Cone-And-Plate and Parallel Plate Flow Chambers |
| Szarvas M |
- |
Comparison of Platelet Deposition on Collagen in Cone-And-Plate and Parallel Plate Flow Chambers |
| |
- |
Time Dependent Increase in Thrombus Size Formed under Flow Conditions upon Exposure to Collagen Correlates Inversely with Surface Expressed VWF |
| Szczech L |
- |
A Multi-Dose Pharmacokinetic Study of Dalteparin in Hemodialysis Patients |
| Szczeklik A |
- |
Simvastatin Given for 3 Days Can Inhibit Thrombin Generation and Activation of Factor V, and Enhance Factor Va Inactivation in Hypercholesterolemic Patients |
| Szczeklik M |
- |
Prediction of the Excessive Perioperative Bleeding in Patients Undergoing Coronary Artery Bypass Grafting: Role of Aspirin and Platelet Glycoprotein IIIa Polymorphism |
| Szczeklik W |
- |
Prediction of the Excessive Perioperative Bleeding in Patients Undergoing Coronary Artery Bypass Grafting: Role of Aspirin and Platelet Glycoprotein IIIa Polymorphism |
| Szczeklik A |
- |
Prediction of the Excessive Perioperative Bleeding in Patients Undergoing Coronary Artery Bypass Grafting: Role of Aspirin and Platelet Glycoprotein IIIa Polymorphism |
| Szczeklik A |
- |
The Angiotensin-Converting Enzyme Gene Insertion/Deletion Polymorphism and Effects of Quinapril and Atorvastatin on Haemostatic Parameters in Patients With Coronary Artery Disease |
| |
- |
Anticoagulant Effects of Statins and Angiotensin-Converting Enzyme Inhibitors in Stable Patients with Coronary Artery Disease: Results of a Randomized Double Blind Study |
| |
- |
Thrombin Generation after Therapy with Lipid-Lowering Drugs in High Cardiovascular Risk Subjects Supplemented with Folic Acid |
| |
- |
Drug Induced Changes in Fibrin Clot Permeability in Patients with Coronary Artery Disease |
| |
- |
Anti-thrombotic Action of Clopidogrel is More Pronounced in Patients with Coronary Artery Disease Carrying PlA2 Allele of Beta3 Integrin |
| |
- |
Complementary Antithrombotic Effects of Aspirin and Clopidogrel Based on PlA1/A2 Glycoprotein IIIa Polymorphism |
| |
- |
Aspirin Resistance |
| |
- |
Venous Thromboembolism, Arterial Thrombosis and Plasma Homocysteine Levels in Families with Inherited Thrombophilia |
| |
- |
Rapid Antithrombotic and Anti-platelet Effects of Simvastatin and Micronized Fenofibrate in Patients with Hypercholesterolemia |
| Szczepanik AB |
- |
Pros and Cons of Rituximab Administration Use in Patient with Immune Thrombocytopenia and Antiphospholipid Antibodies |
| |
- |
Lack of Occult HBV Infection in Polish Haemophilia Patients |
| Szczesiul J |
- |
An Evaluation of Unfractionated Heparin Use to Assess the Magnitude of Risk For Heparin Induced Thrombocytopenia |
| Szemraj J |
- |
Activation of NF-kB by Reactive Oxygen Species Mediates Induction of PAI-1 Expression in Vascular Endothelial Cells |
| Szentandrassy J |
- |
Clotting Factor Prophylaxis in Boys with Haemophilia; Experience from a Single Australian Centre |
| Szmagala P |
- |
Prediction of the Excessive Perioperative Bleeding in Patients Undergoing Coronary Artery Bypass Grafting: Role of Aspirin and Platelet Glycoprotein IIIa Polymorphism |
| Szpotanska M |
- |
Biochemical Predictors of One-Year Total Mortality in Unselected Acute Coronary Syndromes Patients Treated according to Contemporary Guidelines |
| |
- |
Thienopyridines Pretreatment Decreases Long-Term Total Mortality in Unselected Acute Coronary Syndromes Patients Treated according to Contemporary Guidelines |
| Szymanski J |
- |
Functional Analyses of the Reconstituted AlphaIIbbeta3 and AlphaVbeta3 Minireceptors |
| |
- |
Binding Sites for PAI-1 Are Exposed in Fibrin But Not in Fibrinogen |